Synthesis and Reactions of Novel Oxindoles by Edeson, Steven
Synthesis and Reactions of 
Novel Oxindoles 
 
 
 
A thesis submitted to the University of Sheffield in partial fulfilment 
of the requirements for the award of Doctor of Philosophy 
 
Steven J. Edeson 
Department of Chemistry 
The University of Sheffield 
 
October 2015
i 
 
Abstract 
 
An important issue with the assignment of E/Z alkene geometry of 3-acylidene-
oxindoles was addressed. A novel UV/Visible spectroscopic assay was developed in 
order to achieve this, taking advantage of contrasting electronic properties for 
different E/Z isomer sets.  Moreover, a novel acylidene oxindole was prepared and 
used to provide further supporting evidence for this spectroscopic assay. Finally, the 
stability of related E/Z isomers was investigated, and indicated facile isomerisation 
to a thermodynamic minimum. 
A copper promoted cyclisation of o-nitrophenyl iodoacetylenes to 2-iodoisatogens 
was discovered. These compounds were applicable as precursors to novel isatins 
and consequently 3-acylidene oxindoles. 
The metal free aryl and alkyl cross coupling reactions of 2-iodoisatogens was 
developed, providing a divergent synthetic strategy to the medicinally relevant 
isatogen molecular group. Furthermore, an unprecedented isatogen mode of 
reactivity was discovered affording pseudoindoxyls, a privileged class of molecule. 
The mechanism for this transformation was proposed, based on control reactions 
and strong literature precedent. 
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“You can take the boy out of Wakefield but not the Wakefield out of the 
boy” 
- J. P. A. Harrity (multiple occasions) 
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Chapter I 
1.1 – Biological and Synthetic Applications of 3-Acylidene Oxindoles 
 
3-Acylidene-oxindoles are attractive compounds for the discovery of new 
medicines, and there are a vast number of such compounds that exhibit useful 
biological activity.1 Arguably, the most prominent example of a bioactive, 
structurally analogous, 3-alkenyl-oxindole is Sunitinib, the structure of which is 
shown in figure 1. Sunitinib was developed by Pfizer and Sutent), and is a tyrosine 
kinase inhibitor which was approved in 2006 for the treatment of renal cell 
carcinoma and gastrointestinal stromal tumours.2,1  
 
Figure 1. 
Another prominent example is Nintedanib, a potent kinase inhibitor, figure 2. It has 
been screened in several drug assays and has shown remarkably similar efficacy to 
Sunitinib.3 Moreover it has very recently been approved in the European Union for 
the treatment of idiopathic pulmonary fibrosis.4 
 
Figure 2. 
Other recent reports of biologically active acylidene oxindoles include a series of 
examples by Woodard and co-workers. This group identified compounds such as 1 
(Figure 3) that would selectivity inhibit cyclin dependent protein kinases. 
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Interestingly, the authors indicated that all compounds were of a Z-configuration, 
however they did not report how this stereochemical assignment was made.5 
 
Figure 3. 
Khosla and co-workers reported that acylidene oxindoles can act as reversible 
inhibitors of the human transglutaminase-2 enzyme. Such compounds are proposed 
to be useful for the treatment of several diseases such as: cancers, central nervous 
system disorders and celiac sprue. The authors screened several compounds in TG2 
assays and highlighted compound 2 (Figure 4) as being particularly active. 
 
Figure 4. 
An additional example of kinase inhibitors based on this family of heterocycles was 
described by Aldous and co-workers.6 Furthermore, other reported biological 
activities include: phosphatase inhibition,7 antifungal properties8, and TRPA1 ion 
channel activation.9 Moreover, naturally occuring 3-acyldiene oxindoles have been 
reported; costinone A (Figure 5) was isolated from herb Isatis costata and was 
found to demonstrate inhibition of butylcholinesterase and lipoxygenase 
enzymes.10 
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Figure 5. 
A major synthetic application of 3-alkylidene oxindoles is in their use as precursors 
to spirocyclic oxindoles.11 This has been highlighted very nicely by recent 
developments in the Trost group. The authors reported a catalytic [3+2] 
cycloaddition of 3-alkenyl-oxindoles with the trimethylenemethane (TMM) 
precursor 3. The Pd-catalysed reaction could be rendered asymmetric when 
conducted in the presence of a chiral ligand, scheme 1. In this example, the trans 
product was isolated as the major isomer in excellent enantiopurity. Furthermore, 
the minor cis product was also enantioenriched with an ee of 96%. A further 5 
examples were reported, all with excellent yields (90% - 99%) and excellent ee’s 
(92% - 99%) for the major trans isomers, scheme 1. 
 
Scheme 1. 
Additionally, varying the naphthyl-pyrrolidine connectivity of the ligand resulted in a 
complete reverse of diastereoselectivity with the cis product now being afforded as 
the major isomer. However, the excellent enantioselectivty of the reaction was 
retained, affording the products in excellent yield and selectivities of up to 92% ee. 
Overall however, a slight reduction of enantioselectivty was observed with reported 
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ee’s of between 77% - 92% for the cis isomer, scheme 2. Therefore, this 
methodology has the opportunity to access both trans- and cis-isomers with high 
ee, depending on the choice of ligand.11f 
 
 
Scheme 2. 
Trost et al. also applied this chemistry in the total synthesis of the natural product 
marcfortine B.12 The TMM precursor 4 and oxindole 5 were reacted together in the 
presence of catalytic palladium acetate and triisopropylphoshite to afford the key 
spirocyclic intermediate 6 as a racemic and diastereomeric mixture (1:1), which was 
converted to a single diastereoisomer at a later stage. No yield for this step was 
quoted as the authors carried forward the crude material. A further 16 steps were 
then performed to access the natural product, scheme 3.  
 
Scheme 3. 
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1.2 - Synthetic Strategies Towards 3-Alkenyl-Oxindoles: Preparation from Isatin 
Derivatives 
The first reported acylidene oxindole synthesis was by Braude and Lindwall in the 
early 1930’s via an aldol condensation reaction of acetone and isatin, in a single 
isolated example. The reaction proceeded via the addition of the enamine derived 
from acetone and diethylamine to isatin affording the -hydroxy ketone in a good 
yield of 75%. Dehydration of the -hydroxy ketone was carried out in a second step 
by heating at reflux in concentrated acid to give the desired acylidene oxindole 7 in 
a 42% yield and as a single isomer, representing an overall yield of 32%, scheme 4.13 
 
Scheme 4. 
3-Acylidene oxinoles were synthesised by Khosla et al. for biological screening, by 
employment of Braude and Lindwall’s original conditions.13 In doing so, they 
significantly expanded the scope of this reaction both with regards to the 
acetophenone, and the isatin derivatives, demonstrating its broad generality. 
However, with the main focus of this publication being the screening of compounds 
against two different kinase assays, only small quantities of acylidene oxindoles 
were prepared and as such no isolated yields were quoted. In addition, the authors 
also reported that the alkene geometry of all their synthesised compounds was E, 
selected examples are shown in figure 6.14  
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Figure 6. 
 
During this study, the authors highlighted an interesting method for the 
dehydration of the -hydroxy ketone intermediate. Specifically, methanesulfonyl 
chloride dissolved in pyridine was used to form the mesylate of the alcohol, 
resulting in a more facile dehydration step. This protocol avoided the use of 
concentrated acids and as such improved compatibility towards substrates bearing 
basic groups such as pyridyl, scheme 5. However, this approach was limited to isatin 
substrates bearing a substituent at the nitrogen atom.14  
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Scheme 5. 
With regard to alkene stereochemistry Khosla et al.  assigned all compounds as E 
based on the relative olefinic 1H NMR chemical shifts.14 Their justification for this 
came from an interesting report by Righetti et al. who reported that the olefinic 
protons of matching acylidene E/Z isomers would resonate at diagnostically 
different chemical shifts in the 1H NMR spectrum. The authors stated that Z olefinic 
protons resonated at lower field strengths relative to their corresponding E isomers, 
scheme 6.15 
 
Scheme 6. 
The basis of these NMR studies arose from their development of a method for the 
isomerisation of E-acylidene oxindoles to the corresponding Z-isomers. In this 
protocol, the E-isomer was treated with one equivalent of aluminium trichloride.15  
The Z-acylidene oxindoles were isolated after quenching with sodium hydrogen 
carbonate. An interesting observation is that exposure of the E-isomer to one 
equivalent of the Lewis acid resulted in the formation of a dark solid that proved to 
be the Z-product. In contrast, the use of two equivalents of AlCl3 provided an 
orange solid that proved to be recovered E-isomer. They proposed a mechanism to 
explain these results. Specifically, both carbonyls are able to coordinate to one 
equivalent of aluminium trichloride. However, if two equivalents of Lewis acid are 
utilised then each carbonyl coordinates to one equivalent of Lewis acid thereby 
promoting formation of the more thermodynamically favoured product, scheme 
7.15  
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Scheme 7.15 
Another account of this type isomerisation, with structurally analogous 3-alkenyl-
oxindoles, was reported by recently by Takemoto and co-workers during their 
development of a rhodium promoted cyclisation of N-formyl anilides. Over the 
course of their investigations they observed that alkynes bearing aliphatic groups 
such as n-C4H9 and n-C10H21 underwent efficient cyclisation. The desired compounds 
were afforded in respective yields of 85% and 73%, and with very good 
stereoselectivies of (7.4 : 1.0) and (12.5 : 1.0) in favour of the E-isomer. However, 
when R1 was aromatic then more variation in yield and stereoselectivity was 
observed, scheme 8. 
 
Scheme 8. 
Takemoto et al. attributed this variation to the changes in reaction times and 
temperatures used in these reactions. Indeed, they observed isomerisation of a 
pure E isomer when subjecting this compound to the reaction conditions. 
Specifically, a pure sample of the E-compound, where R1 = nBu, was converted to a 
mixture of E and Z (19.4 : 1.0) after heating in toluene for six hours, scheme 9.16 
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Scheme 9. 
Avendaño has also reported the preparation of acylidene oxindole via aldol 
reactions. This study was restricted to utilising N-methyl isatin that allowed them to 
perform the reaction under more classical conditions i.e. using an inorganic base 
such as potassium hydroxide, as opposed to catalytic amounts of secondary amine. 
Nonetheless, they also showed that piperidine was viable as a catalytic base, in 
contrast to previously reported conditions where diethylamine was favoured.17 The 
focus of this particular study was to condense N-methyl isatins with substituted 
acetophenones. Indeed, they were the first to report formation of the Z-acylidene 
oxindole via an elimination reaction. Specifically, treatment of 8 with hydrochloric 
acid in ethanol at room temperature gave the expected E-acylidene oxindole in an 
excellent 96% yield. Interestingly however, when dehydration occurred through 
employment of concentrated sulphuric acid at 0 oC the Z-acylidene oxindole was 
obtained in quantitative yield, scheme 10.18 
 
Scheme 10. 
 
The use of microwave irradiation to promote acylidene oxindole synthesis via an 
aldol reaction has been reported recently. In this case, the acylidene oxindoles were 
synthesised as intermediates en route to novel bioactive spiroindole derivatives. 
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Nonetheless, the results reported by Pawar et al. are promising.19 In their method, 
isatin and the ketone were adsorbed onto basic alumina and irradiated with 
microwaves for 5-6 minutes at 128 oC. The authors claim that 100% conversion is 
achieved with the products returned in reasonable purity, as judged by TLC analysis. 
However, they did not go on to characterise their intermediates so no comment on 
product stereochemistry can be made. The authors also performed the aldol 
condensation reaction using the classical method reported by Braude and Lindwall13 
and compared the yields and reaction times against their microwave assisted 
method, table 1. 
 
Entry Aryl Reaction Time / min Yield / % 
  
Classical Microwave Classical Microwave 
1 6-F(C6H4) 300 5 72 98 
2 6-CH3(C6H4) 300 4 68 98 
3 6-OMe (C6H4) 260 4 60 98 
Table 1. 
As is evident from table 1, the microwave assisted aldol condensation reaction 
shows potential as the reaction time is significantly reduced and the yield is also 
near quantitative. In addition, microwave promoted reactions are becoming more 
popular in organic synthesis for reasons of reduced reaction time, and improved 
efficiency.20 
Another method for the synthesis of acylidene oxindoles can be achieved via 
olefination reactions of isatin such as the Wittig reaction. A large number of such 
compounds were synthesised by Shi et al. utilising stabilised phosphoranes shown 
in scheme 11.21.  
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Scheme 11. 
The Wittig reactions of phosphoranes listed in scheme 11 were performed on a 
variety of isatin derivatives bearing substituents on the nitrogen atom such as: 
hydrogen, benzyl, methyl, allyl, and tert-butoxy carbonyl. Additionally, the 
chemistry was compatible with isatins bearing functionality such as fluoride, 
chloride, bromide, methyl and trifluoromethyl groups. The yields for these Wittig 
reactions were reported to be generally good to excellent.21 Moreover, the 
compounds were all reported to exhibit E-stereochemistry. Notably, the same E 
stereochemistry was reported when these compounds were synthesised via aldol 
chemistry.14  
Wittig reactions were also performed by Barbas III and co-workers, conditions for 
which are outlined in scheme 12.11e In this particular case, no attention was paid to 
the alkene geometry or the yield as the crude acylidene oxindoles products were 
directly subjected to alkene hydrogenation. However from the reported isolated 
yields of their hydrogenated products, it is clear to see that the Wittig reactions 
were very efficient. The substrate scope generally consisted of Boc and Cbz 
protected isatins bearing a range of substituents, the only phosphoranes employed 
however were those bearing a methyl or ethyl ketone.11e  
 
Scheme 12. 
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As such, the Wittig reaction would seem to be an excellent method for the synthesis 
of acylidene oxindoles. Especially for compounds such as 9, figure 6, as this would 
be more challenging to synthesise via aldol chemistry due to the availability of two 
sets of enolisable protons in the required ketone substrate. Both sets of examples 
above utilise very mild conditions and suggest that these reactions could be 
performed on a multi-gram scale.  However, this method does have associated 
limitations such as the formation of E-isomers only, the fact that only simple 
phosphoranes are employed and the formation of phosphine oxide by-product. 
In summary it has been shown that a number of conventional chemical techniques 
can be used to generate 3-acyldidene oxindoles such as aldol reactions and Wittig 
reactions.11e, 13-15, 17-19, 21-22 These reactions can be performed very efficiently and in 
excellent yields. Furthermore, the predominant stereochemistry observed for these 
compounds is E with only a few examples of Z compounds reported.15, 17 However, 
all of these methodologies require isatin starting materials, greatly limiting the 
substrate scope to readily available isatin substrates. 
 
1.3 - Synthetic Strategies Towards 3-Alkenyl-Oxindoles: Synthesis of the Oxindole 
Core 
More recently, increasing interest in synthetic routes to 3-acylidene-oxindoles has 
led to the development of a variety of different one-pot approaches.23  The majority 
of these synthetic methodologies proceed via cyclisation reactions, scheme 13. The 
main benefit of this is that it provides the possibility of a greater substrate 
diversification, i.e. not limited to the starting material isatin and/or commercially 
available isatin analogues. Furthermore the majority of these reactions can also be 
performed catalytically.  
 
Scheme 13. 
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In this context there are a several reports of metal catalysed cyclisations in order to 
generate structurally analogous 3-alkenyl oxindoles, which have then been further 
expanded to cover the functionally specific 3-acylidene oxindoles.2 An early 
example of this type of reaction was reported by Takashi et al. Specifically, 3-alkenyl 
oxindoles were prepared via rhodium catalysed carbonylative annulation of alkynyl-
arylamines, scheme 14. The reaction proceeded very efficiently and required rather 
low catalyst loadings.24 
 
Scheme 14. 
This reaction was found to proceed stereoselectively to provide the E-isomer. 
However the formation of additional side products was also reported. Initially, 
reactions were performed at higher reaction temperatures and with the addition of 
water and triethylamine. However, these conditions were found to favour the 
formation of the hydrogenated product. For example, at 175 oC the major product 
was 3-benzyl-1,3-dihydroindol-2-one 10 and this was isolated in a 83% yield. In 
addition, a small amount of the isomeric product 3-phenyl-2- quinolone 11 was also 
observed. Unfortunately, the authors did not comment on why these additives 
result in in situ hydrogenation, scheme 15. Consequently, Takashi proposed that the 
reaction proceeds via two steps. The first being carbonylation of the aniline 
followed by cyclisation onto the alkyne to give the 3-alkenyl oxindole.24 
 
Scheme 15. 
The scope of this chemistry was further expanded by Chung and co-workers.25 
However, the preferred solvent and catalyst were altered. They preferred the 
anhydrous solvent THF and a heterobimetallic cobalt/rhodium nanoparticulate 
catalyst, albeit with a higher catalyst loading of 3 mol%. Interestingly under these 
Page | 14  
 
slightly modified conditions, no hydrogenation of the alkene functionality was 
observed, scheme 16.25 
 
Scheme 16. 
The methodology offered a broad substrate scope, and the reaction was found to 
proceed well when R1 was 4’-chloro or 4’-tbutyl. Secondary and primary anilines 
were also shown to to be effective. The reaction did not discriminate between 
internal alkynes bearing aromatic and aliphatic groups, with both types of substrate 
performing well. However, it was shown that  terminal alkynes did not give the 
desired product and instead underwent decomposition.25 
Regarding our specific interest in this compound class, the majority of 
methodologies do not accommodate the desired functionality, i.e. acylidene motif 
in the 3’ position. This limitation was addressed by Gabriele et al. when they 
reported the cyclocarbonylation of 2-ethynyl anilines via the use of a palladium 
catalyst under an atmosphere of carbon monoxide with methanol as the solvent, 
scheme 17.26 
 
Scheme 17. 
Reactions were performed between 50 - 70 oC with 2 - 5% PdI2 and 5 - 10 mol% KI 
under 20 atmospheres pressure of CO : air (4 : 1). The reported yields were 
moderately good, between 48-64%. The reaction was shown to be compatible with 
free aniline to give the N-H acylidene oxindole and was also effective when R1 was 
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butyl or benzyl, thereby affording N-substituted analogues. The nature of R2 and R3 
was not extensively studied, with methyl and chloride used in some cases. The 
authors noted that the reaction did not work when R2 / R3 were substituents 
possessing strong electron acceptor behaviour e.g. nitrile or ester groups. With 
regard to product stereochemistry, once again the E-isomer was favoured, as 
determined through X-ray crystallography. It was also reported that the reaction did 
not proceed with internal alkynes.26 Based on some of their earlier results, Gabriele 
and co-workers proposed the reaction mechanism highlighted below, scheme 18.27  
 
Scheme 18. 
Initially, both the aniline motif and carbon monoxide coordinate to palladium 
forming what is referred to as a carbamoylpalladium intermediate I. Insertion of the 
triple bond into the carbamoylpalladium complex would result in II which 
rearranges to form the more stable isomer. Termination of the catalytic cycle via 
subsequent CO insertion and addition of methanol gives the desired product, the 
palladium catalyst is then re-oxidised in the presence of air. This proposed 
mechanism helps explain why internal alkynes do not react; a triple bond bearing a 
substituent is less likely to insert into the carbamoylpalladium bond.27 In addition 
this mechanism is consistent with the observation by Takahasi whereby 
carbonylation occurs first followed by cyclisation.24 
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An alternative approach to in situ carbonylation is to install a carboxy function on 
the aniline prior to cyclisation. Consequently, 2-ethynylanilines have been replaced 
by alternative alkyne substrates that bear N-carboxyl alkynyl groups, such as 
iodoaryl-propionamides. The very first example of this type of cyclisation was 
reported several decades earlier by Heaney and Jordan in 1988. In this case, the 
iodoaryl alkynylamides were cyclised to the form the 3-alkenyl oxindoles via a 
radical reaction utilising tributyltin hydride and the radical initiator 2,2′-azobis(2-
methylpropionitrile)  (AIBN), scheme 19.28 
 
Scheme 19. 
Unfortunately, this reaction generally proceeded in a low yield and gave a mixture 
of stereoisomers with the Z-alkene predominating. Another disadvantage of this 
approach is in the use of tin as a reagent. The use of these reagents is discouraged 
due to their toxicity and difficulty in removal of organotin by-products. 
Subsequently, Brunton and Jones improved this chemistry by expanding the 
reaction scope and suggested that the Z-isomer is predominant due to the stability 
of the vinyl radical intermediate. They proposed that the E-isomer is less stable due 
to an unfavourable steric interaction between the phenyl group and the aromatic 
proton in the C-4 position. As vinyl radicals are known to be configurationally 
unstable, E and Z isomers are thought to be in equilibrium with one another with a 
greater population of Z-isomer thus leading to the observed ratio in the fully 
cyclised product, see figure 7.29 
 
Figure 7. 
Page | 17  
 
More recently, these types of cyclisations have been improved upon by removing 
the requirement for stoichiometric quantities of tin and focussing on the transition 
metal catalysed variants. One of the earliest examples of such a strategy was 
reported by Müller in 2005. The palladium catalysed Heck cyclisation of the tosyl 
protected iodoaryl alkynylamide 12 followed by the subsequent in situ Sonogashira 
coupling with the alkyne 13 afforded compound 14 as a single isomer in near 
quantitative yield, scheme 20.30 
 
Scheme 20. 
This chemistry is not exclusive to tandem Heck/Sonogashira couplings. Takemoto 
and co-workers have reported tandem Heck/Suzuki-Miyaura reactions. In this 
protocol, palladium intermediate 15 is generated and as no -hydrides are available 
for elimination, this can undergo a cross coupling reaction with the boronic acid in 
situ generating the 3-alkenyl oxindole, scheme 21. Caesium fluoride was found to 
be the optimal base giving excellent yield and exclusively the E product, whereas 
sodium hydroxide gave a yield  of 88 % E and 4 % Z. Variation of the boronic acid 
employed yielded a small substrate scope; very good yields and exclusive E 
selectivity were reported for electron rich (p-MeO-C6H4), electron poor (p-CF3-C6H4) 
substrates, scheme 21.31 
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Scheme 21. 
Considering the specific interests of this thesis, i.e. the preparation of 3-acylidene 
oxindoles we were particularly intrigued by the report of a three step 
Heck/carbonylation/Suzuki-Miyaura domino procedure. The transformation is 
similar to the cross-coupling method highlighted earlier, but incorporates a carbon 
monoxide atmosphere. This procedure gave access to the 3-acylidene oxindole 16 in 
a very good yield of 70% with excellent stereoselectivity, and only the E isomer was 
observed, scheme 22.31 
 
Scheme 22. 
In conclusion a diverse range of synthetic strategies to access the biologically 
relevant 3-acylidene-oxindoles have been developed. In particular, recent 
developments in transition metal catalysed cyclisation reactions have the potential 
to afford the desired 3-acylidene-oxindoles efficiently and from easily available 
starting materials. 
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Aims 
3-Acylidene-oxindoles are an attractive template for the discovery of new 
medicines, and there are several compounds containing this and related moieties 
that exhibit useful biological activity.  However, an important challenge associated 
with the characterisation of these compounds is the assignment of alkene 
stereochemistry around the acylidene moiety. In many cases, this assignment is 
ambiguous and there are few reports that offer any general guidance as to how 
stereochemistry can be assigned in a routine way. We therefore set out to address 
this issue by establishing a routine and consistent method for the assignment of 
alkene stereochemistry in this class of compounds. Furthermore, we hoped to 
investigate the divergent synthesis of such compounds, potentially employing 
catalytic conditions.  
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1.4 – Proposed Acylidene Oxindole Synthesis via Metal Catalysed Cyclisation 
Our interest in the stereochemical assignment of acylidene oxindoles resulted from 
two recent reports of bioactive compound analogues. Khosla et al. and Woodard et 
al. demonstrated the potential use of  compound 1 and 2 as kinase and 
transglutaminase inhibitors.5,14 However, they have assigned these compounds as E 
and Z isomers respectively, which we believe could be erroneous as one would 
suspect compound 1 to be exhibit E stereochemistry in order to minimise an 
unfavourable electrostatic interaction between the two carbonyl groups. In 
addition, we considered that 2 may in fact be Z, as to minimise a steric interaction 
between the 4-chloro substituent and the aryl ketone, despite the unfavourable 
electrostatic interaction that could arise between the two carbonyl functionalities, 
figure 8. Consequently, we aimed to synthesise a series of representative 3-
acylidene-oxindoles, and perform investigations into their stereochemical stability 
and classification. 
 
Figure 8. 
Initially we attempted to develop a divergent synthesis of 3-acylidene oxindoles via 
an intramolecular cyclisation similar to that previously reported by Larock and 
Babu.32 In their example, N-acyl-2-haloaniline 17 was converted to 3-alkylidene 
oxindole 18 via the use of a palladium catalyst. Our intention was to utilise this 
chemistry but expand the scope in order to access 3-acylidene oxindoles, i.e. by 
employing amides such as 19. Moreover, this strategy would avoid the use of toxic 
carbon monoxide and would require only simple starting materials, scheme 23. 
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Scheme 23. 
To confirm the validity of the route and provide a proof of concept we initially 
focussed on repeating and optimising the previously reported cyclisation of amide 
17 to oxindole 18.32 As the aryl bromide was significantly cheaper we began our 
studies on amide 20, which was prepared from 2-bromo aniline and cinnamoyl 
chloride in a good yield of 66% utilising the conditions reported by Buchwald et al. 
scheme 24.33  
 
Scheme 24. 
Disappointingly however, when 20 was subjected to the Larock and Babu’s 
cyclisation conditions no desired product was isolated, and we recovered only 
starting material instead, scheme 25.32 From this we concluded that no oxidative 
addition of the palladium catalyst to the aryl bromide had occurred.  
 
Scheme 25. 
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We were intrigued by an analogous Heck cyclisation reported by Grigg and co-
workers whereby the isoindolinone 21 was prepared in a moderately good yield of 
54% via employment of the catalyst system shown in scheme 26.34 
 
Scheme 26. 
Utilising these conditions on our substrate afforded the desired product 18 as solely 
the E stereoisomer in a low yield of 13%, scheme 27. The product stereochemistry 
was assigned in this case through comparison of spectroscopic literature data.26 
Disappointingly however, our attempts to perform this reaction on a preparatively 
useful scale resulted in decomposition and no isolation of the target material. Slight 
variations of the reaction conditions were performed, such as varying the palladium 
catalyst and solvent, however yields remained low with predominantly starting 
material observed in most cases.  
 
Scheme 27.  
Inspection of the proposed mechanism highlighted that, for the coupling to occur, 
the intermediate must adopt a conformation that places the aryl group in close 
proximity to the alkene. However, this presents an unfavourable steric interaction 
that favours the unreactive rotamer. If this effect was responsible for low 
conversion rates then attaching a large group such as Boc onto nitrogen should then 
increase the population of the reactive rotamer, figure 9. 
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Figure 9. 
Pleasingly, Boc protection of 20 was achieved in a near quantitative yield using di-
tert-butyl dicarbonate and the nucleophilic catalyst dimethylaminopyridine, scheme 
28. 
 
Scheme 28. 
With substrate 22 in hand, the cyclisation was attempted using the optimal reaction 
conditions observed in the cyclisation of 20. Regrettably however, no product was 
isolated and the reaction simply resulted in decomposition of starting material, 
scheme 29. 
 
Scheme 29. 
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Several analogues of compounds 20 and 22 were prepared but the cyclisation yields 
were poor in all cases. As such, we decided that this intermolecular cyclisation 
approach was not a viable route to access the target 3-acylidene-oxindoles and 
decided to consider alternative synthetic approaches. 
 
1.5 – Proposed Acylidene Oxindole Synthesis via a Late-Stage Intermediate 
An alternative and attractive option was to generate an acylidene oxindole that 
could be derivatised to incorporate a range of new acylidene moieties as the final 
step. As previously discussed, it is possible to prepare acylidene oxindoles via Wittig 
reactions or aldol condensation reactions.21,13 Therefore, our strategy was to 
prepare a Weinreb amide such as 23 which would then allow the addition of 
nucleophiles in order to access a range of different 3-acylidene oxindoles, see 
scheme 30.  
 
Scheme 30. 
The ester 24 was easily prepared from the cheap and readily available reagents 
isatin and (carbethoxymethylene)triphenylphosphorane, in an excellent yield of 
99% using the procedure reported by Shi et al.21 Ester 24 was isolated as a single 
isomer which was unambiguously assigned as E via X-ray crystallography, figure 10.  
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Figure 10. 
Attempting to prepare Weinreb amide 23 from N,O-dimethylhydroxylamine 
hydrochloride (Weinreb’s amine hydrochloride) and trimethylaluminium was 
unsuccessful,35 resulting in a complex mixture which we believe resulted from the 
uncontrolled addition of the amine at the various different electrophilic sites, 
scheme 31. 
 
Scheme 31. 
Gratifyingly however, we were able to prepare the desired Weinreb amide in 
excellent yield and stereoselectivity via the reaction of isatin with a phosphorane 
that already bears the Weinreb amide, scheme 32. Weinreb amide 23 was isolated 
as a single isomer which was assumed to be E based on the known stereoselectivity 
of the previous ester synthesis, figure 10. 
 
Scheme 32. 
With the desired substrate in hand, we next explored the potential for nucleophilic 
substitution reactions. Phenyl magnesium bromide and methyl magnesium bromide 
were initially added at -78 oC, however no reaction was observed in either case. 
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Attempting the reactions at an elevated temperature of -20 oC generated complex 
mixtures in both cases, table 2. 
 
Entry Organometallic Temperature Result 
1 PhMgBr -78 oC No Reaction 
2 PhMgBr -20 oC Complex Mixture 
3 MeMgBr -78 oC No Reaction 
4 MeMgBr -20 oC Complex Mixture 
Table 2. 
We thought it prudent to also explore nucleophilic addition reactions to protected 
Weinreb amides. This substrate was again prepared via the Wittig reaction of the 
phosphorane 25 with the N-Boc isatin.  Unfortunately however, attempted 
reactions with either: PhMgBr, MeMgBr, or MeLi predominantly resulted in 
decomposition, with complex mixtures observed in the majority of cases.  
Once again, we suspect that these reactions suffer from the addition of the 
nucleophilic reagent at various electrophilic sites on these substrates. We therefore 
abandoned this strategy and decided to change tack. Nonetheless, these attempted 
synthetic strategies provided a small series of useful 3-acyldiene-oxindoles that 
could be employed in stereochemical investigations (see later), scheme 33.  
 
Scheme 33. 
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1.6 - 3-Acylidene Oxindoles – Preparation and Stereochemical Studies 
With limited success in preparing the key acylidene oxindoles using cyclisation and 
Wittig routes, the focus was changed to preparing substrates via an aldol 
condensation reaction of isatin with different aryl methyl ketones, scheme 34. 
 
Scheme 34. 
This was considered to be the simplest method of generating a series of compounds 
that could be used to investigate the E / Z isomeric classification and stereochemical 
stability of acylidene oxindoles. Furthermore, some compounds could have 
biological interest and as such were to be submitted for external multi assay 
screening. 
We opted to employ the conditions first reported by Braude and Lindwall in order 
to generate a series of 3-acylidene oxindoles.13 During our preliminary attempts to 
condense isatin and a selection of aryl methyl ketones, we were disappointed to 
find that only compound 28 was produced reliably when Braude and Lindwall’s 
conditions were used, figure 11. Other substrates generated the corresponding 
products in lower yields.  
 
Figure 11. 
We identified the aldol addition reaction as the problematic step of the process, 
affording the -hydroxy ketones in low yields. In contrast to this, the dehydration 
step generally worked well. We therefore carried out a brief solvent screen in order 
to optimise the aldol addition reaction. Gratifyingly, after a brief solvent screen, 
methanol was found to be very effective, table 3. 
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Entry Alcohol Solvent Conversion / % 
1 2-Propanol 44 
2 Ethanol 53 
3 Methanol 83 
Table 3. 
Consequently, the conditions outlined by Braude and Lindwall were modified for 
our aldol addition step with methanol being employed as the preferred solvent. 
Utilising these conditions we were able to prepare a small series of -hydroxy 
ketones from isatin and a range of aryl methyl ketones, scheme 35.  
 
Scheme 35. 
Incidentally, our attempts to employ these conditions in the preparation of the       
p-OMe(C6H4) analogue 32 were found to be ineffective, resulting in less than 10 % 
conversion. However, increasing the loading of the diethylamine catalyst to 
stoichiometric quantities successfully addressed this issue affording -hydroxy 
ketone 32 in a very good 72% yield, scheme 36. The lower reactivity was attributed 
to reduced concentrations of reactive enamine because of the lower electrophilicity 
of 4-methoxyacetophenone.  
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Scheme 36. 
These -hydroxy ketones were then subjected to elimination using a slight 
modification of Braude and Lindwall’s conditions affording 3-acyldiene oxindoles 28, 
33 and 34 in good to excellent yields.13 The slight modification employed here was 
to perform these reactions in EtOH, as incomplete solvation was observed in some 
cases when HCl and AcOH were used. However, substrate 35 bearing the pyridyl 
group was prepared in a slightly lower yield of 48%. This could have resulted from 
protonation of the basic pyridine which is then lost as a salt during the aqueous 
work up. Nonetheless, we were delighted to have optimised a synthetic route to 
our desired compounds in acceptable yield over two steps. Additionally, it is noted 
that all the 3-acyldiene oxindoles prepared were isolated as a single stereoisomer 
(>98:2), as judged by 400 MHz 1H NMR spectroscopy, scheme 37. 
 
Scheme 37. 
Page | 30  
 
The reaction of p-methoxy acetophenone raised another interesting and 
unexpected observation. During the dehydration process, a small amount, <10%, of 
the quinoline 36 was also observed which is formed via a Pfitzinger-type reaction. 
The structure of this compound was unambiguously determined via X-ray 
crystallography, figure 12. Consequently, in order to avoid this side reaction, all 
subsequent dehydrations were carried out over shorter durations and/or with 
greater amounts of hydrochloric acid.  
 
Figure 12. 
This methodology was then extended to N-substituted analogues, simply by 
exchanging isatin with its N-methylated variant. N-Methyl isatin 37 was prepared in 
quantitative yield via deprotonation of isatin with sodium hydride followed by 
alkylation with iodomethane. With N-Methyl isatin 37 in hand, the aldol 
condensation sequence was employed to afford N-substituted 3-acylidene 
oxindoles: 38, 39, and 40, scheme 38. 
 
Scheme 38. 
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Having prepared a series of acylidene oxindoles from the parent isatin, we opted to 
generate a small family of compounds bearing a 4-chlorosubstituent as these 
related directly to Khosla’s compounds discussed earlier (see figure 6). 3-Acylidenes 
oxindoles of this type were prepared by subjecting 4-chloroisatin and N-Me-4-
chloroisatin to a range of aryl methyl ketones using our modified aldol condensation 
conditions. The addition step worked efficiently affording the -hydroxy ketones 38 
- 42 in generally high yields of 68% - 100%. Interestingly we found that the 
dehydration step was much more challenging, and full conversion of starting 
material was not observed in some cases. However gratifyingly we were able to 
isolate sufficient amounts of 3-acylidene-oxindoles 2 & 46 - 49 for our subsequent 
studies, scheme 39.  
 
Scheme 39. 
Notably, the required N-Me-4-chloroisatin 50 was prepared in a moderate yields via 
treatment of 4-chloroisatin with iodomethane and potassium carbonate, scheme 
40. 
 
Scheme 40. 
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With a small family of oxindoles in hand, we assessed the potential of 1H NMR 
spectroscopy to provide the most direct and simple method for alkene 
stereochemical assignment. We compared CH shift values in the 1H NMR spectrum 
of olefinic protons for the single isomers generated in each case. The NMR shift 
values follow the trend highlighted by Righetti et al. in that Z-acylidene products 
show a downfield shift  compared to the corresponding E-isomers.15 However, in 
the event only a very narrow range was observed for these compounds. And 
interestingly, N-methyl derivatives 38 - 40, 48 - 49 also display a slight downfield 
shift relative to their N-H analogues 28, 33 - 35, 2 & 46 - 47. Overall, the relatively 
narrow shift range observed for these compounds (7.69 - 8.03), in combination 
with the potential for N-substitution to affect peak position suggests that the use of 
1H NMR spectroscopy alone for assignment of configuration could be unreliable. 
This would be especially problematic if only a single isomer is available as a 
comparative assessment of chemical shift values could not be made, table 4. 
 
Entry Compounda Alkylidene CH (ppm)b 
1 33 (E) 7.72 
2 28 (E) 7.69 
3 34 (E) 7.69 
4 35 (E) 7.72 
5 38 (E) 7.80 
6 39 (E) 7.77 
7 40 (E) 7.77 
10 46 (Z) 7.94 
11 47 (Z) 7.91 
12   2 (Z) 7.92 
13 48 (Z) 8.03 
14 49 (Z) 8.01 
aAssumed compound configuration in parenthesis  
   bNMR data for compounds dissolved in d6-DMSO. 
Table 4.  
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In order to begin the task of confirming the suspected product stereochemistry, we 
attempted to grow crystals of some representative 3-acylidene-oxindoles. The 
alkene stereochemistry of the 3-acylidene oxindoles 33, 28 and 40 was 
unambiguously assigned as E via X-ray crystallography, figure 13. In addition, the 
aforementioned compounds were found to adopt solid state conformations that 
minimised the interaction between the acyl-aromatic group with the proton at C-4 
of the oxindole ring. With these results in hand the stereochemistry of the other 3-
acylidene oxindoles was assumed to be E by comparison. 
 
 
 
Figure 13. 
In addition the crystal structures of two 4-chloro analogues were derived, and in 
contrast, and contrary to the reports of Khosla et al.,14 4-chloro derived acylidene 
oxindoles 46 and 49 were found to exhibit the Z-configuration, figure 14. The Z 
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configuration is demonstrated by the olefinic proton and the 4-chloro aromatic 
substituent which are clearly on the same side of the carbon-carbon double bond. 
Notably, all other spectroscopic data of 46 and 49 matched that of Khosla’s. 
 
 
Figure 14. 
With the stereochemical assignment of these compounds confirmed via X-ray 
crystallography, attention was briefly turned to the relative isomeric stabilities. In 
order to study this, we needed to isomerise the E-compounds to the corresponding 
Z-products. In this context, Righetti et al.  reported the conversion of E-acylidene 
oxindoles to Z-acylidene oxindoles in the presence of 1.0 equivalent of aluminium 
trichloride.15 Gratifyingly, when 28 was treated with one equivalent of Lewis acid, 
followed by a quench with saturated sodium hydrogen carbonate we observed an 
inseparable mixture of the E and Z-acylidene oxindoles. Attempts to drive this 
isomerisation to full conversion were unsuccessful and so the mixture was 
employed directly. Interestingly, isomerisation of the Z-isomer back to the 
thermodynamically more stable E-isomer was observed under mild conditions (as a 
room temperature DMSO solution), scheme 41. To the best of our knowledge, this 
is the first time that this isomerisation has been observed under ambient 
conditions. 
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Scheme 41. 
The Z-E isomerisation can be monitored over time by 1H NMR spectroscopy. The 
spectra of E-28 (red) is overlaid with the spectra of the crude reaction mixture 
(green), thirdly the blue spectra represents the same mixture after 4 days in d6-
DMSO, figure 15. 
 
Figure 15. 
The emergence of a doublet at  7.93 and a triplet at  7.31 were attributed to the 
aromatic protons of the p-Cl moiety and the indole moiety of the Z isomer 
respectively. Over time, these peaks are reduced in intensity relative to the peaks 
for the E isomer i.e. an increase in intensity of the triplet at7.36 and a reduction 
of intensity of the triplet at 7.31 shows that a conversion of Z to E is occurring, 
figure 15. This observation implies that 3-acylidene-oxindoles can undergo facile 
interconversion under ambient conditions, and isomeric mixtures could in fact exist 
as a thermodynamic minimum. This would be an important consideration with 
regards to biological screening. 
Crude mixture: (time = 4 days) 
Crude mixture: (time = 0 min) 
 
E-28 
 

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1.7 – 3- Acylidene Oxindoles:- Novel Methodology for Stereochemical Assignment. 
Although it had been shown that X-ray crystallographic techniques could be 
employed to unambiguously assign product stereochemistry, this type of technique 
can be time consuming and it is not possible to obtain a crystal structure of all 
compounds. Consequently we postulated whether a simpler and more general 
method could be devised. 
Interestingly, the solid state structures of Z-acylidene oxindoles 46 and 49 deviate 
significantly from a planar orientation observed for the E substrates 28, 33, 40, and 
24. This is demonstrated by the dihedral angle between atoms b and c, see figure 
16, for the E compounds this angle is around 180o whereas for Z it is much closer to 
a right angle at around 90o. These conformations presumably result from dipole-
dipole alignment in the case of E-isomers, or allylic strain that arises in the Z-isomer 
arrangement. In the case of the Z-isomers, dehydration requires that the substrate 
must adopt a high energy and sterically demanding planar conformation before 
rearranging into the bent conformation observed in the solid state structure, hence 
explaining why the yields of these products are generally lower. 
 
Figure 16. 
Inspection of the solid state X-ray structures of compounds 28, 33, 40, 46, 49, 
highlight that E- and Z-acylidene oxindoles exhibit different levels of conjugation. 
This is visibly noticeable in that compounds 28, 33 – 35, 38 - 40 are an intense red or 
orange colour while compounds 2, 46 - 47 are pale yellow. Consequently we 
considered the use of UV-Visible spectroscopy as a convenient tool for assigning 
product stereochemistry. The UV-Visible spectra (over 200 – 700 nm) of these 
compounds were recorded as stock solutions of anhydrous MeOH (75 M), figure 
17. The spectra of compounds 28, 33 - 35, 38 - 40 (red bands) are very similar to one 
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another, additionally the spectra of compounds 2, 46 - 47 (green bands) show 
similar traces to one another as well. However, the major difference between the 
two data sets is their relative appearance to one another. Compounds 28, 33 - 35, 
38 - 40 show three distinct peaks, whereas of 2, 46 - 47 are represented by two 
distinct peaks and a shoulder, figure 17. 
 
 
Figure 17. Spectra recorded as 75 M solutions in MeOH 
For the purposes of this study, we were looking to identify significant differences in 
the respective compound spectra that would be diagnostic. It appears that the 
traces of 2, 46 - 47 are in fact quite similar to 28, 33 – 35, 38 - 40, showing three 
distinct absorption bands labelled I, II, III, figure 17.  However there is significant 
variation for the Z-subset in regions II and III which are blue shifted and appear at 
higher energy (shorter wavelengths) and exhibit a reduction in intensity. Molar 
absorption coefficients were calculated from the maxima of regions II and III for 
both isomer sets. With regard to region II, the E compounds 28, 33 – 35, 38 - 40 
were all found to exhibit maxima in the range of 334 - 341 nm, and with extinction 
coefficients in the range of 8890 - 13820 M-1 cm-1. In contrast, Z compounds 2, 46 - 
47 all exhibited a shorter-wavelength maximum in the range of 292 - 302 nm, and 
with a smaller extinction coefficient in the range of 3980 - 6390 M-1 cm-1. 
I 
II III 
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Absorption region III was then considered. The E-compound set all exhibited 
maxima in the range of 419 - 436 nm, and with absorption coefficients in the range 
of 1190 - 2890 M-1 cm-1. Whereas, for Z compounds the maxima are again blue-
shifted and appear between 370 - 390 nm, similarly they have smaller extinction 
coefficients in the range 760 - 1190 M-1cm-1. Given that we were able to confirm the 
absolute alkene stereochemistry for several compounds via X-ray crystallography, 
we assigned the remaining compounds on the basis of similarities shown in their 
UV-Vis. spectra.  
To demonstrate that the observed shift in UV-Visible spectra was a result of alkene 
stereochemistry and not the functionality of the oxindole substrate, we decided to 
prepare isomeric compounds 53 and 54 from commercially available 6-chloroisatin. 
Both the condensation and elimination steps of the aldol reaction worked very well 
affording 6-chloro analogues as single isomers in yields of 77 % and 52% over the 
two steps, scheme 42. 
 
Scheme 42. 
The UV-Visible spectra of 6-chloro substrates 53 and 54 were recorded and are 
shown in figure 18. Both compounds followed the established pattern for E 
compounds with region II showing a max = 336 nm,  11500 M
-1 cm-1 for 
compound 53, and max = 338 nm,  13660 M
-1 cm-1 for compound 54. Region III 
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was also in keeping with the expected trends and the E isomer showed a max = 419 
nm 2520 M-1 cm-1, and max 422 nm, 2890 M-1 cm-1. The calculated molar 
extinction coefficients for region III were slightly higher than the previous E-
isomers, however the value of max was in accord with other analogues. Moreover, 
region II absorbance bands were consistent with the data for other E isomers. 
Therefore it was concluded that compounds 53 and 54 have the E configuration, 
and consequently the observed differences in the UV-Visible spectra of E and Z 
acylidene oxindoles is in fact a consequence of alkene geometry. 
 
Figure 18. Spectra recorded as 75 M solutions in MeOH 
The complete UV-Visible absorption data for compounds 28, 33-35, 38-40, 2, 46 – 
49, 53, 54 is shown in table 5. The data implies that as a general rule E-isomers 
exhibit absorbances between 330 - 345 nm and 415 - 440 nm with respective 
extinctions coefficients in the range of 8890 - 13820 M-1 cm-1 and 1200 - 2890 M-1 
cm-1. In contrast, Z-isomers exhibit absorbances between 290 - 305 nm and a 
shoulder band at around 370 - 390 nm with respective extinction coefficients of 
3980 - 6390 M-1 cm-1 and 890 - 1170 M-1 cm-1.  
 
 
I 
II 
III 
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Entry Compounda 
II III 
max 
/ nm 
 / 
M-1 cm-1 
max 
/ nm 
 / 
M-1 cm-1 
1 33(E) 334 10200 422 1870 
2 28(E) 337 11000 426 1800 
3 34 341 11520 426 1960 
4 35 339 9080 436 1670 
5 38 334 8890 424 1200 
6 39 337 11470 431 1290 
7 40(E) 341 13820 426 1890 
8 53 336 11500 419 2520 
9 54 338 13660 422 2890 
10 46(Z) 294 5720 380 1190 
11 47 298 6390 380 940 
12 2 302 4080 380 760 
13 48 292 5320 380 1080 
14 49(Z) 302 3980 380 910 
    aCompound configuration in parenthesis assigned on the  
         basis of X-ray crystallography.  
Table 5.  
We envisaged that the potential of UV-Visible spectroscopy to assist stereochemical 
assignment of acylidene oxindoles could be further demonstrated by performing 
this technique on an individual set E/Z-isomers of a specific compound. As 
previously described, AlCl3 has been established as an effective reagent for the E-Z 
isomerisation of 3-acylidene-oxindoles.15 Consequently, we opted to employ this 
methodology to generate Z-33. Accordingly, a sample of E-33 was subjected to 
these conditions over the course of three days, affording an inseparable mixture of 
the E and Z-acylidene oxindoles. Given the rate of isomerisation is relatively slow in 
this substrate, we were confident that we could isolate and characterise a pure 
sample of Z-33. Z and E isomers could be separated via preparative reverse phase 
high performance liquid chromatography (HPLC). Interestingly we recovered a 
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greater proportion of E isomer after the separation relative to Z, implying that 
isomerisation could be occurring during the separation process, scheme 43. 
 
Scheme 43. After separation the ratio of isolated isomers was E : Z (3 : 1) 
The UV-Vis spectrum (75 M solution in MeOH) of Z-33 was recorded and 
compared with the E-isomer, figure 19. The spectra of Z-33 is consistent with UV-
Visible spectra of previously described Z-acylidene oxindoles, Z-33 shows a 
characteristic blue-shift and reduced absorbance intensity relative its corresponding 
E-isomer, figure 19. Furthermore, the 1H NMR spectrum of Z-33 shows a resonance 
at  7.70 for the olefinic proton, interestingly the E-isomer exhibits a very similar 
resonance at  7.72 ppm. This confirms that the small variations in proton chemical 
shift values cannot be confidently used to assign product stereochemistry. In 
contrast, the observed changes in the UV-Visible spectra are pronounced and 
consistent with the previous examples. 
Figure 19. Spectra recorded as 75 M solutions in MeOH 
I 
II III 
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In an effort to further validate our methodology, 3-acylidene oxindole 60 was 
prepared. Moreover, this compound was prepared via a novel isatin synthesis 
developed within our group, scheme 43. Details of this synthetic methodology are 
discussed later in this thesis. Compound 60 was isolated as a single isomer in a good 
yield of 52% from 4-methylisatin via a slightly modified aldol condensation reaction. 
Scheme 43. 
The UV-Visible spectrum of 60 was recorded as a 75 M solution in MeOH. It clearly 
showed two distinctive maxima and a broad shoulder at max: 252 nm I, 293 nm II, 
and 370 - 390 nm III, respectively. The molar absorption coefficients calculated for 
peaks II and III were 4460 M-1 cm-1 and 900 M-1 cm-1 (at 380 nm) respectively, figure 
20. The pattern of peaks and intensities in the spectrum strongly indicated that this 
alkene has a Z-geometry. Moreover, further support for this assignment was 
gathered by nOe spectroscopy, see appendix. 
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Figure 20. Spectra recorded as 75 M solutions in MeOH 
In order to better understand the observed spectroscopic differences in the UV-
Visible spectra, DFT (density functional theory) methods were used to model the 
UV-visible spectra of compounds E/Z-33. This work was carried out in collaboration 
with Meijer and Jiang in this department. Gratifyingly, it was clear that the 
calculated spectra are consistent with the observed experimental trends. 
Furthermore, inspection of the principle FMO (frontier molecular orbital) 
contributions to these bands indicated that HOMO-1, HOMO and LUMO were 
dominant. Electron density maps of these orbitals for E/Z-33 are shown in figure 
21.36 
 
Figure 21. Calculated UV-Vis spectra of E/Z-33 & selected FMO’s of E/Z-33 
I 
II 
III 
Page | 44  
 
Calculated energies of these specific molecules indicated that the LUMO energies 
were significantly different whereby the LUMO of E-33 was 0.81 eV lower than the 
corresponding Z-33 LUMO, thus the corresponding band gap in E-33 is smaller, 
resulting in the observed red shift. The above electron density maps show that the 
two LUMO’s are fully extended, whereas the HOMO’s are predominantly localised 
on the oxindole fragment. Consequently, the LUMO energies are more affected by 
the significant structural differences between the two isomer sets.36 
In conclusion, we believe that the alkene stereochemistry of 3-acylidene oxindoles 
can be assigned through UV-Visible spectroscopy based on the following general 
empirical observations): E-acylidene oxindoles are expected to have two diagnostic 
peaks in the region of 330 - 345 nm and 415 - 440 nm, with extinction coefficients of 
8890 - 13820 M-1 cm-1 and 1200 - 2890 M-1cm-1, respectively. In contrast, Z-
acylidene oxindoles have a weaker band in the range of 290 - 305 nm, with a 
shoulder band around 370 - 390 nm, and possess smaller extinction coefficients 
between 3980 - 6390 M-1cm-1 and 890 - 1170 M-1 cm-1.36  
 
1.8 – 3-Acylidene Oxindoles: Isomeric Stability Studies 
Having already demonstrated the ability of Z-acylidene oxindoles to isomerise back 
to their more thermodynamically stable arrangement, we decided to investigate 
this phenomenon further. We considered how the Z-E isomerisation rate could be 
affected by varying the conditions. This involved isomerising a sample of E-acylidene 
oxindole 28 to give a mixture of E : Z products (1.0 : 0.42), followed by storing 
samples of these mixtures under different conditions. Specifically, a sample was 
stored at 20 oC in the absence of light, and a sample was stored at 20 oC in the 
presence of light. In addition, a sample was stored at -20 oC in the dark (i.e. stored 
in the freezer), and a sample subjected to heating at 50 oC in the light. These 
experiments led to the conclusion that only temperature has an effect on the 
equilibrium position of E/Z isomers; significantly less isomerisation was observed at 
-20 oC. Furthermore, storing the sample in the absence of light had no discernible 
effect on the isomerisation rate relative to a sample stored in light at the same 
temperature, figure 22. 
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Figure 22. Isomer ratios determined by 400 MHz 1H NMR spectroscopy 
An investigation aimed at establishing whether the electronic properties of the 
acylidene motif could affect the rate at which equilibrium was performed. 
Compounds 28, 33, 34 and 38 were subjected to 1.0 equivalent of aluminium 
trichloride and stirred at 20 oC for a time period of 5 days. In the event, the 
respective E : Z percentage ratios of each compound was as follows: 33: 58% E; 28: 
70% E; 34: 43% E, figure 22. The samples were stored, over several days, in DMSO 
and the relative isomer ratios were measured, from this initial data it could be 
concluded that electronic properties of the acylidene motif was not having an 
effect. The only variation being that 28 appeared to reach equilibrium relatively 
faster than 33 and 34, however, this variation was not significant enough. Finally, an 
interesting observation was made in relation to the N-substituted example 38; the 
compound was found to undergo isomerisation much slower than any of the 
examples bearing a free N-H. Only a very minor variation in E : Z ratios was 
observed, for this time scale, implying that the N-substituted analogue may in fact 
be kinetically stabilised, figure 23. 
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Figure 23. Isomer ratios determined by 400 MHz 1H NMR spectroscopy 
Additionally, the isomerisation was also performed on ester 24 resulting in an E : Z 
ratio of (1.00 : 0.35). After storing in deuterated chloroform for three days, full 
conversion to the E isomer was observed, scheme 44. 
 
Scheme 44.  
Furthermore Weinreb amide 23 was subjected to aluminium trichloride affording 
the isomeric ratio E : Z  (0.20 : 1.00). Indeed, the expected isomerisation of Z to E 
was again observed, when 23 was stored as a room temperature solution of CDCl3 
scheme 45. 
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Scheme 45. 
Overall the isomerisation of ketone, amide and ester based acylidene oxindoles has 
been observed during this study, thus highlighting that such compounds are 
configurationally labile, and that they most likely exist as thermodynamic mixture. 
Interestingly, it was noted that N-substitution can dramatically reduce the rate of 
isomerisation under ambient conditions.  
 
1.9 – Novel Isatin synthesis: Elaboration to 3-Acylidene Oxindole 
With a synthetic methodology for preparing 3-acylidene oxindoles in hand we next 
turned our attention to developing a broader substrate scope. We were particularly 
keen to explore diversification at the oxindole motif, modifications to this region 
can be provided by utilising different isatins in the aldol condensation sequence. As 
there is a limit to the availability functionalised isatins available we sought to 
develop a novel isatin synthesis in the hope of applying this to prepare a range of 
different isatins. These functionalised isatins could then be used to prepare a more 
diverse array of acylidene oxindoles.  
Within the literature, there are many isatin syntheses reported such as the 
Sandmeyer and Stolle syntheses, and more recently an example where indole is 
oxidised to isatin which was reported by Yadav, scheme 46.37,38,39 
 
Scheme 46. 
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However, there are very few examples of metal catalysed isatin syntheses and as 
such, we envisaged that this could be an interesting and practically relevant avenue 
of research. One such example reported by Söderberg and co-workers involves the 
palladium catalysed cyclisation of 1-iodoethynyl-2-nitrobenzenes. The authors 
demonstrated that this approach delivered 8 examples of isatins in yields of 47% - 
70%, scheme 47.40 
 
Scheme 47. 
In order to assess the effectiveness of this method for generating isatins, we 
decided to prepare 1-iodoethynyl-2-nitrobenzene 62 from 1-iodo-2-nitrobenzene. A 
Sonogashira cross coupling of trimethylsilylacetylene and 1-iodo-2-nitrobenzene 
afforded 61 excellent yield of 96%. Compound 61 was then readily iodinated 
affording 62 in a very good yield of 81% using N-iodosuccinimide and catalytic 
amounts of silver nitrate. Furthermore, the terminal alkyne 63 was also prepared in 
a moderate yield of 32% via the trimethylsilyl deprotection of 61 under basic 
methanolic conditions, scheme 48. 
Scheme 48. 
Unfortunately however, in our hands Söderberg’s conditions proved to be 
unreliable providing the expected isatin 64 in a reduced yield of 46%. A solvent 
screen highlighted THF as a potential alternative as the desired product was isolated 
in a 55% yield under these conditions, scheme 49. 
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Scheme 49. 
We aimed to try to improve upon Söderberg’s conditions through a series of 
empirical experiments; for example, Söderberg’s conditions were applied to the 
trimethylsilyl bearing alkyne 61 which resulted in no reaction, returning starting 
material only. In addition, when these conditions were applied to the terminal 
alkyne 63, decomposition of starting material was observed with the alkyne 
appearing to be reduced, table 6. 
 
Entry X Isolated Yield / % 
1 SiMe3 0
a 
2 H 0b 
3 I 46 
aRecovered starting material 
bDecomposition of starting material 
Table 6. 
During our solvent screening studies, we observed compounds assigned as 65 and 
66 in the crude mixture of reactions conducted in acetone (1H NMR spectroscopy), 
figure 24. This implied the formation of acid during the cyclisation process that was 
subsequently promoting the aldol condensation of the acetone solvent. In addition, 
when the reaction was performed in THF we observed a broad peak at  1.8 ppm 
which was attributed to the ring opening polymerisation of the solvent, again 
presumed to be facilitated by the production of hydroiodic acid. 
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Figure 24. 
These observations prompted us to monitor the pH of the reaction. Initial pH at the 
reaction start point was a neutral pH 7. However, after several hours the pH had 
dropped sharply to pH ~2, scheme 50.  
 
Scheme 50. 
We considered that the formation of acid may have an adverse effect on product 
formation and as such we opted to repeat the reaction but in the presence of base. 
2,6-Lutidine was chosen as the base as we thought it would be less likely to poison 
the catalyst. Unfortunately, performing the reaction in the presence of base didn’t 
result in any improvement of yield giving the desired compound in a comparable 
yield to base free conditions. Additionally, the crude reaction mixtures were still 
contaminated with solvent based side products, scheme 51. 
 
Scheme 51. 
Attempting to synthesise isatin directly via the metal catalysed cyclisation of 1-
iodoethynyl-2-nitrobenzenes was proceeding with limited success, and as such we 
decided to employ a change of tactic. It was envisaged that we could potentially 
access the proposed intermediate 2-iodoisatogen compounds and then separately 
reduce and hydrolyse this to the isatin, scheme 52. The general idea of this 
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approach was that it would hopefully allow us to bypass some decomposition 
pathways, thereby generating isatins cleanly over two steps. 
 
Scheme 52. 
Söderberg and co-workers provided evidence for the reaction proceeding via the 
proposed isatogen intermediate. Performing the cyclisation with bromo-alkynes in 
place of the corresponding iodides, the authors isolated 2-bromoisatogens in two 
separate examples. In addition, when attempting to perform the iodination of the 
5-methoxy arylacetylene substrate they noted the formation varying amounts of 2-
iodoisatogens, scheme 53.40 Furthermore, it has been reported that structurally 
analogous o-nitro diarylacetylenes will undergo cycloisomerisation to isatogens 
under the influence of transition metal catalysts.41  
 
Scheme 53.40 
We envisaged that moving from palladium to a less electrophilic Lewis acid, such as 
copper, could offer access to the intermediate isatogen, and in turn prevent any 
decomposition as a result of the generation of HI. Initially we attempted the 
transformation in the presence of copper iodide, as this had shown some success 
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when employed in Söderberg’s conditions. However, in the event no product 
formation was observed with only starting material being recovered. Pleasingly 
when switching to a more soluble source of copper, CuBr.DMS, we observed 
predominantly isatogen formation, with 25 mol% of CuBr.DMS being the optimal 
loading level. Notably, these conditions did not preclude the formation of isatin. 
Evidently, it appears that CuBr.DMS will effect this transformation, complete 
conversion of iodoalkyne to isatin was observed with stoichiometric quantities of 
CuBr.DMS. Moreover, subjection of isolated isatogen 70 to additional CuBr.DMS 
resulted in conversion to isatin, table 7. 
 
Entry 
Catalyst 
Solvent 
Isolated Yield / % 
(loading / mol%) 2-Iodoisatogen (70) Isatin (60) 
1 Pd(PPh3)2Cl2 (5%) Acetone 0 46 
2 Pd(PPh3)2Cl2 (5%) THF 0 55 
3 CuI (10%) Acetone 0 27 
4 CuCl2 (10%) Acetone 0 22 
5 CuI (10%) THF 0 0 
6 CuBr.DMS (10%) THF 66 16 
7 CuBr.DMS (25%) THF 89 8 
8 CuBr.DMS (50%) THF 73 13 
9 CuBr.DMS (100%) THF 0 60 
Table 7. 
As this was only the second reported example of a 2-iodoisatogen,40 we sought to 
provide confirmation of its proposed structure. Confirmation that the compound 
was in fact the desired iodoisatogen 70 was evident from the solid state crystal 
structure, figure 25. The structure was not straightforward to solve due to the 
symmetrical nature of the molecule and there is some ambiguity with regards to 
the carbonyl and the N-oxide functionality. However, the crystal structure clearly 
shows the correct number of atoms and bonds and, key to our structural 
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assignment, the carbon-iodine bond, figure 25. Exploration of the scope of the 
iodoisatogen chemistry has been performed within the Harrity group and is 
reported  elsewhere.42,43  
 
Figure 25. 
With conditions for the preparation of the iodoisatogen in hand, we next turned our 
attention to reducing the N-oxide bond for the synthesis of novel isatins. 
Intriguingly, when assessing isatogen stability by monitoring its 1H NMR spectrum 
(d6-DMSO), we observed complete and rapid conversion to two separate 
compounds in a 1.0 : 0.3 ratio after 12 hours. 
The minor compound was identified as isatin whereas the major compound was 
determined to be the N-hydroxy isatin 71, upon isolation via fractional 
recrystallization. The N-hydroxy isatin was found to be a stable red solid, with only 
limited literature precedent. Moreover, this procedure was applicable on a 
preparative scale utilising reagent grade DMSO. In the event, the transformation 
proceeded efficiently affording a 3 : 1 mixture of N-hydroxy isatin 71 : isatin 64 in an 
excellent reproducible yield of 80%, scheme 54. Separation of the mixture proved to 
be challenging, although a small amount of analytically pure N-hydroxy isatin was 
afforded via fraction crystallisation. 
 
Scheme 54. 
We considered alternative methods for the reduction of the nitrogen-oxygen bond. 
Indeed, subjecting an isatin : N-hydroxy isatin mixture to triphenylphosphine and 
heating at 135 oC in DMF led to formation of isatin in a very good yield, scheme 55. 
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Moreover, a one-pot procedure was achieved by heating isatogen 70 and 
triphenylphosphine in dimethylsulphoxide overnight at 135 oC, affording the desired 
isatin 60 in a very good yield of 70%, scheme 55. 
 
Scheme 55. 
Having developed a novel synthetic route to isatins, we sought to apply this 
chemistry in connection with the previously discussed 3-acylidene oxindole isomer 
study. Consequently, we considered the preparation of the novel 4-methyl 3-
acylidene oxindole from 4-methyl isatin 57, scheme 56.  
 
Scheme 56. 
The relevant ethynyl iodide 56 was prepared in an excellent 84% yield via the 
Sonogashira cross coupling reaction of 2-iodo-3-nitrotoluene and trimethylsilyl 
acetylene. Iodination was achieved with stoichiometric amounts of silver nitrate 
and N-iodosuccinimide affording the iodoacetylene 56 in an 88% yield, scheme 57.   
 
Scheme 57. 
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Cycloisomerisation of iodoalkyne 56 proceeded slowly and required stoichiometric 
amounts of CuBr.DMS, and 24 hours to observe complete conversion. In addition, 
the cyclisation step afforded a 1 : 1 mixture of isatogen 58 and 4-methyl isatin 57 in 
practically useful quantities and a very good overall yield of 81%. Subsequent 
conversion of 4-methyl iodoisatogen 58 to 4-methyl isatin 57 was achieved with 
DMSO and triphenylphosphine mediated reduction / hydrolysis, scheme 58. 
 
Scheme 58. 
The desired novel 3-acylideneoxindole 60 was afforded via the aldol condensation 
of acetophenone and 4-methylisatin in a good overall yield of 52%. Moreover, it 
was isolated solely as the Z isomer, determined via UV-Visible spectroscopy and 
nOe spectroscopy (see figure 20, page 45), scheme 59.  
 
Scheme 59. 
In conclusion, we have developed a reliable catalytic system for the preparation of 
novel and interesting iodosatogens.43 It turn, the preparation of such compounds 
can be beneficial for the synthesis of novel acylidene oxindoles. Further studies will 
seek to discover new synthetic applications of iodoisatogen compounds. 
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CHAPTER II 
2.1 – Chemistry of Isatogens 
Isatogens are a class of stable 1,3-dipolar compounds, which are typically quite 
brightly coloured and to-date there is no report of their natural occurrence. The 
very first reported isatogen preparation was by Adolf Baeyer as early as the late 19th 
century. The compound was functionalised with a 2-carboxylic acid ethyl ester 
group, and generated from the corresponding o-propiolate nitrobenzene and 
concentrated cold sulphuric acid, scheme 60.44,45 Isatogens have been reported to 
possess some useful biological activities, additionally their synthetic applications 
have involved nucleophilic addition as well as dipolar cycloadditions. Furthermore, 
they have been described to be effective spin traps for radical intermediates.46,47 
Unambiguous isatogen structural confirmation, via spectroscopic and 
crystallographic techniques, was provided by Hooper.48  
 
Scheme 60. 
 
2.2 – Isatogen Syntheses: Classical Methodologies 
The traditional methodology for isatogen synthesis is analogous to Adolf Baeyer’s 
initial route, the cycloisomerisations of o-nitro diarylacetylenes, under the influence 
of various promotors, scheme 61. Herein follows a brief description of some general 
methods for this transformation. 
 
Scheme 61. 
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After Baeyer’s initial report, another classical and widely employed method was 
described independently by Pfeiffer and Kröhnke, wherein light promoted 
cycloisomerisation of o-nitro diarylacetylenes in the presence of pyridine at 
elevated temperature provided 2-arylisatogens, scheme 62.49,50,51 This methodology 
was widely employed in the early 20th century by various researchers, however only 
simple isatogens with limited functionalities were accessible by this technique.52 
This was in part due to the limited availability of the corresponding pre-cyclised o-
nitro diarylacetylenes.  
 
Scheme 62. 
A mechanism for this transformation was described by Rolf Huisgen. Initially, a 
pyridinium betaine 73 is generated via the photochemical reaction of tolane 72 with 
pyridine. Cyclic intermediate 74 is then generated by carbanion-nitro cyclisation, 
which can then re-open to provide the nitroso compound 75. The final step 
provides the isatogen via pseudo enolate addition to the nitroso group followed by 
eliminate of pyridine, scheme 63.53 Kröhnke et. al. have shown that treatment of 
betaine 73, HBr salt, with sodium carbonate would effect isatogen formation, thus 
implying that only the initial betaine formation requires photochemical promotion,  
scheme 63 inset.50  
 
Scheme 63. 
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However, with the development of Castro-Stephens coupling and more recently 
Sonogashira coupling, access to this type of o-nitro diarylacetylenes has become 
relatively trivial.54,55 Consequently, the first major report of diverse isatogen 
synthesis came from Malcolm Hooper and co-workers during the late 1960’s. They 
reported the preparation of 18 bespoke isatogens in generally very good yields, up 
to 93%, via photo-induced catalytic pyridine promoted cycloisomerisations. A 
significant scope with regard to functionality was achievable both on the 3-oxindole 
core and pendant aryl ring, scheme 64.56,57 Hooper and co-workers also reported 
the nitrosobenzene promoted preparation of a small selection of 2-substituted 
isatogens from the cycloisomerisation of o-(alkynyl)nitrobenzenes.58 
 
Scheme 64. 
An isolated example of isatogen formation was reported by Abramovitch and Cue 
Jr. They documented the formation of 2-cyanoisatogen 77 in a moderate 48% yield 
by subjection of the corresponding o-(alkynyl)nitrobenzene 76 to ultraviolet light, 
scheme 65.59 
 
Scheme 65. 
Tour and co-workers reported a novel isatogen synthesis method, wherein a sub-
stoichiometric amount tetrabutylammonium fluoride (TBAF) was used to promote 
the cycloisomerisation of 78 in a very good 73% yield.  This represented the first 
time that TBAF had been used to induce this cycloisomerisation, however, isatogen 
79 was only prepared as a single isolated example. Furthermore, the generality of 
this technique was potentially limited, as the analogous isatogen 80 was not 
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accessible through this technique, and consequently was prepared via the classical 
pyridine promoted conditions, scheme 66. Tour’s interest in isatogens was for the 
application of molecular electronic devices, specifically with regards to isatogen’s 
potential ability to stabilise radicals. In this context, they recorded the cyclic 
voltammogram of isatogen 79 and identified two reductions, the first being rapidly 
reversible at –0.62 V and the latter irreversible at –1.39 V.60  The polarographic 
reduction of isatogens had previously been reported by Hooper and Bunney.61 
 
Scheme 66. 
Within the last couple of decades, advances in isatogen formation have resulted 
from the employment of milder transition metal promoter systems. The first 
example of such was reported by Yamamoto in 2003 when employing a gold(III) 
catalyst. Subjection of o-(alkynyl)nitrobenzenes to AuBr3 (3 mol%) in toluene 
afforded six isatogens in very good yields (78% - 86%, as estimated by 1H NMR 
spectroscopy), including a single alkyl example in 2-cyclohexylisatogen. 
Furthermore, this procedure was more practical relative to classical methods due to 
the use of toluene at ambient temperature as opposed to previously employed 
pyridine/heat. Interestingly, isomeric anthranils 81 were also observed as minor by-
products, scheme 67. The relative amount of anthranils was found to vary 
depending on the solvent or temperature employed.41  
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Scheme 67. 
Consistent with Yamamoto’s observation, Crabtree reported the formation of 
anthranil 82 in a very good yield via the cycloisomerisation of 1-nitro-2-(pent-1-yn-
1-yl)benzene. Iridium complex 83 was used to promote this cyclisation, and in the 
event no isatogen was observed, scheme 68.47 
 
Scheme 68. 
Very recently Ramana et al. improved upon Yamamoto’s original concept, 
demonstrating the palladium(II) promoted highly selective isatogen forming 
cycloisomerisation of o-(alkynyl)nitrobenzenes. The transformation occurred 
efficiently under mild conditions, and with low loadings of [Pd(MeCN)2Cl2] (5 mol%) 
allowing for the preparation of twenty isatogens in generally very good to excellent 
yields. Moreover, the reaction exhibited a remarkable functional group tolerance, 
representing the first general procedure to access 2-alkyl isatogens, scheme 69.62   
In connection with the above discovery, detailed DFT studies were performed and a 
plausible mechanism proposed. The initial step involves alkyne palladium 
complexation which promotes a 5-exo-dig cyclisation generating intermediate II. A 
rearrangement of II occurs and affords carbene III, the calculations indicate nitroso 
coordination through the nitrogen atom. Species III is then converted to IV which, 
after the loss of the palladium(II) species, generates the desired isatogen, scheme 
70.  
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Scheme 69. 
 
 
Scheme 70. 
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Additionally, Ramana considered the anthranil formation reported by Yamamoto 
and Crabtree and postulated a reason for its absence under their conditions. The 
anthranil forming transformation is thought to initiate via a 6-endo-dig cyclisation, 
which after an oxygen transfer rearrangement  provides carbene 84. Subsequently, 
a Cope type rearrangement occurs generating the vinyl iridium species, the process 
then terminates with a reductive elimination affording the observed anthranil, 
scheme 71.47 Calculations by Ramana indicate that for their system 6-endo-dig 
cyclisation is significantly disfavoured, with the relevant transition states (6-endo-
dig versus 5-exo-dig) differing by 18.8 kcal mol-1 in energy.62 Therefore, it could be 
implied that isatogen or anthranil formation may be controlled through judicious 
choice of reaction conditions. 
 
Scheme 71. 
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2.3 – Isatogen Syntheses: Alternative methodologies 
Isatogen formation is not only limited to just alkyne-nitro cycloisomerisation, 
scheme 72 route I. There are in fact several other reported techniques. Herein 
follows a brief overview of some the other alternative methodologies, which are 
summarised in scheme 72.   
 
Scheme 72. 
Splitter and Calvin reported the appearance of isatogens from the 
cycloisomerisation of ortho-nitro stilbenes, whilst performing photochemical 
reactions of these compounds, scheme 72, route II.63 In the 1970’s a similar 
methodology was reported by Hayward and Leznoff that involved a photo-catalysed 
cycloisomerisation. However, in this case only a small number of isatogens were 
synthesised and in poor yields, scheme 72, route II.64  
Other alternative cyclisation routes were reported by Bhamare and Nepveu, 
scheme 72 routes III and IV.65,66 Nepveu’s methodology involved the in situ 
reduction of the nitro functionality to a hydroxylamine, which upon condensation to 
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the diketone afforded the desired isatogens, scheme 72 route IV. Four isatogens 
were prepared via this methodology, in yields up to 91%, scheme 73.66 
 
Scheme 73. 
Different synthetic strategies that avoid cyclisation as the key isatogen forming 
step, and instead involves the direct oxidation of indole derivatives have also been 
reported, scheme 72 route V. Hooper and co-workers demonstrated the m-CPBA 
(meta-chloroperoxybenzoic acid) promoted oxidation of N-hydroxy indoles to 
isatogens, with yields up to 60%. The method was reported to be general and also 
included the first example of alkyl isatogens formation.67,68 Similarly, a technique 
whereby (N-H)indoles were oxidised was first discovered by Sakamoto, generating 
2-phenylisatogen in a good 58% yield from 2-phenylindole in the presence of 
MoO5.HMPA as the oxidant.
69 More recently this technique was further developed 
by Bergman and Slätt, whereby a small series of isatogens were generated in 
moderate to good yields, 30% - 59%, from a two-step procedure. Initially indoles 
were reduced to dihydro-indoles using tin and acid, oxidation to isatogens was then 
readily achieved using m-CPBA, scheme 72 route VI.70 
 
2.4 – Isatogen Biological Importance 
There have been a number of reports of isatogen biological activity. Various 2-
substituted isatogens were reported by Wibberley, Patterson, and Hooper to show 
moderate antibacterial properties.71,72 Another example of bioactivity was again 
demonstrated by Hooper and co-workers wherein they reported the ability of 2-
phenylisatogen to affect energy transfer systems in rat liver mitochondria figure 26. 
Specifically in this context 2-phenyl isatogen’s potency was likened to known energy 
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transfer inhibitors.73 In a later publication the authors identified that 2-
phenylisatogen was actually inhibiting the mitochondrial transhydrogenase enzyme. 
Interestingly however, in their assays they discovered that 2-phenylisatogen’s 
potency was reduced due to its inability to reach its site of action.74 
 
Figure 26. 
The parasite associated with malaria, P. falciparum, is becoming increasingly 
resistant to conventional treatments such as chloroquine. As a consequence there is 
an urgent requirement to discover alternative treatments, which operate via a 
different mode of action. Nepveu and co-workers postulated that isatogens could 
potentially show antiplasmodial activity and offer novel anti-malarial compounds, 
their reasoning deriving from the observed electrochemical reducibility of 
isatogens.75 The activity of known antimalarial compound artemisinin is believed to 
be derived from the reducibility of the endoperoxide functionality, figure 27.76,77 
Nepveu et al. proposed that the reducible motif on isatogens could offer a 
complimentary mode of action, in addition N-oxide derivatives have been reported 
to demonstrate antimalarial activity, figure 27.78,79 
 
Figure 27. 
In this context, Nepveu et al. screened sixty six isatogens against a chloroquine 
resistant strain of P. falciparum (FcB1 Strain). The authors reported some desirable 
biological activity and were able to derive some positive structure activity 
relationship (SAR) data. It was observed that the indolone moiety had to contain a 
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phenyl group as replacing this with either the pyridine or pyridine N-oxide resulted 
in a significant loss of activity. Additionally, it was noted that alkyl substituents in 
the 2’ position lead to a decrease in activity, and in contrast, aromatic groups 
bearing a mesomeric functionality improved activity. Ultimately, from their assays 
they identified two potential lead compounds with very high antiplasomodial 
activity. Moreover, the compounds demonstrated very satisfactory selectivity with 
low cytotoxicity against a human tumor cell line (MCF7), figure 28.  
 
Figure 28. 
 
2.5 – Reactivity of Isatogens 
Previous reports of isatogen derivatisations have been dominated by two modes of 
reactivity.  
 Nucleophilic addition to either the carbon of the nitroxide or at the carbonyl 
function.  
 Dipolar cycloadditions.  
An early report of nucleophilic addition to isatogens came from the groups of 
Hooper and Robertson. The nucleophilic addition of amino acids at the C-2 position 
of 2-phenylisatogen was demonstrated.80  Around the same time, Colonna and co-
workers reported that organometallics could be added to 2-phenylisatogen. In their 
report they stated that organolithium and Grignard reagents would add 
indiscriminately to either the carbonyl functionality or at the nitroxide carbon, 
generating a mixture of products. The authors showed that selective addition to the 
N-oxide carbon, generating hydroxylamine 86, could be achieved by protection of 
the carbonyl as imine 87, scheme 74.81  
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Scheme 74. 
Several contemporary examples of nucleophilic addition to isatogens have been 
demonstrated by Ramana and co-workers. An indium(III) mediated carbon-carbon 
bond forming reaction between isatogens and indole was reported. This process 
allowed the selective syntheses of indolin-3-one or N-hydroxyindolin-3-one, simply 
by modifying the reaction conditions. Moreover the authors employed this 
chemistry for the total synthesis of the natural product 13-deoxy-isatisine A in ten 
steps from commercial starting materials, scheme 75.82 
 
Scheme 75. 
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More recently Ramana and co-workers expanded the scope of their method to 
include 3-substituted indoles. Interestingly InCl3 failed to promote any useful 
reactivity. Gratifyingly however, when switching to a Au(I) and Ag(I) system the 
reaction proceeded efficiently. The authors applied this methodology to the total 
synthesis of (±)-trigonoliimine C, in 4 steps from simple commercially available 
starting materials, scheme 76.83 
Scheme 76. 
The first example of an isatogen dipolar cycloaddition was presented by Hooper and 
Bunney. The authors subjected various 2-substituted isatogens to ethyl 
cyanoacetate, and noted that reactivity occurred in cold ethanol and with catalytic 
pyridine, scheme 77.56  
 
Scheme 77. 
Ramana and co-workers have very recently developed two different [3+2] 
cycloaddition reactions of isatogens with alkenes. Their first example demonstrated 
that 2-substituted isatogens bearing a suitably positioned alkene function would 
undergo spontaneous [3+2] cycloadditions, affording spiro-pseudoindoxyl 
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compounds. However, for this process to occur new substrate specific conditions 
had to be identified, in order to increase the efficiency of the isatogen forming 
cycloisomerisation. Moreover, isomeric homologues were accessible, however the 
authors were surprised to observe a complete reversal of exo / endo selectivity 
when switching from N-allyl to N-but-3-enyl moieties, scheme 78. Interestingly, 
exchange of the N-Boc function to a methylene resulted in no isatogen formation, 
with isomeric anthranils formed instead.84    
 
Scheme 78. 
The second recent example from Ramana et al. featured the [3+2] dipolar 
cycloaddition of isatogens with external alkenes, via a ruthenium promoter system. 
The reaction initially generates a tetrahydroisoxazole intermediate, which upon 
cleavage of the N-O bond affords -aminoketone indoxyls. The protocol is general 
and tolerates functionality on the oxindole fragment as well as various alkyl or aryl 
groups at C-2. The scope with regard to the alkene is very good with the reaction 
performing efficiently with various functionalised alkenes: simple alkyls, enol 
ethers, and styrenes, scheme 79.85 
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Scheme 79. 
Finally in this context, Lu et al. very recently developed a complimentary procedure 
to the above methodology, whereby they described a formal [3+3] cycloaddition of 
isatogens and enals, affording the polycyclic heterocycles. This was achieved 
through the use of an N-heterocyclic carbene catalysed umpolung reaction of enals 
providing homoenolates as the reactive species. Furthermore, the reaction was 
tolerant of various functionalities and in most cases resulted in predominantly the 
syn-isomer, scheme 80.86 
 
Scheme 80. 
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2.6 – Reactivity of Novel 2-Iodoisatogens 
 
Within this thesis the discovery of 2-iodoisatogens was reported, and their potential 
as synthetic intermediates was postulated. In this context, two different examples 
of derivatisation, in addition to isatin formation, have been demonstrated within 
the Harrity research group. Initially a novel enolate displacement strategy followed 
by carboxylation allowed accesses to a series of 2-acylidene oxindoles. This class of 
molecule had previously been difficult to access, and in addition are also 
structurally isomeric to 3-acylidene oxindoles previously discussed herein, scheme 
81.43 
 
Scheme 81. 
The second piece of methodology presented was the ability of iodoisatogens to 
undergo cross coupling reactions via a palladium catalysed Sonogashira reaction, 
whereby a series of isatogens, bearing a synthetically attractive alkyne functionality, 
were prepared, scheme 82. Specifically in this case it was pleasantly surprising to 
observe successful reactivity, as it had previously been shown that 2-iodoisatogens 
were unstable in the presence of palladium resulting in either decomposition or 
conversion to isatins.43 
 
Scheme 82. 
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Aims 
Having a general methodology for the preparation of 2-iodoisatogen discovered we 
sought to investigate the potential application of this interesting class of 
compounds. In particular, we hoped to perform cross coupling reactions and thus 
develop a divergent synthesis of bespoke isatogens, a biologically and synthetically 
interesting class of compound. 
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2.7 – 2-Aryl Isatogens: Cycloisomerisation Condition Screening 
 
Before attempting functionalisation of the carbon iodide bond, an investigation into 
the practicality of the copper promoted iodoisatogen forming cycloisomerisation 
was undertaken. The possibility of employing the optimised copper promoted 
reaction to 1-alkynyl-2-nitrobenzenes bearing pre-functionalised internal alkynes 
was considered. This class of cycloisomerisation is known, however, these processes 
rely on expensive gold / palladium promoters.41,62 Thus, it was hypothesised that 
copper salts could function as a more economical Lewis acid for the formation of 
other isatogens, scheme 83.42,43  
 
Scheme 83. 
Consequently, 1-alkynyl-2-nitrobenzene 88, prepared via the Sonogashira cross 
coupling of phenylacetylene and the corresponding aryliodide, was subjected to a 
series of reaction conditions whereby the loading of the CuBr.DMS metal promoter 
was varied. Pleasingly, full conversion of phenylacetylene 88 was observed after 8 
hours and afforded the cycloisomerised 5-methoxy-2-phenylisatogen 89 in an 
excellent 79% yield, table 8. 
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Entry 
Reaction time 
/ h 
Conversion 
/ % 
Isolated Yield 
/ % 
1 1 57 - 
2 3 67 - 
3 8 100 79 
Table 8. 
Comparison of this result with the equivalent palladium promoted sequence 
highlighted that the palladium reaction proceeds quicker, reaching full conversion 
after only 1 hour in the presence of 10 mol% Pd(MeCN)2Cl2 and giving a 61% yield of 
the corresponding product.62 Furthermore, and with respect to substrate reactivity, 
the 2-iodoisatogen forming reaction proceeded much faster than the 2-phenyl 
analogue and was complete after only 30 minutes, scheme 84.  It can be inferred 
from these observations that the cyclisation of iodoacetylenes is inherently more 
rapid than the corresponding arylacetylenes, and thus can be promoted via a less 
reactive Lewis acid. Moreover, a beneficial consequence of this is that the relatively 
mild reaction conditions also mimimise decomposition of the sensitive iodoisatogen 
products that was evident under Söderberg’s palladium promoted conditions.40 
 
Scheme 84.62,43 
 
Page | 75  
 
Cycloisomerisation to provide 5-methoxyiodoisatogen 69 was observed to be the 
fastest of all the iodoalkyne cyclisations studied.43  As such, we wanted to extend 
the cycloisomerisation study to a more generic, electron neutral substrate. 
Accordingly, 1-ethynyl-2-nitrobenzene 90 was subjected to a series of reaction 
conditions whereby the nature of the transition metal promoter, loading and 
reaction time were varied, table 9. Notably, during the preparation of the substrate 
1-ethynyl-2-nitrobenzene 90, via the Pd(PPh3)2Cl2 (10 mol%) catalysed Sonogashira 
cross coupling reaction, a significant amount of 2-phenylisatogen 85 was isolated, 
36%, in combination with the intended alkyne product, 49%. This result confirmed 
the propensity of these compounds to undergo Lewis acid promoted 
cycloisomerisation, scheme 85.  
 
Scheme 85. 
With regard to the transformation of 90 to 85, we initially screened two copper 
sources, CuBr.DMS and [Cu(MeCN)4][BF4]. Stoichiometric CuBr.DMS failed to effect 
cycloisomerisation, while stoichiometric [Cu(MeCN)4][BF4] provided only low 
conversion through to 2-phenylisatogen 85, entry 3. Interestingly, incomplete 
conversion was observed when Pd(PPh3)2Cl2 was used, even at high loadings, entries 
5 and 6. Gratifyingly however, when employing a more electrophilic source of 
palladium, Pd(MeCN)2Cl2, complete conversion was achieved after only 6 hours, 
with the desired material isolated in a very good yield of 74%. The low reactivity 
observed in the case of 1-ethynyl-2-nitrobenzene 90 in the presence of a copper 
promoter reaffirmed the observation that these cyclisation reactions are much 
slower than the analogous alkynyliodide compounds, table 9.  
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Entry Promoter (loading / %) Time 
/ hr 
Conversion 
/ % 
Isolated 
Yield / % 
1 CuBr.DMS (25 mol%) 18 0  - 
2 CuBr.DMS (100 mol%) 18 0 - 
3 [Cu(MeCN)4][BF4] (100 mol%) 18 20 - 
4 Pd(PPh3)2Cl2 (10 mol%) 18 65 - 
5 Pd(PPh3)2Cl2 (20 mol%) 18 85 - 
6 Pd(MeCN)2Cl2 (10 mol%) 18 100 - 
7 Pd(MeCN)2Cl2 (10 mol%) 6 100 74 
Table 9. 
In conclusion, it is apparent that copper salts are not efficient at promoting 
cycloisomerisation of 2-arylacetylene nitrobenzenes towards 2-arylisatogens. 
However, it is evident from their successful participation in the cycloisomerisation 
to the corresponding 2-iodoisatogens that these milder promoters can exploit the 
increased reactivity of 2-iodoacetylene nitrobenzenes. Moreover, we believe that 
the reduced reactivity of these copper salts minimises potential decomposition 
pathways, thus allowing access to novel and relatively unstable 2-iodoisatogen 
products. 
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2.8 – 2-Iodo Isatogens: Aryl Cross Coupling Condition Screening and Scope 
Research within the group had demonstrated that 2-iodoisatogens could undergo 
palladium catalysed sp–sp2 coupling.43 In order to complement this methodology, 
efforts were directed to investigating the possibility of performing sp2-sp2 cross-
couplings. Such a synthetic strategy would be of particular interest as the resulting 
2-arylisatogens have been reported to possess interesting biological activity. For 
example, the p-dimethylaniline derived 2-arylisatogen has been reported to 
demonstrate potent anti-malarial activity, figure 29.75 
 
Figure 29. 
Conventional synthetic strategies towards 2-arylisatogens are generally limited to 
pre-functionalisation of the substrate followed by isatogen formation in the final 
step, a process which is usually catalysed by an expensive transition metal complex. 
Representative examples include a gold(III) catalysed procedure developed by 
Yamamoto et al.41 and the complementary palladium(II) promoted methodology 
developed by Ramana et al.62 As such, a divergent synthetic approach that allows 
access to a varied compound library, from a single synthetic intermediate, would be 
beneficial with regard to compound library synthesis and screening, scheme 86. 
 
Scheme 86. 
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We began our studies by investigating the palladium-catalysed Suzuki-Miyaura cross 
coupling of aryl boronic acid derivatives. Unfortunately, these reactions were 
unsuccessful and complex mixtures were recovered. Furthermore, Kumada type 
cross-coupling reactions were attempted using aromatic Grignard reagents. 
However, once again, only intractable mixtures were isolated. These observations 
were not too surprising considering the previously highlighted ability of Lewis acidic 
transition metals such as palladium to effect decomposition of iodoisatogens, 
scheme 87. 
 
Scheme 87. 
Undeterred, we decided to continue the study by investigating alternative 
organometallic coupling partners, and explored the use of arylzinc reagents. 
Consequently, Negishi reactions were attempted by subjecting iodoisatogen 69 to 
freshly prepared PhZnCl in the presence of Pd2dba3 (2.5 mol%) and SPhos (5.0 
mol%).87 Stoichiometric quantities of aromatic zinc halides were prepared via 
transmetallation of the corresponding Grignard reagents with anhydrous zinc 
chloride, conversion was assumed to be quantitative and the in situ generated 
organozinc halides were used immediately.88 Initial results were disappointing as 
low conversions were achieved when stoichiometric quantities of organometallic 
reagent were used in the presence of 5% Pd catalyst. Gratifyingly however, 
increasing the equivalents of PhZnCl (5 equivalents) resulted in complete conversion 
of starting material and the product 2-phenylisatogen 89 was successfully 
generated, albeit in a low yield of 30%, scheme 88. 
 
Scheme 88. 
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We chose to perform these experimental studies on 5-methoxy-2-iodoisatogen, due 
to its ease of preparation and inherent stability versus other 2-iodoisatogens. 5-
Methoxy-2-iodoistogen 69 was prepared from the corresponding alkynyl iodide 68 
via the CuBr.DMS promoted cycloisomerisation, scheme 89. 
 
Scheme 89. 
In the event, a substantial quantity of biphenyl was also observed, and although this 
could have originated from Wurtz coupling of the phenylmagnesium bromide, we 
considered other possible mechanisms for its formation. An intriguing report by Lei 
and co-workers highlighted that homo coupling of aryl zinc halides can take place 
during Negishi coupling. In their mechanistic studies they proposed two possible 
competing reaction pathways: pathway a, reductive elimination of [Ar-Pd-Ar'] 
complex I to afford the desired cross coupled product. Or alternatively pathway b, 
where an additional transmetallation of ArZnCl occurs generating the new [Ar-Zn-
Ar] complex II. This biaryl complex II can undergo reductive elimination, thus 
generating homocoupled biaryl compounds and consequently converting the initial 
aryliodide coupling partner into the protonated analogue, scheme 90.89 
 
Scheme 90 
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Pleasingly, when performing the coupling reaction in the absence of a Pd catalyst, it 
was discovered that that the desired product was formed, and the amount of 
biphenyl generated was drastically reduced.  Furthermore, the isolated yield for 5-
methoxy 2-phenylisatogen was just over twice that of the palladium-catalysed 
reactions examined, scheme 91.  
 
Scheme 91. 
Having previously demonstrated the ability of a palladium catalyst to promote 
conversion of isatogens to isatins, the potential for side reactions in this process is 
the likely reason for low isolated yields. Therefore, in order to avoid decomposition 
of the starting isatogen it was decided to explore the scope of the process in the 
absence of Pd catalysts.   
 
A small scope of 2-arylisatogens were generated via the cross coupling of 5-
methoxy 2-iodoisatogen 69 with a series of aryl zinc halides. Three additional 2-
arylisatogens bearing electron rich and poor groups were synthesised in good 
yields, scheme 92.  
 
Scheme 92. 
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To conclude, the cross coupling of iodoisatogens with arylzinc halides was 
developed and a small scope of substrates was investigated. Further research within 
the Harrity group extended the scope of this reaction to include additional 
isatogens bearing halides in the 5- and 6-positions.90   
 
2.9 – 2-Iodo Isatogens: Alkyl Cross Coupling Condition Screening and Formation of 
N-Alkoxy-3-Oxindoles 
 
Having uncovered effective conditions for aryl cross couplings of 2-iodoisatogens, it 
was decided to explore the possibility of generating the corresponding 2-
alkylisatogens via an analogous sp3- sp2 cross coupling strategy. The desire to 
prepare such compounds derived mainly from the fact that there are very limited 
examples of alkylisatogens reported in the literature.62 Consequently, it was hoped 
that the coupling methodology would deliver a new and divergent approach to 
these novel heterocycles, scheme 93.  
 
Scheme 93. 
We opted to carry out our intial studies using ethyl zinc iodide, prepared via the 
insertion of Rieke zinc into iodoethane using the conditions reported by Knochel 
and co-workers, scheme 94.91 The concentration of alkylzinc halide solutions was 
determined via the iodometric titration method develop by Knochel.92 
 
Scheme 94. 
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Initial studies attempted to replicate the conditions employed for the aryl cross 
coupling, and so a large excess of EtZnI in THF was added to 69 at room 
temperature. However, it was surprising to only isolate a minor amount of the 
expected 2-ethylisatogen together with a large quantity of an unexpected by-
product. Analysis of the 1H NMR spectrum of the unknown compound indicated 
that there were two different types of ethyl group, in a 2:1 ratio. Combining this 
data with mass spectrometry and 13C NMR analyses led to the conclusion that the 
major product from the reaction was a result of double addition of ethyl groups to 
the isatogen at the 2-position, and a subsequent O-alkylation. The mechanism for 
this unusual transformation was unclear at this stage. Ultimately, the reaction 
afforded the interesting N-alkoxy-3-oxindole 95 as the major product in a moderate 
yield of 45% and the intended 2-ethyl isatogen 94 in a low 15% yield, as shown in 
scheme 95. 
  
Scheme 95. 
This preliminary experiment was followed by a study of the effect of organometallic 
stoichiometry on product distribution. The overall conclusion that was drawn from 
this screening study was that varying the stoichiometry of ethylzinc iodide did not 
result in any significant change in the proportions of the two products. Indeed, the 
only effect of lowering the equivalents of EtZnI was to lower conversion resulting in 
an increased recovery of starting material (see entries 1 and 2, table 10).  
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Entry EtZnI 
(Equiv.) 
Isolated Yield / % 
2-Iodoisatogen 
(69) 
2-Ethylisatogen 
(94) 
N-alkoxy-3-oxindole 
(95) 
1 1.0 44 31 <10 
2 2.0 33 35 20 
3 3.0 Trace 22 37 
4 4.0 0 15 45 
Table 10. 
In order to better understand the origin of the formation of-compound 95, it was 
decided to subject the 2-alkylisatogen to the reaction conditions in order to 
determine whether this would result in formation of 95.  Accordingly, 2-ethyl 
isatogen 94 was treated with 3 equivalents of ethylzinc iodide which resulted in 
complete conversion of ethylisatogen, affording N-alkoxy-3-oxindole 95 in a 
moderate 49% yield. This result indicated that 2-alkylisatogens are potential 
intermediates in the production of the N-alkoxy-3-oxindoles, scheme 96.  
 
Scheme 96. 
Having demonstrated that the observed N-alkoxy-3-oxindole 95 was formed from 2-
ethylisatogen, thereby consuming the desired product in the process, the possibility 
of optimisation towards selective formation of 2-ethylisatogen was reinvestigated. 
As reagent stoichiometry had little impact on by-product formation, we decided to 
vary the nature of the organozinc reagent and as such diethylzinc was employed. In 
the event, similar results were observed to those recorded during the screening of 
ethylzinc iodide stoichiometry, albeit with a greater degree of reproducibility. 
Specifically, when excess diethylzinc was employed the major product was found to 
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be 1-ethoxy-2,2-diethyl-5-methoxyindolin-3-one 95. Similarly, lowering the 
equivalents of diethylzinc afforded mixtures of products and starting materials. 
After some optimisation we found that the use of 1.5 – 2.0 equivalents of 
diethylzinc resulted in full conversion of iodoisatogen over a time period of two 
hours, providing N-alkoxy-3-oxindole 95 as the sole product in a good 68% yield, 
scheme 97. The mechanism of formation of the N-alkoxy-3-oxindole 96 will be 
discussed later on in this thesis. 
 
Scheme 97. 
Maintaining the objective of improving selectivity for generation of the 2-
alkylisatogen, the possibility of using ‘hard’ main group organometallics such as 
Grignards and alkyllithium reagents was investigated. However, in these cases no 
desired product was observed and it appeared that predominantly decomposition 
of 2-iodoisatogen had occurred. This was not too surprising as Grignard reagents 
have been shown to attack at the carbonyl position of 2-phenylisatogen. 
Furthermore, this procedure was reported to be somewhat capricious and low 
yielding, thus highlighting the observed incompatibility of iodoisatogens and 
Grignard reagents.81  Complementary to this, McWhorter, Jr. reported that 
exposure of the structurally analogous 2-aryl-indolones to Grignard reagents also 
resulted in predominant reactivity at the carbonyl position, figure 30.93 
 
Figure 30. 
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We therefore returned to organozinc reagents, and were attracted to work 
reported by Knochel and Sewald whereby the reactivity of alkylzinc reagents was 
modulated by the use of metal salt additives.91,94,95 We were specifically interested 
in the in situ transmetallation of alkylzinc halides with copper salts to generate 
mixed-metal higher order cuprates, analogues of Lipshutz reagents.96,97 The mixed 
metal higher order organocuprate, EtCu(CN)ZnI.2LiCl was prepared according to the 
literature procedure reported by Knochel, scheme 98. Transmetallation of zinc to 
copper was assumed to be quantitative and the resulting cuprate was used 
immediately.91 
 
Scheme 98. 
A slight excess of cuprate was added to a solution of iodoisatogen 69 and the 
reaction mixture left to stir overnight. We were delighted to observe the formation 
of the desired 2-ethylisatogen 94 as the major product, which was isolated in 57% 
yield, significantly higher than the best example recorded with EtZnI. Notably, the 
organocopper reagent did not preclude the formation of the N-alkoxy-3-oxindole 
95, and this was recovered in a low yield of 8%, scheme 99. 
 
Scheme 99. 
A brief stoichiometry screening was performed, however, unsurprisingly it was 
found that fewer equivalents (1.0) did not result in complete conversion of the 
starting material. A small increase in the number of equivalents of organozinc 
halides (1.5 equiv as opposed to 1.2 equiv) resulted in full conversion of 
iodoisatogen, however a greater proportion of N-alkoxy-3-oxinolde 95 (~ 1:3 ratio 
relative to 2-alkylisatogen 94) was observed. It was therefore decided to employ our 
initial conditions to study alternative organozinc cuprates in order to establish the 
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generality of this procedure. Primary organozinc halides were prepared in the same 
manner as EtZnI i.e. insertion of alkyl iodides into Rieke zinc, scheme 100.91 
 
Scheme 100 
A small series of primary alkylzinc iodidies were prepared, unfortunately however, 
this methodology was not applicable to cyclohexyl iodide as solutions of the 
corresponding organometallic were generated with inadequate concentrations 
(~0.15 M). Gratifyingly however, employment of the modified conditions developed 
more recently by Knochel efficiently provided a more concentrated solution of 
cyclohexylzinc iodide (0.44 M solution in THF), scheme 101.98 
 
Scheme 101. 
 
The stock solutions of organozinc halides were then transmetallated to copper and 
reacted with 5-methoxy-2-iodoisatogen 69. The initial screening showed that the 
reaction was compatible with primary alkylcuprates of varying chain length, 
affording the desired 2-alkylisatogens in moderate to good yields. Additionally, the 
methodology could be successfully extended to the preparation of 2-cyclohexyl 
isatogen 99, albeit in a moderate 49% yield, scheme 102. 
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Scheme 102. 
In order to further define the scope of the process, two different isatogens were 
reacted with ethyl zinc cuprate. Although the isolated yields were relatively low, this 
study confirmed that the established reaction conditions were in fact compatible 
with other substrates. Notably however, a significant amount of the corresponding 
isatins were also observed but not isolated cleanly from these reactions. This 
observation suggests that isatogens that do not contain a 5-MeO group are 
significantly less stable under the reaction conditions. Nonetheless, we were 
pleased to find good recovery of overall mass in each of these reactions (85% and 
61%, respectively), scheme 103. 6-Methly-2-iodoistogen 102 was prepared in a 
moderate 48% yield from the corresponding alkynyl iodide 101 via the CuBr.DMS 
(25 mol %) promoted cycloisomerisation, in THF at 65 oC for 2 hours. 
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 aProduct could not be isolated cleanly 
Scheme 103. 
With regard to applying the methodology to generating structurally interesting 
compounds, we were particular intrigued by a recent report from Ramana and co-
workers that showed isatogens bearing a pendant alkene underwent spontaneous 
dipolar cycloaddition, affording the novel class of angularly fused polycycles, 
scheme 104.84  
 
Scheme 104. 
It was envisaged that we could employ our coupling chemistry to install a 1-
pentenyl group which would undergo cycloaddition towards spiro-pseudoindoxyls, 
scheme 105. 
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Scheme 105. 
We considered preparing the requisite pentenyl derived organometallic by direct 
insertion of zinc into the corresponding alkyl bromide, however this proved to be 
inefficient when employing Knochel’s conditions.98 Attention was turned to an 
alternative method developed by Shouquan Huo during the last decade. This 
involved the treatment of zinc dust with a sub-stoichiometric amount of molecular 
iodine in DMA, then addition of the required alkyl halide.99 Gratifyingly, this 
procedure was reproducible in our hands and useful concentrations of pent-4-en-1-
ylzinc 0.69 M in DMF were accessible, scheme 106. 
 
Scheme 106. 
Disappointingly however, subsequent attempts to prepare the corresponding 
cuprate of this organometallic appeared to prove fruitless as only starting 
iodoisatogen was recovered from the subsequent coupling reaction. Increasing the 
stoichiometry of the putative organometallic reagent as well as the use of portion-
wise addition failed to improve matters and recovered iodoisatogen was observed 
in all cases, scheme 107. 
 
Scheme 107. 
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It was concluded that cuprates of this class were not compatible with the THF : DMF 
solvent mixture required for generation of the organozinc reagent. Pleasingly 
however, direct subjection of iodoisatogen 69 to pent-4-en-1-ylzinc bromide 0.69 M 
in DMF afforded the target tricyclic product 108 in a moderate 44% yield and as a 
single diastereoisomer. Additionally, the O-alkylated indoxyl 109 was isolated in a 
slightly lower yield of 33%, scheme 108.  
 
Scheme 108. 
The reaction shown in scheme 108 is intriguing as the product distributions reflect 
the relative rates of two competing processes. Specifically, if the dipolar 
cycloaddition was very rapid then it would not be possible to generate O-alkylated 
indoxly 109.  In contrast, if cycloaddition was slow it could be possible to invert 
product ratios by adding more organozinc reagent. Therefore, iodoisatogen 69 was 
subjected to a greater excess of organometallic reagent. Interestingly, a 
comparative yield of 37% of cycloadduct 108 was produced, indicating that 
cycloaddition was able to compete with indoxyl 109 formation, scheme 109.  
 
Scheme 109. 
Having explored the basic reaction scope, attention returned to the formation of 
the 3-oxindole by-products.  The assignment of these compounds was based on 
NMR, MS, IR but as this compound class had not been reported before, it was 
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thought prudent to find additional structural evidence in order to support our 
proposed structure. It was hoped to elucidate this via X-ray crystallographic 
techniques. In this regard, the only solid example was the cyclohexyl derived 
compound 100. In order to generate sufficient material to grow appropriate quality 
crystals, 5-methoxy 2-iodoisatogen 69 was subjected to an excess of commercially 
available dicyclohexylzinc, affording the desired material 100 in a moderate 41% 
yield, scheme 110.  
 
Scheme 110. 
A crystalline sample of 100 of sufficient quality was grown from isopropyl alcohol, 
and the resulting solid state structure is shown in figure 31 (hydrogen atoms are 
omitted for clarity). It is clear from the solid state structure that double addition of 
the alkyl groups has resulted at the 2 position generating the suspected germinal 
substitution pattern. The remaining alkyl group is clearly shown to be attached to 
the nitroxide, as we assumed. In addition, the carbonyl functionality is preserved 
which could be due to its proximity to the quaternary carbon centre. 
   
Figure 31. 
Having confirmed the structural assignment of the N-alkoxy-3-oxindole products, 
the lability of the N-alkoxy group was investigated. It was envisaged that this 
compound class could potentially provide a novel synthetic strategy towards 2,2-
dialkyl 3-oxindoles. This would be of interest as this structural core is present in a 
number of medicinally important molecules, pesticides and dyes, and also several 
other biologically active compounds bearing this structural fragment at their 
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core.100,101 Moreover, this motif is observed in a variety of natural products such as: 
austamide, aristotelone, and flurocarpamine, figure 32.102,103,104,105 
 
Figure 32. 
Access to these compounds is currently relatively challenging and somewhat 
limited. However, one very effective piece of methodology was recently developed 
by Gagosz and Wetzel, who reported a gold(I) catalysed conversion of 2-alkynyl 
arylazides  to indol-3-ones. The reaction requires the presence of an external allylic 
alcohol nucleophile which generates an intermediate that undergoes a Claisen 
rearrangement to furnish the 3-oxindole, scheme 111.106 
 
 
Scheme 111. 
In the context of this research it was envisaged that N-alkoxy ethers could be 
cleaved via simple hydrogenolysis. Pleasingly, this was confirmed by subjecting N-
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alkoxy-3-oxindole 95 to a catalytic amount of palladium on carbon under 
atmospheric hydrogen, affording 2,2-dialkyl 3-oxindole 110 in a very good 77% 
yield, scheme 112. Notably, use of alternative conditions such as Zn/AcOH failed to 
deliver the reduced product. 
 
Scheme 112. 
Overall, a novel route to 2,2-dialkyl 3-oxindoles has been uncovered. The developed 
route proceeds in 5 steps from commercial starting materials, and proceeds via O-
alkylated indoxlys, a novel class of synthetic intermediates, scheme 113. 
 
Scheme 113. 
2.10 – 2-Iodo Isatogens: Alkyl Lower Order Cuprate Optimisation and Scope 
With the initial reaction procedure investigated it was clear that the reaction was 
not proceeding as efficiently as possible with an average of 60-70% recovery of 
mass. It had been noted that a small amount of isatins were recovered from the 
reactions, around 5%, which is not too surprising as previous investigations had 
shown that isatins were a known decomposition product of isatogens.40 
Additionally, over the course of reaction screening it was observed that there was a 
degree of irreproducibility. When employing the same reaction conditions, yields as 
low as 40% for 2-ethylisatogen 94 were observed together with varying amounts of 
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N-Alkoxy-3-oxindole 95 (10 – 20%). Consequently, a reinvestigation of the reaction 
conditions was undertaken in an attempt to increase the relative amounts of 
desired material and/or identify where the loss of material was occurring.  
We first decided to establish the innate selectivity of lower order cuprates in order 
to form 2-alkylisatogens in preference to N-alkoxy-3-oxindoles, with the possibility 
of the latter originating from unreacted alkyl zinc halides. In the event, subjecting 5-
methoxy 2-ethylisatogen 69 to EtCu(CN)ZnI.2LiCl resulted in complete conversion to 
N-ethoyl-3-oxindole 95, which was isolated in a very good yield of 79%, scheme 114. 
This result provided further support that alkyl isatogens were intermediates 
towards the formation of N-alkoxy-3-oxindoles (c.f. alkylzinc control reaction 
highlighted in scheme 96).  
 
Scheme 114. 
Further optimisation studies included the investigation of classical organocuprate 
reagents in this reaction. However, these failed to provide product, resulting in 
either recovered starting material or decomposition. In the context of reaction 
solvent, we were aware of a report by Gagné and co-workers describing the ability 
of organozinc reagents to react with THF resulting in ring opening and formation of 
butoxide.107 This behaviour was also observed by Lemaire and Knochel during some 
attempted Negishi cross coupling reactions.108 For this reason we also conducted a 
screen of ethereal solvents such as: diethyl ether, dibutyl ether, and cyclopentyl 
methyl ether. However, cuprate formation appeared limited to THF and in addition 
iodoisatogen reactivity and solubility was only observed in THF. 
As variation of solvent or cuprate failed to improve the reaction, it was considered 
that varying the reaction atmosphere could be more effective. In order to 
investigate this, two side by side experiments were performed; one under argon in 
degassed THF and the other simply under nitrogen, i.e. essentially a repeat of the 
original conditions. Somewhat surprisingly, it was observed that the reaction did 
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not perform as well under an argon atmosphere relative to when it was conducted 
under a nitrogen atmosphere, and a lower isolated yield of 2-ethylisatogen was 
observed, table 11.  
 
Entry 
Atmosphere 
(ATM.) 
Isolated Yield / % 
2-Ethylisatogen (94) N-Alkoxy 3-oxindole (95) 
1 N2 47 16 
2 Ar 38 20 
Table 11. 
 
Both sets of conditions yielded a small amount of isatin, <5%, however notably for 
the experiment performed under argon a significant amount of additional material, 
around 10%, was observed (as estimated by 1H NMR spectroscopy of the crude 
reaction mixture). The major impurity in this case was thought to be N-H indol-3-
one 110, which could not be isolated cleanly however contributed to <10% of the 
overall reaction yield. One could assume that N-H indole-3-one 110 and isatin 71 
are possible reduction products of N-ethoxyl indol-3-one and 2-iodoisatogen 
respectively, scheme 115. The appearance of such reduction products may indicate 
why the reaction performed better under a less anaerobic environment. Thus, it 
was chosen to perform the following optimisation reactions solely under a nitrogen 
atmosphere and not under air, as it was considered that over exposure of the 
reaction mixture to too much air could be detrimental in a practical sense.  
 
Scheme 115. 
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It was evident from the previous reaction studies that the transformation appeared 
to be proceeding to full conversion of starting material over the course of 18 hours. 
However, we had not carried out a careful study of the actual reaction time. 
Therefore, experiments were performed over time frames of 2 and 5 hours. It then 
became  apparent that the reaction had stopped at some point before 2 hours, with 
only a ~80% conversion of starting material. We suspected that full conversion was 
observed over 18 hours due to the decomposition of residual starting material 
under the reaction conditions, table 12. 
 
 
Entry Time 
/ h 
Conversion 
/ % 
Isolated Yield/ % 
2-Ethylisatogen 
(94) 
N-Alkoxy 3-oxindole 
(95) 
Overall 
1 2.0 80 56 9 65 
2 5.0 80 62 9 71 
Table 12. 
 
Taking into account the incomplete conversion of starting material under the 
optimal conditions, an empirical study was performed in an attempt to identify a 
more effective cuprate stoichiometry. Several experiments were performed 
whereby 2-iodoisatogen 69 was subjected to increasing amounts of ethyl cuprate, 
then left to react over the course of 2 hours. In the event, 1.7 equivalents were 
found to be optimal and resulted in the best overall yield of 86%, table 13. The 
conditions employing 1.7 equivalents, entry 4, were repeated and left over an 
extended period of 18 hours and gratifyingly, it appeared to have no adverse impact 
on product yield.  
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Entry Equiv. Conversion 
/ % 
Isolated Yield/ % 
2-Ethylisatogen 
(94) 
N-Alkoxy 3-oxindole 
(95) 
Overall 
1 1.3 74 - - - 
2 1.4 80 - - - 
3 1.5 87 59 7 66 
4 1.7 100 68 18 86 
Table 13. 
Optimal conditions had employed an isatogen concentration of 0.03 M, in the hope 
that this would limit the formation of N-alkoxy 3-oxindole by-products. As expected, 
performing the reaction at a relatively high concentration (0.3 M) resulted in a 
larger proportion of N-alkoxy 3-oxindole 95 being formed, 32% versus the 18% 
isolated for 2-ethylisatogen 94. In addition, more decomposition resulted when 
employing these conditions, with an overall yield of only 50% observed. In keeping 
with the previous observation, a low conversion of starting material resulted when 
a very low concentration of 0.003 M was employed, table 14. 
 
Entry Overall Molarity Isolated Yields / % 
/ M 2-Ethylisatogen (94) N-alkoxy-3-oxindole (95) 
1 0.3 18 32 
2 0.03 68 18% 
3 0.003 40% conversion - 
Table 14. 
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The optimised reaction conditions arising from the studies described in this section 
are summarised in scheme 116. Cuprates were prepared in situ as THF solutions 
from their corresponding alkylzinc halides (also generated as THF solutions). 
Iodoisatogens were prepared as a 0.03 M THF solutions, and the reactions were 
conducted under a nitrogen atmosphere and were subjected to 1.7 equivalents of 
cuprate at an ambient temperature before being stirred over the course of 18 
hours.  
 
Scheme 116. 
Before investigating the scope of the reaction, the generation of appropriate 
organozinc reagents was required. Primary organozinc halides were prepared from 
alkyl iodides utilising the procedure outlined by Knochel.91 These organometallics 
were all prepared in useful concentrations, scheme 117.  
 
Scheme 117. 
Secondary organic zinc halides, specifically cyclic variants, were again accessible 
from Knohchel’s modified conditions, scheme 118.98  
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Scheme 118. 
With these organometallics in hand, the scope of the reaction was investigated 
under the newly optimised conditions. The main product in each case was the 
desired 2-alkylisatogen. In addition, the corresponding N-alkoxy 3-oxindoles were 
observed in various proportions (<5 – 23%), the yields for which are quoted in 
parenthesis, scheme 119. It was assumed that transmetallation from zinc to copper 
was a quantitative process. The cyclopropyl substate was derived from commercial 
cyclopropyl zinc iodide (0.14 M, THF). 
Scheme 119. 
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The optimised conditions provided quite consistent product yields and these were 
generally higher than those obtained in our preliminary studies (c.f. scheme 102). 
With specific attention to the lower yielding compounds, 2-cyclopentylisatogen was 
still afforded in a good yield of 49%. However, the major additional material from 
the reaction with the N-alkoxy 3-oxindole 114 isolated in 23%, the highest amount 
observed across the compound class, thus the overall yield for the reaction was still 
a very good 72%. 2-Cyclopropylisatogen 113 was isolated in a moderately good yield 
of 45%, albeit lower than the other examples. Unfortunately, isatogens bearing a 6-
chlorohexylgroup were not accessible as the reaction did not proceed to 
completion, scheme 119. 
The optimised conditions were extended to different iodoisatogens, specifically the 
6-methyliodoisatogen and the parent unsubstituted iodoisatogen. In these cases, 
the overall yields were considerably lower relative to 2-ethyl-5-methoxyisatogen 94, 
and this was consistent with observations made in our preliminary screening, (c.f. 
scheme 103). However, utilisation of the newly optimised conditions did pleasingly 
afford higher yields of the desired 2-ethylisatogens and their N-alkoxy 3-oxindole 
variants, than had been previously observed. Yields for 2-ethylisatogen 103 and 2-
ethyl-6-methyl isatogen 105 formation were improved to ~40% as compared to 
~30-35%, scheme 120.  
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aProduct could not be isolated cleanly 
Scheme 120. 
In order to confirm the impact of using pre-prepared and stored cuprate reagents 
on the efficiency of the coupling reaction, a sample of the n-hexyl iodide derived 
cuprate was prepared. Using an aliquot of this material in the iodoisatogen 
substitution reaction resulted in full conversion of the starting material with 
isolated yields of 72% and 18% (alkylisatogen 97 and N-alkoxy-3-oxindole 98, 
respectively). The remaining sample was stored over a period of 24 h at room 
temperature before reacting with iodoisatogen 69. In the event, only an 80% 
conversion of iodoisatogen was observed. This confirmed that cuprate reagents 
should be used immediately after their preparation by reported literature 
procedures, scheme 121.91  
 
Scheme 121. 
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Having established the scope of the coupling reaction using simple alkyl and 
cycloalkyl groups, it was decided to investigate more elaborate alkyl groups i.e. 
those that contain additional functionality. Accordingly, substrates bearing an ester, 
a boronic ester and a terminal olefin were prepared. Unfortunately, zinc insertion 
did not occur at all when the corresponding alkyl bromides were used, the 
exception being the more activated allyl bromide. 
The low reactivity of zinc towards the key insertion reaction was solved simply by 
changing to the corresponding iodides. Therefore, performing a Finkelstein reaction 
of the alkyl bromides with excess sodium iodide provided the more reactive alkyl 
iodides in excellent yield on useful scales, scheme 122.109 
 
Scheme 122. 
Gratifyingly, insertion of zinc into these alkyl iodides proceeded smoothly, affording 
the organozinc reagents bearing functional tags in useful concentrations. Insertion 
was achieved by using Knochel’s recently reported modified conditions, scheme 
123.98  
 
Scheme 123. 
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With these four functionalised organometallics in hand, their reactivity towards 
iodoisatogens was investigated. To begin this investigation, 5-methoxy iodoisatogen 
69 was subjected to 1.7 equivalents of organometallic in THF at room temperature, 
in accordance with the previously optimised conditions, scheme 124.  
 
Scheme 124. 
In the event, it was disappointing to only observe successful coupling in two out of 
the four organometallic reagents investigated. The ethyl butyrate example 120 and 
the terminal butene substituted example 119 provided products in isolated yields of 
50% and 29%, respectively. In addition, variable amounts of the corresponding N-
alkoxy-3-oxindoles were also observed. It is not clear why the remaining two 
examples did not promote product formation, although in both cases isatogen 
decomposition was observed rather than the recovery of starting material. We 
therefore believe that the reagents were generated in these cases, indeed, there is 
literature precedent for both reagent classes.110,111,112 Regardless, the successful 
application of the terminal alkene and terminal ester examples 119 and 120 were 
deemed enough evidence to demonstrate that this chemistry was compatible with 
some functional groups and so further examples were not pursued. 
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The final aspect of this chemistry to be pursued was a reinvestigation into the 
formation of the interesting tricyclic compound 108, as this would represent a very 
attractive iodoisatogen functionalisation methodology.  Previously it had been 
shown that this could only be afforded in a moderate 44% yield when utilising pent-
4-en-1-ylzinc bromide, with the intramolecular [3+2] dipolar cycloaddition running 
in competition with N-alkoxy-3-oxindole formation. It was hoped that using alkyl 
iodide substrates would allow the zinc insertion step to take place in THF, and thus 
consequently allowing for efficient copper transmetallation. In the event, a 0.71M 
THF solution of pent-4-en-1-ylzinc iodide was realised via the above mentioned 
strategy, scheme 125. 
 
Scheme 125. 
 
With a THF solution of the relevant organometallic in hand, the corresponding 
cuprate was prepared and reacted with iodoisatogen 69, in accordance with the 
optimised conditions. Pleasingly, the desired cycloadduct 108 was isolated in a good 
yield of 62% which was notably higher than the 44% isolated previously when 
directly employing the organozinc halide. In addition, a significant amount of 
material accounted for the structurally attractive spirocyclic amino alcohol 123, the 
reduced derivative of cycloadduct 108. It can therefore be inferred that the overall 
yield of the intermediate isatogen 124 was around 91%. Finally, the N-alkoxy-3-
oxindole 109 was isolated in a 14% yield, a similar yield to that observed in the 
other cuprate reactions, scheme 126.  
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Scheme 126. 
 
The generality of this methodology was also briefly demonstrated via subjection of 
the parent iodoisatogen 70 to the same conditions. Pleasingly, the product was 
isolated in a good 52% yield. In addition, a small amount, <9%, of N-alkoxy-3-
oxindole was also observed, however this was not isolated in pure form, scheme 
127. 
 
Scheme 127. 
In conclusion, the cross coupling of 2-iodoisatogens with alkyl organometallics has 
been developed that allows a series of 2-alkylisatogens to be prepared in good to 
excellent yields. Moreover, this methodology was then extended to more 
interesting substrates bearing additional functionalities. However, in all cases the 
formation of N-alkoxyl-3-oxindoles was observed and this prompted us to 
undertake an investigation into the mechanism of their formation. 
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CHAPTER III 
3.1 – N-Alkoxy-3-oxindole: Condition Screening 
Intrigued by the observed formation and potential application of N-alkoxy-indoles 
95, 106, 104, 100, 98, 112, 121, and 109 we decided to undertake studies to 
elucidate the mechanism of their formation, figure 33.  
 
Figure 33. 
The generation of N-alkoxy-oxindoles from a variety of isatogens took place when 
employing different organometallics such as: dialkylzinc reagents, alkylzinc halides 
and also higher order alkylzinc cuprates. Alkylzinc halides were initially chosen as 
the primary organometallic for the mechanistic investigations as they were easier to 
access and handle relative to the other reagents. Furthermore, 2-phenyl isatogen 85 
was chosen as the model substrate as it was easily prepared. In addition, it was 
thought that the overall transformation would be simplified when starting from a 2-
alkylisatogen as opposed to the 2-iodoisatogens. 
As we had decided to employ a 2-arylisatogen (as opposed to the 2-alkylisatogens 
largely studied up until this point), we decided to revisit the effect of alkylzinc halide 
stoichiometry, table 15. It was immediately clear that three equivalents of 
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organometallic were required to achieve complete conversion of starting material, 
entry 3, with the desired product 126 isolated in a 60% yield. Unfortunately, a 
significant amount of decomposition material was also observed which proved to 
be difficult to remove. Interestingly however, with two equivalents of 
organometallic only a 50% conversion of starting material was observed. It was not 
clear as this stage if the additional equivalent of organometallic was required to 
affect O-alkylation or was consumed via some other means. In connection with 
these studies, the reaction was also conducted under nitrogen, air, and argon. 
However, no significant variations were apparent and similar amounts of N-alkoxy-
3-oxindole product and decomposed material were isolated in each case. 
 
Entry 
EtZnI 
/equiv. 
Product Ratio 
Starting Material (85) N-alkoxy-oxindole (126) 
1 1.0 5.00 1.00 
2 2.0 1.00 1.00 
3 3.0 0.00 1.00 (60%a)b 
aIsolated yield contains additional unknown material (~5%) 
bVariation of reaction medium (Ar, N2, air) had no significant impact 
Table 15. 
Additional organometallic reagents were tested in order to assess the consistency 
of these conditions. nHexylzinc iodide performed as expected affording the product 
127 in a moderately good 61% yield, three equivalents of the organometallic were 
still required with fewer equivalents resulting in lower conversions. Interestingly 
however, attempting the reaction with methylzinc iodide did not result in any 
conversion, and starting isatogen 85 was recovered from this experiment. This 
observation is consistent with the reaction of methyl cuprate which only afforded 
trace amounts of the corresponding N-alkoxy-3-oxindole. We attributed this result 
to the lower nucleophilicity of methyl organometallics. In addition, if this process 
proceeds through the intermediacy of alkyl radicals, then one would suspect this 
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transformation to be disfavoured as a methyl radical is less readily formed relative 
to other carbon based radicals. Finally, secondary alkyl zinc halides were 
investigated, however in the event both cyclopentylzinc iodide and cyclohexylzinc 
iodide produced only small amounts of desired material. Moreover, these 
compounds were heavily contaminated with undefined side-products, scheme 128. 
 
aContains impurities (~5%) 
Scheme 128. 
Pleasingly, N-alkoxy ether cleavage of one of these new N-alkoxy-3-oxindoles was 
achievable through the previously employed hydrogenolysis conditions. In the 
event, 2,2-disubstituted oxindole 128 was afforded in a moderately good 62% yield, 
thus further justifying this chemistry as a viable route towards these biologically 
relevant molecules. Additionally, compound 128 featured two different groups at 
the 2-position, strengthening the possible practical applications of this chemistry, 
scheme 129. 
 
Scheme 129. 
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3.2 – N-Alkoxy-3-oxindole: Mechanistic Proposal 
A literature search provided some insights as to how this interesting transformation 
could be occurring. It was originally reported by Whitesides and Newirth, that the 
oxygen centred radical TEMPO ((2,2,6,6-tetramethylpiperidin-1-yl)oxyl) could be 
alkylated by nBuLi.113 Moreover, Curran and Nagashima further demonstrated the 
generality of this transformation. The reaction was found to be quite general when 
employing a series of different organometallics, including alkylzinc halides and 
higher order zinc cuprates, scheme 130.114 
 
Scheme 130. 
Investigations into this interesting transformation were further performed by 
Bertrand and co-workers. In the context of their research they were specifically 
focusing on the reactions of dialkylzinc reagents with oxygen, which was monitored 
via electron paramagnetic resonance spectroscopy (EPR) techniques. In this study, 
TEMPO was subjected to diethylzinc and in accordance with Curran they suggest 
that TEMPO is trapped by an ethyl radical. This radical can either be generated from 
the reaction of diethylzinc with oxygen or via the single electron reduction of 
TEMPO to the corresponding zinc alkoxide 129, consequently affording an ethyl 
radical in the process. This latter step was found to be reversible when 
reintroducing oxygen into the system. Specifically, it was shown that oxygen could 
convert the “mute” zinc alkoxide species back into TEMPO, which could be further 
trapped by an ethyl radical, scheme 131.115 
 
Scheme 131. 
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The reaction of organometallic reagents with oxygen is well established, and was 
originally reported by Walling and Buckler.116 Evidence for a free radical reaction 
mechanism was later provided by Hock and Ernst.117 With the development of EPR 
techniques, investigations into this reaction were performed by Davies and Roberts, 
prompting them to propose a radical chain mechanism, which is now generally 
accepted, scheme 132.118 
 
Scheme 132. 
On the basis of Curran’s original observations and Bertrand’s more recent results, 
an initial mechanism was proposed which is outlined in scheme 133. The first step 
involves nucleophilic addition to isatogen 130 providing zinc alkoxide 131, which 
undergoes oxidation to give nitroxyl radical 132. We believe that this intermediate 
should behave in a similar manner to TEMPO, based on their structural similarities. 
Accordingly, the final step involves combination of 132 with an alkyl radical, thus 
affording the N-alkoxy-3-oxindole product 133. With regard to reactions of 
iodoisatogens, a preliminary step occurs involving the displacement of iodide by an 
additional equivalent of organometallic, scheme 133 inset.   
 
Scheme 133. 
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Although the proposed scheme is based on strong literature precedent, it requires 
an oxidant to promote the transformation. It was not clear how these oxidative 
processes were occurring and so we considered the possibility that adventitious 
oxygen was mediating these steps. Evidence to suggest that intermediate zinc 
alkoxide 131 could be prone to air oxidation is provided by Pedulli and co-workers. 
Over the course of their investigations into hydroxylamines as oxidation catalysts, 
they report that nitroxyl radical 135 was readily generated from the corresponding 
nitroxide 134 simply from exposure to molecular oxygen, scheme 134.119 In our case 
however, the effect of changing reaction atmosphere from nitrogen and argon to 
air had little impact on the product distribution, which doesn’t appear to be fully 
consistent with this proposal (c.f. table 15). Considerations into other possibilities 
are discussed later on in this thesis. 
 
Scheme 134. 
 
3.3 – N-Alkoxy-3-oxindole: Expansion of Scope 
Regarding the efficiency of the transformation of isatogens to N-alkoxy-3-oxindoles, 
diethylzinc proved to show the highest degree of consistency versus other 
organometallic reagents, (c.f. scheme 97). A possible reason for this could due to 
diethylzinc’s propensity to generate ethyl radicals relative to other ethyl 
organometallics. Bertrand and co-workers described how diethylzinc could be 
employed in a similar manner to the known radical precursor triethylborane.120,121 
Consequently, our subsequent studies into this transformation were performed 
with diethylzinc. Furthermore, it was decided to perform the reactions under a 
nitrogen atmosphere in non-degassed dry solvent, which we believed would 
provide a sufficiently aerobic environment without the risk of igniting pyrophoric 
dialkylzinc reagents. Gratifyingly, treatment of phenylisatogen 85 with a slight 
excess diethylzinc afforded the desired N-alkoxy-3-oxindole 126 in a good 61% yield. 
Moreover this procedure was found to be much more reproducible relative to 
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related reactions with ethylzinc iodide, and also proceeded more cleanly with 
smaller amounts of decomposed material observed, scheme 135.  
 
Scheme 135. 
This methodology was then extended to a small variety of iodoisatogens. Pleasingly, 
N-ethoyl-3-oxindoles 104, and 106 were afforded in good yields, which were 
consistent with those reported for 95, scheme 136.  
 
Scheme 136. 
Finally, we demonstrated that it was possible to perform this chemistry on a 
selection of 2-alkylisatogens, prepared using the cuprate chemistry described in the 
previous chapter. In the event, N-alkoxy-3-oxindoles 136 and 137 were generated in 
good overall yields, scheme 137. 
 
Scheme 137. 
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3.4 – N-Alkoxy-3-oxindole: Additional Mechanistic Considerations 
Returning to the proposed reaction mechanism (c.f. scheme 133) it was clear that 
electron transfer processes on N-alkoxy 3-oxindoles are important for product 
formation. In other words, a formal oxidation was required for this transformation 
to occur. However, the identity of the oxidant was not clear. In this context, Tour 
and co-workers had originally reported the electrochemical reduction of a specific 
isatogen (c.f. scheme 66).60 More recently this has been further demonstrated by  
Nepveu et al., wherein they undertook electrochemical investigations that showed 
isatogen 138 was readily reversibly reduced to the radical anion 139, based on in 
situ EPR studies, scheme 138. Furthermore, it was shown that this is a general 
phenomenon for 2-arylisatogens, and the reduction potential of a series of these 
compounds was recorded.122,123 In addition to this, isatogens are known to be redox 
active and have in fact been reported to form a redox pair with the structurally 
analogous indolone, in a manner analogous to benzoquinone and hydroquinone.124 
 
Scheme 138. 
Based on these observations, we postulated that starting isatogens may act as 
internal oxidants. However, this idea proved difficult to fully rationalise. Specifically: 
 If isatogens were acting as oxidants, we would expect these to be consumed 
in the process. Unfortunately however, we were unable to identify any 
redox related by-products 
 Isatogens could not be acting as the sole oxidant to form radical species 132 
(c.f. scheme 133) as this would limit the maximum potential reaction yield to 
50%. Many experiments provided yields >50% suggesting that this could not 
be the case.  
As well as the isatogens, other potential oxidants were considered. For example, we 
envisaged that the reaction solvent THF could undergo reduction to ring opened 
compounds, but with no indication of n-butanol formation this was ruled out. We 
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next considered the reaction products, N-alkoxy-3-oxindoles. This was in part due to 
an experimental observation whereby a rapid colour change from a dull brown to 
an intense yellow occurred during the reaction quench. It should be noted that the 
N-alkoxy-3-oxindoles form bright yellow solutions. We hypothesised that N-alkoxy-
3-oxindoles could be acting as in situ oxidants, thus being reduced in the process. If 
this reduced form of N-alkoxy-3-oxindole was stable under the reaction conditions 
the final product could be formed upon exposure to air during the reaction quench, 
hence the rapid and intense colour change.  
 
In order to see if the reduction of N-alkoxy-3-oxindoles was possible an 
electrochemical study was performed. The cyclic voltammogram of N-alkoxy-3-
oxindole 95 was recorded figure 34. It was clear from, from figure 34, that N-alkoxy-
3-oxindole 95 could in fact undergo reduction, with two reductions at -2.00 V and -
2.11 V, the first appearing to be irreversible and the latter being rapidly reversible. 
With this observation in mind, it was proposed that N-alkoxy-3-oxindoles could act 
as potential oxidising agents. However, it should be noted that this process requires 
a very low potential. 
 
 
Figure 34. Cyclic voltammogram of 95 (7 mmol cm-3) at a glassy carbon electrode in MeCN-
NBu4PF6 (0.1 mol cm
-3), potential scan rate 0.1 V s-1 
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Additionally, we noted an oxidation at -0.33 V, which we believed could be the 
reverse of the reduction at -2.00 V. This was confirmed as when the cyclic 
voltammogram was recorded without going below a potential of – 1.9 V then the 
proposed opposite oxidation event is not observed, figure 35. From this it can be 
implied that the reduced species formed at- -2.00 V is in fact stable over a large 
range of oxidising conditions, which is consistent with our proposal that a stable 
reduced from of N-alkoxy-3-oxindoles is formed under the reaction conditions. The 
final piece of information gained from this data is that N-alkoxy-3-oxindoles can in 
fact be reversibly oxidised (c.f. the peak at +1.08 V).  However, this is not too 
surprising as one could easily imagine the generation of an aryl cationic species 
being responsible for this.  
 
Figure 35. Cyclic voltammogram of 95 (7 mmol cm-3) at a glassy carbon electrode in MeCN- 
NBu4PF6 (0.1 mol cm
-3), potential scan rate 0.1 V s-1 
Further data that could help substantiate the reversible reduction of N-alkoxy 
oxindoles was gleaned from control experiment alkoxy-3-oxindole 126. Specifically, 
subjection of this compound to either diethylzinc or ethylzinc iodide resulted in 
recovery of starting material without any apparent decomposition of the carbonyl 
or N-alkoxy ether. Notably however in the case of the EtZnI reaction, a 
discolouration of the reaction mixture occurred which was attributed to the 
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apparent formation of molecular iodine, an apolar purple band (characteristic of I2) 
was observed during silica gel chromatographic purification. This formally 
represents an oxidation of the organometallic reagent. As the above 
electrochemical data suggested that N-alkoxy-3-oxinoles can act as oxidants, we 
wondered if these compounds were responsible for the apparent oxidation of the 
ethylzinc iodide. A proposed mechanism that illustrates this hypothesis is presented 
in scheme 140. Moreover, if something akin to this process is occurring then it could 
explain why a super-stoichiometric amount of organometallic reagent is required 
(c.f. table 15), as the formed product would potentially consume an additional 
equivalent of organozinc reagent. 
 
Scheme 140. 
In conclusion, the generality of N-alkoxy-3-oxindole formation from various 
isatogens has been established, with dialkylzinc reagents proving to be optimal for 
this transformation. Additionally, we have formulated a mechanism that appears to 
highlight the potential of these compounds to undergo reversible redox processes. 
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Chapter IV - Experimental 
4.1 – General Experimental 
Infrared (IR) Spectra were recorded on a Perkin Elmer Paragon 100 FTIR 
spectrophotometer, max in cm-1. Samples were recorded as thin films using 
sodium chloride plates. Bands are characterised as broad (br), strong (s), medium 
(m), and weak (w). 1H NMR spectra were recorded on a Bruker AC-250 (250 MHz), 
Bruker AMX-400 (400 MHz) or Avance-400 (400 MHz) supported by an supported by 
an Aspect 3000 data system. Chemical shifts are reported in ppm from 
tetramethylsilane with the residual protic solvent resonance as the internal 
standard (CHCl3: δ 7.27 ppm), (DMSO: δ 2.50 ppm). Data are reported as follows: 
chemical shift, integration, multiplicity (app = apparent, s = singlet, d = doublet, q = 
quartet, quin = quintet, m = multiplet), coupling constants (Hz), and assignment. 13C 
NMR spectra were recorded on a AMX-400 (100.6 MHz) with complete proton 
decoupling. Chemical shifts are reported in ppm from tetramethylsilane with the 
solvent as the internal reference (CDCl3: δ 77.0 ppm), (DMSO: δ 39.52 ppm), 
(Acetone: 29.84 ppm & 206.26 ppm).  
High-resolution mass spectra (HRMS) recorded for accurate mass analysis, were 
performed on either a MicroMass LCT operating in Electrospray mode (TOF ES+), 
Electrospray mode (TOF ES-)  or Electron ionisation(EI+) mode.  
Melting points performed on recrystallised solids, were recorded on a Gallenkamp 
melting point apparatus and are uncorrected. All solvents and reagents were 
purified using standard laboratory techniques according to methods published in 
“Purification of Laboratory Chemicals” by Armarego and Chai.125 THF was distilled 
from sodium metal/benzophenone ketyl (for preliminary iodoisatogen research). 
THF (for optimisation of the reaction of iodoisatogen 69 with organometallics, and 
subsequent studies including N-alkoxy-3-oxindole synthesis), DMF, Et2O, and PhMe 
were purified in accordance to the procedure described by Grubbs.126 
Chemicals purchased from; Sigma-Aldrich® Company Ltd, Alfa Aesar®, VWR 
international®, and Fluorochem® Ltd 
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Flash chromatography was performed on silica gel (BDH Silica Gel 60 43-60). Thin 
layer chromatography (TLC) was performed on aluminium backed plates pre-coated 
with silica (Merck TLC silicagel 60 F254) which were developed using standard 
visualizing agents: Ultraviolet light or potassium permanganate. 
UV-Visible spectra were recorded between 200 – 800 nm as 75 m MeOH solutions 
with a 1 cm path length on a Perkin Elmer lamda 35 spectrometer. 
Cyclic voltammograms were performed on a Princeston Applied Electronics 
VersaSTAT3 with glassy carbon and platinum electrodes and Ag/AgCl as the 
reference in degassed MeCN with tetrabutylammonium hexafluorophosphate (0.1 
M) as the electrolyte at a scan rate of 0.1 V s-1. 
All reactions were performed using flame dried glassware and under an inert 
nitrogen atmosphere, unless otherwise stated.  
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(20) N-(2-Bromophenyl)cinnamamide33 
 
2-Bromoaniline (2.5 g, 14.6 mmol) was dissolved in EtOAc (30 mL), and cinnamoyl 
chloride (5.3 g, 32.1 mmol) in EtOAc (5.0 mL) was added drop-wise at 20 oC resulting 
in the formation of a slurry. The slurry was heated to 85 °C and stirred for 90 
minutes until it became homogeneous, after which the reaction mixture was cooled 
to 0 °C and 3N NaOH was added dropwise until the pH reached 8. Saturated 
NaHCO3(aq) (25 mL) was added and aqueous layer was extracted with EtOAc (2 x 25 
mL). The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo affording a crude colourless solid which was purified by flash 
column chromatography on silica gel (1:4 ethyl acetate : petroleum ether) providing 
the title compound as a colourless solid (2.8 g, 66%). 
1H NMR (250 MHz, CDCl3) δ 8.51 (d, J = 7.5 Hz, 1H, ArH), 7.88 (s, 1H, NH), 7.80 (d, J = 
16.0 Hz, 1H, CH, alkene), 7.62 – 7.53 (m, 3H, ArH), 7.44 – 7.39 (m, 3H, ArH), 7.34 (t, J 
= 7.5 Hz 1H, ArH), 7.00 (t, J = 7.5, 1H), 6.63 (d, J = 15.5 Hz, 1H, CH, alkene); 13C NMR 
(100.6 MHz, CDCl3) δ 163.9, 143.0, 135.9, 134.4, 132.3, 130.2, 128.9, 128.5, 128.1, 
125.2, 122.0, 120.6, 113.5. M.p = 108 – 110 oC (lit = 107 – 108 oC).127 
 
(18) E-3-Benzylideneindolin-2-one 
 
N-(2-Bromophenyl)cinnamamide (100 mg, 0.34 mmol) was dissolved in dry DMF (1 
mL), to this was added sodium formate (26 mg, 0.37 mmol), tetrabutylammonium 
chloride (78 mg, 0.34 mmol), triphenylphosphine (9 mg, 0.03 mmol), and 
palladium(II) acetate (4 mg, 0.02 mmol). The resultant reaction mixture was heated 
at 120 oC for 24 hours, after which it was diluted with EtOAc (10.0 mL) and then 
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washed with water (2x 10 mL) followed by brine (5 mL). Organic layer was dried 
over MgSO4, filtered and then concentrated in vacuo to give a yellow residue which 
was purified by flash column chromatography on silica gel (1:4 ethyl acetate : 
petroleum ether) providing the title compound as a yellow solid as single 
stereoisomer (20 mg, 13%). Stereochemistry of alkene assigned as E based on 
literature precedent.25 
1H NMR (250 MHz, CDCl3) δ 8.42 (s, 1H, NH), 7.86 (s, 1H, CH alkene), 7.74 – 7.63 (m, 
3H), 7.55 – 7.42 (m, 3H), 7.23 (t, 1H, J = 7.5), 6.92 (d, J = 8.0 Hz, 1H), 6.89 (t, J = 7.5 
Hz, 1H); 13C NMR (100.6 MHz, CDCl3) δ 170.2, 141.6, 137.7, 135.0, 132.1, 130.0, 
129.8, 129.5, 128.8, 128.5, 123.2, 122.0, 110.3; M.p = 190 – 194 oC (CH2Cl2) (lit = 195 
– 196 oC).128 
(22) (E)-Tert-butyl (2-bromophenyl)(cinnamoyl)carbamate 
 
N-(2-Bromophenyl)cinnamamide (0.500 g, 1.7 mmol)  was dissolved in THF (20 mL), 
to this was added 4-dimethylaminopyridine (0.250 g, 2.21 mmol) and di-tert-butyl 
dicarbonate (0.480 g, 2.21 mmol). The resulting reaction mixture was stirred at 20 
oC for 50 minutes and then diluted with Et2O (50 mL). The organic layer washed with 
1N HCl(aq) (15 mL) then saturated NaHCO3(aq) (15 mL) and then brine (10 mL). 
Organic layer dried over MgSO4, filtered and then concentrated in vacuo to afford 
the tile compound as a colourless solid (0.670 g, 98%). 
1H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 15.5 Hz, 1H, CH Alkene), 7.70 (d, J = 15.5 Hz, 
1H CH Alkene), 7.68 (dd, J = 8.5, 1.0 Hz, 1H, ArH), 7.65 – 7.61 (m, 2H, ArH), 7.44 – 
7.38 (m, 4H, ArH), 7.27 (d, J = 7.5 Hz, 2H, ArH), 1.45 (s, 9H, CH3);
 13C NMR (100.6 
MHz, CDCl3) δ 167.5, 151.8, 144.9, 138.4, 135.0, 133.0, 130.2, 130.2, 129.5, 128.8, 
128.4, 128.2, 123.3, 120.3, 83.6, 27.8; FTIR (film cm-1)max: 2984 (m), 1736 (s), 1686 
(s), 1474 (m), 1370 (m), 1336 (m), 1298 (s), 1103 (s), 843 (m); HRMS (TOF MS ES+) 
m/z calculated for [C20H21
79BrNO3]
+: 402.0705 [M+H]+, found 402.0722; M.p = 108 – 
109 oC (CH2Cl2) 
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(24) (E)-Ethyl 2-(2-oxoindolin-3-ylidene)acetate21 
 
Isatin (1.00 g, 6.8 mmol) was dissolved in PhMe (20 mL), to this was added 
(carbethoxymethylene)triphenylphosphorane (2.61 g, 7.5 mmol) and the resultant 
reaction mixture was then stirred at 21 oC for 16 hours. After which the reaction 
mixture was concentrated in vacuo to give a crude orange solid which was purified 
by flash column chromatography on silica gel (1:1 ethyl acetate : petroleum ether) 
providing the title compound as an orange solid (1.46 g, 99%). 
1H NMR (400 MHz, DMSO) δ 10.80 (s, 1H, NH), 8.34 (d, J = 7.5 Hz, 1H, ArH), 7.35 (td, 
J = 7.5, 1.0 Hz, 1H, ArH), 7.00 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.87 (d, J = 7.5 Hz, 1H, 
ArH), 6.58 (s, 1H, CH alkene), 4.27 (q, J = 7.0 Hz, 2H, CH2), 1.29 (t, J = 7.0 Hz, 3H, 
CH3);
 13C NMR (100.6 MHz, DMSO) δ 167.8, 165.1, 145.0, 138.2, 133.0, 128.0, 121.9, 
120.7, 119.6, 110.3, 61.0, 14.0; M.p = 178 – 179 oC (EtOAc) (lit = 183 – 185 oC).21 
 
(26) (E)-N-methoxy-N-methyl-2-(2-oxoindolin-3-ylidene)acetamide 
 
Isatin (1.00 g, 6.8 mmol) was dissolved in PhMe (20 mL), to this was added N-
methoxy-N-methyl(triphenylphosphoranylidene)acetamide (2.70 g, 7.5 mmol), The 
resultant reaction mixture was then stirred at 21 oC for 18 hours. After which the 
reaction mixture was concentrated in vacuo to give a crude orange solid which was 
purified by flash column chromatography on silica gel (1:1 ethyl acetate : petroleum 
ether) providing the title compound as an orange solid (1.48 g, 94%). 
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1H NMR (250 MHz, CDCl3) δ 8.73 (s, 1H, NH), 8.36 (d, J = 7.5 Hz, 1H, ArH), 7.35 (s, 
1H, CH alkene), 7.26 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.98 (td, J = 7.5, 1.0 Hz, 1H, ArH), 
6.85 (d, J = 7.5 Hz, 1H, ArH), 3.76 (3H, CH3), 3.35 (s, 3H, CH3);
 13C NMR (100.6 MHz, 
CDCl3) δ 169.8, 165.9, 143.0, 136.4, 132.0, 128.5, 122.9, 122.5, 120.6, 110.2, 62.4, 
32.5. FTIR (film cm-1)max: 1718 (s), 1650 (s), 1464 (s), 1369 (w), 1343 (s), 1213 (m), 
1090 (w), 785(m); HRMS (TOF MS ES+) m/z calculated for [C12H13N2O3]
+: 233.0926 
[M+H]+, found 233.0916; M.p = 132 – 134 oC (CH2Cl2) 
 
(26) Tert-butyl 2,3-dioxoindoline-1-carboxylate (N-Boc Isatin)129 
 
Isatin (5.00 g, 34.0 mmol) was dissolved in THF (200 mL), 4-dimethylaminopyridine 
(4.95 g, 44.2 mmol) and di-tert-butyl dicarbonate (9.60 g, 44.2 mmol) were added. 
The reaction mixture was stirred at 20 oC for 50 minute and then diluted with Et2O 
(200 mL). The organic layer washed with 1N HCl(aq) (100 mL) then saturated 
NaHCO3(aq) (100 mL) and then brine (50 mL). Organic layer dried over MgSO4, 
filtered and then concentrated in vacuo to afford the title compound as a yellow 
solid (8.77 g, 100%). 
1H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 8.5 Hz, 1H, ArH), 7.75 – 7.66 (m, 2H, ArH), 
7.28 (td, J = 7.5, 0.5 Hz, 1H, ArH), 1.65 (s, 9H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 
180.4, 155.8, 150.5, 148.4, 138.9, 125.5, 118.7, 116.9, 85.7, 28.1;1 M.p = 119 – 120 
oC (CH2Cl2) 
 
 
 
 
                                                          
1
 Quaternary carbon not observed. 
Page | 123  
 
(27) (E)-Tert-butyl 3-(2-(methoxy(methyl)amino)-2-oxoethylidene)-2-oxoindoline-
1-carboxylate 
 
Tert-butyl 2,3-dioxoindoline-1-carboxylate (2.00 g, 6.3 mmol) was dissolved in PhMe 
(20 mL), and to this was added N-Methoxy-N-methyl-
(triphenylphosphoranylidene)acetamide (2.53 g, 7.0 mmol). The resultant reaction 
mixture was then stirred at 21 oC for 16 hours. The reaction mixture was then 
concentrated in vacuo to give a crude orange solid which was purified by flash 
column chromatography on silica gel (1:1 ethyl acetate : petroleum ether) providing 
the title compound as a yellow solid (2.10 g, 100%). 
1H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 7.5 Hz, 1H, ArH), 7.81 (d, J = 8.0 Hz, 1H, ArH), 
7.31 (s, 1H, CH alkene), 7.30 (app td, J = 7.5, 1.0 Hz, 1H, ArH), 7.06 (app td, J = 8.0, 
1.0 Hz, 1H, ArH), 3.65 (s, 3H, CH3), 3.26 (s, 3H, CH3), 1.57 (s, 9H, CH3);
 13C NMR 
(100.6 MHz, CDCl3) δ 166.2, 165.6, 149.0, 141.3, 134.3, 132.1, 127.5, 124.6, 123.4, 
120.2, 114.9, 84.6, 62.3, 32.3 28.1; FTIR (film cm-1)max: 2980 (m), 1755 (s), 1732 (s), 
1655 (s), 1423 (s), 1351 (s), 1253 (m), 1153 (s), 1093 (m), 1004 (w), 784 (w); HRMS 
(TOF MS ES+); HRMS (TOF MS ES+) m/z calculated for [C20H21N2O5]
+: 333.1450 
[M+H]+, found 333.1452; M.p = 198 – 192 oC (CH2Cl2) 
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4.2  – Representative Procedure: 1 
(29) 3-Hydroxy-3-(2-oxo-2-phenylethyl)indolin-2-one13 
 
Isatin (5.00 g, 34.0 mmol) was dissolved in MeOH (340.0 mL) and to this was added 
acetophenone (6.10 g, 34.0 mmol) followed by diethylamine (catalytic). The 
reaction mixture was stirred at 20 oC for 20 hours upon which the title compound 
precipitated as a colourless solid, isolated via filtration and dried in vacuo (8.85 g, 
64%). 
1H NMR (250 MHz, DMSO) δ 10.27 (s, 1H, NH), 7.88 (d, J = 8.5 Hz, 2H, ArH), 7.67 – 
7.56 (m, 1H, ArH), 7.54 – 7.43 (m, 2H, ArH), 7.27 (d, J = 7.0 Hz, 1H, ArH), 7.16 (td, J = 
7.5, 1.0 Hz, 1H, ArH), 6.89 – 6.74 (m, 2H, ArH), 6.07 (s, 1H, OH), 4.07 (d, J = 17.5 Hz, 
1H, CH2), 3.58 (d, J = 17.5 Hz, 1H CH2);
 13C NMR (100.6 MHz, DMSO) δ 197.0, 178.8, 
143.4, 136.6, 133.9, 132.2, 129.4, 129.2, 128.4, 124.1, 121.6, 109.9, 73.5, 46.2; M.p 
= 200 – 201 oC (MeOH) (lit = 196.6 – 197.8 oC).130 
 
(30) 3-(2-(4-Chlorophenyl)-2-oxoethyl)-3-hydroxyindolin-2-one 
 
Using representative procedure 1, isatin (0.50 g, 3.40 mmol), 4-chloroacetophenone 
(0.53 g, 3.40 mmol) and diethylamine (catalytic) in EtOH (35 mL) gave 38 as a 
colourless solid (1.00 g, 100%).  
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1H NMR (250 MHz, DMSO) δ 10.28 (s, 1H, NH), 7.89 (d, J = 8.5 Hz, 2H, ArH), 7.56 (d, J 
= 8.5 Hz, 2H, ArH), 7.26 (d, J = 7.0 Hz, 1H, ArH), 7.16 (app td, J = 7.5, 1.0 Hz, 1H, 
ArH), 6.90 – 6.75 (m, 2H, ArH), 6.08 (s, 1H, OH), 4.05 (d, J = 17.5 Hz, 1H, CH2), 3.55 
(d, J = 17.5 Hz, 1H, CH2); 
13C NMR (100.6 MHz, DMSO) δ 195.6, 178.3, 142.9, 138.4, 
134.9, 131.6, 129.9, 129.0, 128.8, 123.7, 121.2, 109.5, 73.04, 45.8; M.p = 189 – 192 
oC (MeOH) (lit = 196.0 – 197.4 oC).130 
 
(31) 3-Hydroxy-3-(2-oxo-2-(pyridin-3-yl)ethyl)indolin-2-one 
 
Using representative procedure 1, isatin (1.00 g, 6.80 mmol), 3-acetylpyridine (1.23 
g, 3.40 mmol) and diethylamine (catalytic) in MeOH (50.0 mL) afforded the title 
compound as a colourless solid (1.60 g, 88%).  
1H NMR (250 MHz, DMSO) δ 10.30 (s, 1H, NH), 9.05 (d, J = 1.5 Hz, 1H, ArH), 8.77 (dd, 
J = 5.0, 1.5 Hz, 1H, ArH), 8.25 – 8.17 (m, 1H, ArH), 7.52 (dd, J = 8.0, 5.0 Hz, 1H, ArH), 
7.28 (d, J = 7.0 Hz, 1H, ArH), 7.16 (app td, J = 8.0, 1.5 Hz, 1H, ArH), 6.90 – 6.75 (m, 
2H, ArH), 6.11 (s, 1H, OH), 4.10 (d, J = 17.5 Hz, 1H, CH2), 3.59 (d, J = 17.5 Hz, 1H, 
CH2);
 13C NMR (100.6 MHz, DMSO) δ 196.2, 178.2, 153.6, 149.3, 142.8, 135.5, 131.5, 
131.5, 129.0, 123.8, 123.8, 121.2, 109.5, 73.0, 46.0; FTIR (film cm-1)max: 3211 (br), 
1722 (s), 1693 (s), 1621 (m), 1588 (m), 1472 (m), 1356 (m), 1182 (w), 754 (m), 734 
(m), 700 (m); HRMS (TOF MS ES+) m/z calculated for [C15H13N2O3]
+: 269.0926 
[M+H]+, found 269.0923; M.p = 73 – 75 oC (MeOH) 
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(32) 3-Hydroxy-3-(2-(4-methoxyphenyl)-2-oxoethyl)indolin-2-one  
 
Using representative procedure 1, isatin (2.00 g, 13.6 mmol), 4-
methoxyacetophenone (3.10 g, 20.4 mmol) and diethylamine (1.50 g, 20.4 mmol) in 
MeOH (100. 0 mL) afforded the title compound as a colourless solid (3.00 g, 72%). 
1H NMR (250 MHz, DMSO) δ 10.24 (s, 1H, NH), 7.85 (d, J = 9.0 Hz, 2H, ArH), 7.24 (d, J 
= 7.0 Hz, 1H, ArH), 7.15 (app td, J = 7.5, 1.0 Hz, 1H, ArH), 7.00 (d, J = 9.0 Hz, 2H, 
ArH), 6.89 – 6.75 (m, 2H, ArH), 6.02 (s, 1H, OH), 4.00 (d, J = 17.5 Hz, 1H, CH2), 3.50 
(d, J = 17.5 Hz, 1H, CH2);
 13C NMR (100.6 MHz, DMSO) δ 194.8, 178.5, 163.3, 143.0, 
131.9, 130.3, 129.2, 128.9, 123.6, 121.10, 113.9, 109.4, 73.1, 55.6, 45.4; M.p = 172 – 
173 oC (MeOH) (lit = 181.2 – 183.7 oC).130 
 
4.3 – Representative Procedure: 2  
 (33) (E)-3-(2-Oxo-2-phenylethylidene)indolin-2-one 
 
3-Hydroxy-3-(2-oxo-2-phenylethyl)indolin-2-one  (5.00 g, 18.7 mmol) was dispersed 
in EtOH (100.0 mL) and treated with 37% HCl(aq) (2.0 mL) and glacial ethanoic acid 
(50.0 mL). The reaction mixture was heated to reflux upon which it became 
homogeneous and turned red. After heating at reflux for 24 hours, the reaction 
mixture was cooled to room temperature and quenched with saturated NaHCO3(aq). 
The reaction mixture was extracted with ethyl acetate (2 x 100 mL), and the 
combined extracts were dried over magnesium sulphate. The solvent was removed 
in vacuo to afford the title compound as an orange solid, (4.10 g, 95%). 
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1H NMR (250 MHz, DMSO) δ 10.82 (s, 1H, NH), 8.07 (d, J = 7.0 Hz, 2H, ArH), 8.01 (d, J 
= 7.5 Hz, 1H, ArH), 7.75 – 7.67 (m, 2H, ArH, CH alkene), 7.65 – 7.55 (m, 2H, ArH), 
7.35 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.95 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.88 (d, J = 7.5 
Hz, 1H, ArH); 13C NMR (100.6 MHz, CDCl3) δ 191.1, 169.7, 143.4, 137.5, 136.9, 133.9, 
132.8, 129.0, 128.8, 128.0, 126.5, 122.9, 120.6, 110.3; FTIR (thin film cm-1)max: 1714 
(s), 1660 (s), 1462 (m), 1326 (s), 1228 (s), 1016 (m), 780 (w), 749 (w); HRMS (TOF MS 
ES+) m/z calculated for [C16H12NO2]
+: 250.0869 [M+H]+, found 250.0871; M.p. = 179-
180 oC (iPrOH) 
 
(28)  (E)-3-(2-(4-Chlorophenyl)-2-oxoethylidene)indolin-2-one 
 
Using representative procedure 2, 3-(2-(4-chlorophenyl)-2-oxoethyl)-3-
hydroxyindolin-2-one  (1.00 g, 3.40 mmol) in EtOH (35.0 mL), HCl(aq) (0.4 mL), and 
glacial ethanoic acid (10.0 mL) provided the title compound as a dark red solid, 
(0.68 g, 70%).  
1H NMR (250 MHz, DMSO) δ 10.83 (s, 1H, NH), 8.09 (d, J = 8.5 Hz, 2H, ArH), 8.05 (d, J 
= 7.5 Hz, 1H), 7.69 (s, 1H, CH alkene), 7.67 (d, J = 8.5 Hz, 2H, ArH), 7.36 (td, J = 7.5, 
1.0 Hz, 1H, ArH), 6.96 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.89 (d, J = 7.5 Hz, 1H, ArH); 13C 
NMR (100.6 MHz, DMSO) δ 190.1, 168.1, 145.1, 139.0, 136.8, 135.8, 133.2, 130.5, 
129.3, 126.9, 125.3, 121.8, 119.9, 110.4; FTIR (thin film cm-1)max: 1717 (s), 1667 (w), 
1602 (m), 1403 (w), 1332 (m), 1233 (w), 1009 (w), 839 (m), 782 (m); HRMS (TOF MS 
ES+) m/z calculated for [C16H11
35ClNO2]
+: 284.0478 [M+H]+, found 284.0490; M.p. = 
177-178 oC (iPrOH) 
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(35)  (E)-3-(2-Oxo-2-(pyridin-3-yl)ethylidene)indolin-2-one 
 
Using representative procedure 2, 3-hydroxy-3-(2-oxo-2-(pyridin-3-yl)ethyl)indolin-
2-one  (1.00 g, 3.40 mmol) in EtOH (30.0 mL), 37% HCl(aq) (0.4 mL), and glacial 
ethanoic acid (10.0 mL) provided the title compound as a dark red solid, (0.23 g, 
48%). 
1H NMR (250 MHz, DMSO) δ 10.84 (s, 1H, NH), 9.21 (s, 1H, ArH), 8.86 (dd, J = 5.0, 
1.0 Hz, 1H, ArH), 8.49 – 8.36 (m, 1H, ArH), 8.16 (d, J = 7.5 Hz, 1H, ArH), 7.72 (s, 1H, 
CH alkene), 7.64 (dd, J = 7.5, 5.0 Hz, 1H, ArH), 7.64 (dd, J = 7.5, 5.0 Hz, 1H, ArH), 7.38 
(t, J = 7.5 Hz, 1H, ArH), 6.98 (t, J = 7.5 Hz, 1H, ArH), 6.89 (d, J = 7.5 Hz, 1H, ArH); 13C 
NMR (100.6 MHz, DMSO) δ 191.3, 169.1, 154.8, 150.5, 146.2, 138.2, 137.0, 134.3, 
133.6, 128.0, 125.7, 125.1, 122.7, 120.8, 111.4; FTIR (thin film cm-1)max: 1714 (m), 
1599 (s), 1462 (w), 1015 (m), 786 (m), 751 (m); HRMS (TOF MS ES+) m/z calculated 
for [C15H11N2O2]
+: 251.0821 [M+H]+, found 251.0828; M.p. = 160-161 oC (EtOH) 
 
(34)  (E)-3-(2-(4-Methoxyphenyl)-2-oxoethylidene)indolin-2-one & (36) Ethyl 2-(4-
methoxyphenyl)quinoline-4-carboxylate
 
Following representative procedure 2, 3-hydroxy-3-(2-(4-methoxyphenyl)-2-
oxoethyl)indolin-2-one(1.00 g, 3.37 mmol) in EtOH (35.0 mL), HCl(aq) (0.4 mL) and 
glacial ethanoic acid (10.0 mL) gave a mixture of two products which were 
separated by flash column chromatography on silica gel (1:1 ethyl acetate : 
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petroleum ether). The major product 34 was afforded as an orange solid, (0.58 g, 
62%). The minor product 36 was afforded as a white crystalline solid (0.09 g, 9%) 
- (34) 
1H NMR (250 MHz, DMSO) δ 10.78 (s, 1H, NH), 8.03 (d, J = 9.0 Hz, 2H, ArH), 7.96 (d, J 
= 8.0 Hz, 1H, ArH), 7.65 (s, 1H, ArH), 7.31 (td, J = 8.0, 1.0 Hz, 1H, ArH), 7.08 (d, J = 9.0 
Hz, 2H, ArH), 6.93 (t, J = 8.0 Hz, 1H, ArH), 6.87 (d, J = 8.0 Hz, 1H, ArH), 3.85 (s, 3H, 
CH3);
 13C NMR (100.6 MHz, DMSO) δ 189.6, 168.3, 163.9, 144.7, 135.7, 132.6, 131.1, 
130.0, 126.6, 126.5, 121.7, 120.1, 114.4, 110.3, 55.7; FTIR (thin film cm-1)max: 1715 
(s), 1655 (m), 1614 (m), 1572 (m), 1465 (w), 1335 (w), 1241 (m), 1181 (m), 1015 (w), 
842 (w), 782 (m); HRMS (TOF MS ES+) m/z calculated for [C17H14NO2]
+: 280.0974 
[M+H]+, found 280.0983; M.p. = 169-170 oC ( iPrOH). 
- (36) 
1H NMR (400 MHz, CDCl3) δ 8.72 (d, J = 8.5 Hz, 1H), 8.35 (s, 1H), 8.22 (d, J = 9.0 Hz, 
2H), 8.18 (d, J = 8.5 Hz, 1H), 7.75 (t, J = 8.5 Hz, 1H), 7.60 (t, J = 8.5 Hz, 1H), 7.07 (d, J 
= 9.0 Hz, 2H), 4.55 (q, J = 7.0 Hz, 2H), 3.90 (s, 3H), 1.51 (t, J = 7.0 Hz, 3H); 13C NMR 
(100.6 MHz, CDCl3) δ 166.7, 161.2, 156.4, 149.4, 136.1, 131.5, 130.2, 129.9, 129.0, 
127.4, 125.5, 123.8, 119.9, 114.4, 62.0, 55.5, 14.5; FTIR (thin film cm-1)max: 2916 
(m), 2853 (w), 1594 (s), 1548 (m), 1504 (s), 1370 (m), 1346 (s), 1253 (s), 1175 (s), 
1194 (s), 1033 (s), 775 (m); HRMS (TOF MS ES+) m/z calculated for [C19H18NO3]
+: 
308.1287 [M+H]+, found 308.1296; M.p. = 70 – 72 oC (CH2Cl2). 
 
(37) 1-Methylindoline-2,3-dione (N-methylisatin) 
 
Isatin (1.00 g, 6.8 mmol) was added to a suspension to of sodium hydride (0.41 g, 
10.2 mmol) in THF (50 mL) at 0 oC. Reaction stirred at 0 oC for 1 hour after which 
methyl iodide (1.10 g, 7.5 mmol) was added and reaction was heated at reflux for a 
further 16 hours. The reaction mixture was cooled to 19 oC and quenched with H2O 
(50 mL) then extracted with ethyl acetate (2 x 70 mL). The organic layers were 
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combined and dried over MgSO4, filtered and then concentrated in vacuo to afford 
the title compound as a red solid, which was purified via recrystallisation (CH2CL2 : 
Petroleum ether 40-60) (1.10 g, 100 %). 
1H NMR (400 MHz, DMSO) δ 7.67 (td, J = 7.5, 1.2 Hz, 1H, ArH), 7.53 (d, J = 7.5 Hz, 1H, 
ArH), 7.14 (d, J = 7.5 Hz, 1H, ArH), 7.12 (t, J = 7.5 Hz, 1H, ArH), 3.13 (s, 3H, CH3); 
13C 
NMR (100.6 MHz, CDCl3) δ 183.4, 158.2, 151.4, 138.5, 125.2, 123.8, 117.4, 110.0, 
26.2; M.p = 121-123 oC (lit = 129 -130 oC).131 
 
(38a) 3-Hydroxy-1-methyl-3-(2-oxo-2-phenylethyl)indolin-2-one 
 
Using representative procedure 1 N-methylisatin (1.00 g, 6.2 mmol), acetophenone 
(1.12 g, 9.32 mmol) and diethylamine (catalytic) in MeOH (50.0 mL) afforded the 
title compound as a colourless solid (1.08 g, 65%). 
1H NMR (400 MHz, DMSO) δ 7.87 (d, J = 8.5 Hz, 2H, ArH), 7.62 (t, J = 7.5 Hz, 1H, 
ArH), 7.48 (app t, J = 8.0 Hz, 2H, ArH), 7.34 (d, J = 7.5 Hz, 1H, ArH), 7.27 (t, J = 7.5 Hz, 
1H, ArH), 6.98 (d, J = 7.5 Hz, 1H, ArH), 6.94 (t, J = 7.5 Hz, 1H, ArH), 6.15 (s, 1H, OH), 
4.14 (d, J = 17.5 Hz, 1H, CH2), 3.65 (d, J = 17.5 Hz, 1H, CH2), 3.15 (s, 1H, CH3); 
13C 
NMR (100.6 MHz, DMSO) δ 196.5, 176.7, 144.4, 136.0, 133.5, 131.1, 129.1, 128.7, 
127.9, 123.2, 121.8, 108.2, 72.7, 46.1, 26.0; M.p = 177 – 179 oC (CH2Cl2) (lit = 176.5 – 
178.0 oC).130 
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(38) (E)-1-Methyl-3-(2-oxo-2-phenylethylidene)indolin-2-one 
 
Using representative procedure 2, 3-hydroxy-1-methyl-3-(2-oxo-2-
phenylethyl)indolin-2-one (0.90 g, 3.20 mmol) in EtOH (30.0 mL), HCl(aq) (0.4 mL) 
and glacial ethanoic acid (10.0 mL) for 3 hours afforded the title compound as a red 
solid, (0.54 g, 94%). 
1H NMR (400 MHz, DMSO) δ 8.08 (d, J = 7.5 Hz, 2H, ArH), 7.99 (d, J = 7.5 Hz, 1H, 
ArH), 7.80 (s, 1H, CH alkene), 7.73 (t, J = 7.5 Hz, 1H, ArH), 7.61 (t, J = 7.5 Hz, 2H, 
ArH), 7.44 (t, J = 7.5 Hz, 1H, ArH), 7.07 (d, J = 7.5 Hz, 1H, ArH), 7.02 (t, J = 7.5 Hz, 1H, 
ArH), 3.21 (s, 3H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 188.6, 146.3, 137.3, 135.7, 
134.7, 133.3, 129.7, 129.3, 129.1, 127.4, 126.6, 122.8, 119.7, 109.7, 26.7; FTIR (thin 
film cm-1)max: 1715 (s), 1662 (s), 1601 (s), 1367 (m), 1338 (m), 1228 (s), 1100 (w), 
1011 (w), 778 (w), 750 (m); HRMS (TOF MS ES+) m/z calculated for [C17H14NO2]
+: 
264.1025 [M+H]+, found 264.1036; M.p. = 97-98 oC. (CH2Cl2 : Petroleum ether 40 - 
60) 
(39a) 3-(2-(4-Chlorophenyl)-2-oxoethyl)-3-hydroxy-1-methylindolin-2-one 
 
Using representative procedure 1, N-methylisatin (0.50 g, 3.10 mmol), 4-
chloroacetophenone (0.72 g, 4.66 mmol) and diethylamine (5 drops) in MeOH (30 
mL) gave a crude colourless solid. This was purified by recrystallisation with CH2Cl2 
Page | 132  
 
and petroleum ether, affording the title compound as a colourless solid (0.81 g, 
97%). 
1H NMR (400 MHz, DMSO) δ 7.88 (app d, J = 8.5 Hz, 2H, ArH), 7.55 (app d, J = 8.5 Hz, 
2H, ArH), 7.33 (dd, J = 7.5, 1.0 Hz, 1H, ArH), 7.27 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.98 
(d, J = 7.5 Hz, 1H, ArH), 6.94 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.18 (s, 1H, OH), 4.13 (d, J 
= 17.5 Hz, 1H, CH2), 3.63 (d, J = 17.5 Hz, 1H, CH2), 3.14 (s, 3H, CH3); 
13C NMR (100.6 
MHz, DMSO) δ 195.5, 176.6, 144.3, 138.4, 134.7, 130.9, 129.9, 129.1, 128.8, 123.2, 
121.9, 108.2, 72.7, 46.0, 26.0; FTIR (film cm-1)max: 3345 (br), 1683 (s), 1618 (m), 
1590 (w), 1479 (m), 1355 (w), 1212 (w), 1694 (m), 990 (w), 754 (w); HRMS (TOF MS 
ES+) m/z calculated for [C17H15
35ClNO3]
+: 316.0740 [M+H]+, found 316.0725; M.p = 
156 – 158oC (CH2Cl2). 
 
(39) (E)-3-(2-(4-Chlorophenyl)-2-oxoethylidene)-1-methylindolin-2-one 
 
Using representative procedure 2, 3-(2-(4-chlorophenyl)-2-oxoethyl)-3-hydroxy-1-
methylindolin-2-one (0.81 g, 2.60 mmol) in EtOH (25.0 mL), HCl(aq) (0.3 mL), and 
glacial ethanoic acid (8.0 mL) for 3 hours provided the title compound as a red solid, 
(0.73 g, 94%). 
1H NMR (400 MHz, DMSO) δ 8.10 (app d, J = 8.5 Hz, 2H, ArH), 8.02 (d, J = 7.5 Hz, 1H, 
ArH), 7.77 (s, 1H, CH alkene), 7.68 (app d, J = 8.5 Hz, 2H, ArH), 7.46 (app td, J = 8.0, 
1.0 Hz, 1H, ArH), 7.08 (d, J = 8.0 Hz, 1H, ArH), 7.04 (app td, J = 7.5, 1.0 Hz, 1H, ArH), 
3.21 (s, 1H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 189.7, 167.9, 146.3, 140.4, 137.2, 
136.1, 133.0, 130.3, 129.3, 128.0, 125.3, 122.9, 120.1, 108.4, 26.4; FTIR (thin film 
cm-1)max: 1705 (s), 1660 (s), 1601 (s), 1470 (m), 1402 (w), 1369 (m), 1336 (m), 1231 
(s), 1093 (m), 1009 (m), 837 (m), 780 (m), 743 (s); HRMS (TOF MS ES+) m/z 
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calculated for [C17H13
35ClNO2]
+: 298.0635 [M+H]+, found 298.0646; M.p. = 140-141 
oC (CH2Cl2 : Petroleum ether 40 - 60). 
 
(40a) 3-Hydroxy-3-(2-(4-methoxyphenyl)-2-oxoethyl)-1-methylindolin-2-one 
 
Using representative procedure 1, N-methylisatin (0.50 g, 3.10 mmol), 4-
chloroacetophenone (0.70 g, 4.66 mmol) and diethylamine (5 drops) in MeOH (30 
mL) gave a crude colourless solid. This was purified by recrystallisation with CH2Cl2 
and petroleum ether, affording the title compound as a colourless solid (0.88 g, 
91%). 
1H NMR (250 MHz, DMSO) δ 7.84 (d, J = 9.0 Hz, 1H, ArH), 7.36 – 7.20 (m, 2H, ArH), 
7.04 – 6.87 (m, 4H, ArH), 6.10 (s, 1H, OH), 4.07 (d, J = 17.5 Hz, 1H, CH2), 3.82 (s, 3H, 
CH3), 3.56 (d, J = 17.5 Hz, 1H, CH2), 3.14 (s, 3H, CH3);
 13C NMR (100.6 MHz, DMSO) δ 
194.7, 176.8, 163.3, 144.4, 131.2, 130.3, 129.1, 129.0, 123.1, 121.8, 113.9, 108.2, 
72.7, 55.5, 45.7, 25.9;  M.p = 186 – 189 oC (CH2Cl2) (lit = 192.3 -193.8 
oC).130 
 
(40) (E)-3-(2-(4-Methoxyphenyl)-2-oxoethylidene)-1-methylindolin-2-one 
 
Using representative procedure 2, 3-hydroxy-3-(2-(4-methoxyphenyl)-2-oxoethyl)-1-
methylindolin-2-one (0.88 g, 2.82 mmol) in EtOH (30.0 mL), HCl(aq) (0.3 mL), and 
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glacial ethanoic acid (8.0 mL) for 3 hours provided the title compound as an orange 
solid, (0.77 g, 94%). 
 
1H NMR (400 MHz, DMSO) δ 8.06 (app d, J = 9.0 Hz, 2H, ArH), 7.91 (d, J = 7.5 Hz, 1H, 
ArH), 7.77 (s, 1H, CH, alkene), 7.43 (t, J = 7.5 Hz, 1H, ArH), 7.13 (app d, J = 9.0 Hz, 2H, 
ArH), 7.07 (d, J = 7.5 Hz, 1H, ArH), 7.01 (t, J = 7.5 Hz, 1H, ArH), 3.87 (s, 3H, CH3), 3.21 
(s, 3H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 189.4, 167.9, 164.0, 145.7, 135.6, 132.1, 
131.1, 130.6, 127.4, 126.7, 122.6, 120.0, 114.0, 108.0, 55.5, 26.1; FTIR (thin film cm-
1)max: 1713 (m), 1656 (m), 1602 (s) 1469 (m), 1337 (m), 1238 (s), 1172 (m), 1100 
(w), 1026 (m), 841 (w), 783 (w), 752 (w); HRMS (TOF MS ES+) m/z calculated for 
[C18H16NO3]
+: 294.1130 [M+H]+, found 294.1124; M.p. = 104-105 oC (CH2Cl2 : 
Petroleum ether 40 - 60). 
 
(41) 4-Chloro-3-hydroxy-3-(2-oxo-2-phenylethyl)indolin-2-one 
 
Using representative procedure 1, 4-chloroisatin (1.00 g, 5.50 mmol), acetophenone 
(0.72 g, 6.00 mmol) and diethylamine (0.44 g, 6.00 mmol) in MeOH (50 mL) afforded 
the title compound as a colourless solid (1.25 g, 75%). 
1H NMR (400 MHz, DMSO) δ 10.55 (s, 1H, NH), 7.89 (d, J = 8.5 Hz, 2H, ArH), 7.64 (t, J 
= 7.5 Hz, 1H, ArH), 7.50 (app t, J = 8.0 Hz, 2H, ArH), 7.19 (s, J = 8.0 Hz, 1H, ArH), 6.84 
(dd, J = 8.0, 1.0 Hz, 1H, ArH), 6.79 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 6.28 (s, 1H, OH), 4.37 
(d, J = 18.0 Hz, 1H,CH2), 3.66 (d, J = 18.0 Hz, 1H,CH2), 3.33 (s, 3H,CH3);
 13C NMR 
(100.6 MHz, DMSO) δ 197.0, 178.0, 145.7, 136.1, 134.1, 131.2, 130.2, 129.3, 128.3, 
128.1, 122.5, 109.1, 74.4, 44.8;132 M.p = 201 – 205 oC (MeOH). 
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(46) (Z)-4-Chloro-3-(2-oxo-2-phenylethylidene)indolin-2-one14 
 
Using representative procedure 2, 4-chloro-3-hydroxy-3-(2-oxo-2-
phenylethyl)indolin-2-one  (0.50 g, 1.66 mmol) in EtOH (15.0 mL), HCl(aq) (0.2 mL) 
and glacial ethanoic acid (5.0 mL) for 4 hours, provided the title compound as a 
yellow solid, (0.21 g, 45%). 
1H NMR (400 MHz, DMSO) δ 10.90 (s, 1H, NH), 7.95 (s, 1H, CH alkene), 7.93 (d, J = 
8.0 Hz, 2H, ArH), 7.67 (app t, J = 7.5 Hz, 1H, ArH), 7.54 (t, J = 7.5 Hz, 2H, ArH), 7.34 (t, 
J = 8.0 Hz, 1H, ArH), 7.11 (d, J = 8.0 Hz, 1H, ArH), 6.87 (d, J = 8.0 Hz, 1H, ArH); 13C 
NMR (100.6 MHz, DMSO) δ 194.4, 166.2, 145.3, 138.9, 136.0, 135.0, 132.5, 131.3, 
130.8, 129.8, 129.4, 123.3, 118.0, 109.6;14 M.p. = 156-158 oC (iPrOH). 
 
(42) 4-Chloro-3-(2-(4-chlorophenyl)-2-oxoethyl)-3-hydroxyindolin-2-one 
 
Using representative procedure 1, 4-chloroisatin (1.00 g, 5.50 mmol), acetophenone 
4-chloroacetophenone (0.93 g, 6.00 mmol) and diethylamine (5 drops) in MeOH (50 
mL) afforded the title compound as a colourless solid (1.26 g, 68%). 
1H NMR (400 MHz, DMSO) δ 10.57 (s, 1H, NH), 7.92 (d, J = 8.5 Hz, 2H, ArH), 7.58 (d, J 
= 8.5 Hz, 2H, ArH), 7.20 (t, J = 8.0 Hz, 1H, ArH), 6.85 (d, J = 8.0 Hz, 1H, ArH), 6.80 (d, J 
= 8.0 Hz, 1H, ArH), 6.31 (s, 1H, OH), 4.34 (d, J = 18.0 Hz, 1H, CH2), 3.67 (d, J = 18.0 
Hz, 1H, CH2); 
13C NMR (100.6 MHz, DMSO) δ 195.6, 177.5, 145.2, 138.8, 134.4, 
130.8, 129.8, 129.0, 127.6, 122.1, 108.7, 74.0, 44. 3;2 FTIR (film cm-1)max: 3095 (br), 
                                                          
2 Two signals at same chemical shift 
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1706(m), 1673 (s), 1618 (m), 1445 (m), 1180 (m), 1092 (m), 1054 (w), 991 (m); 
HRMS (TOF MS ES+) m/z calculated for [C16H12
35Cl2NO3]
+: 336.0194 [M+H]+, found 
336.0198; M.p = 194 – 198 oC (MeOH). 
 
(47) (Z)-4-Chloro-3-(2-(4-chlorophenyl)-2-oxoethylidene)indolin-2-one14 
 
Using representative procedure 2, 4-chloro-3-(2-(4-chlorophenyl)-2-oxoethyl)-3-
hydroxyindolin-2-one (0.56 g, 1.66 mmol) in EtOH (15.0 mL), HCl(aq) (0.2 mL) and 
glacial ethanoic acid (5.0 mL) for 4 hours, provided the title compound as a yellow 
solid, (0.43 g, 81%). 
1H NMR (250 MHz, DMSO) δ 10.91 (s, 1H, NH), 7.93 (d, J = 8.0 Hz, 2H, ArH), 7.91 (s, 
1H, CH alkene), 7.59 (d, J = 8.0 Hz, 2H, ArH), 7.34 (t, J = 7.5 Hz, 1H, ArH), 7.10 (d, J = 
7.5 Hz, 1H, ArH), 6.86 (d, J = 7.5 Hz, 1H, ArH); 13C NMR (100.6 MHz, DMSO) δ 194.8, 
165.7, 144.8, 136.2, 135.7, 133.6, 131.9, 130.5, 129.3, 128.8, 128.5, 122.8, 117.7, 
109.0;14 M.p = 218-219 oC (iPrOH). 
 
(43) 4-Chloro-3-hydroxy-3-(2-oxo-2-(pyridin-3-yl)ethyl)indolin-2-one 
 
Using representative procedure 1, 4-chloroisatin (0.50 g, 2.75 mmol), 3-acetyl 
pyridine (0.50 g, 4.13 mmol) and diethylamine (0.30 g, 4.13 mmol) in MeOH (30 mL) 
afforded the title compound as a colourless solid (0.83 g, 100%). 
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1H NMR (400 MHz, DMSO) δ 9.06 (s, 1H, NH), 8.78 (d, J = 5.0 Hz, 1H, ArH), 8.23 (d, J 
= 8.0 Hz, 1H, ArH), 7.52 (dd, J = 8.0, 5.0 Hz, 1H, ArH), 7.30 (t, J = 8.0 Hz, 1H, ArH), 
7.00 (d, J = 8.0 Hz, 1H, ArH), 6.94 (d, J = 8.0 Hz, 1H, ArH), 6.46 (s, 1H, OH), 4.46 (d, J = 
18.0 Hz, 1H, CH2), 3.84 (d, J = 18.0 Hz, 1H, CH2); 
13C NMR (100.6 MHz, DMSO) δ 
196.2, 177.5, 153.9, 149.2, 145.1, 135.6, 131.1, 130.9, 129.9, 127.6, 124.0, 122.2, 
108.8, 74.0, 44.6; FTIR (film cm-1)max: 3090 (br), 1715 (s), 1693 (s), 1589 (s), 1451 
(m), 1355 (m), 1227 (w), 1176 (m), 1672 (w), 992 (w), 782 (m); HRMS (TOF MS ES+) 
m/z calculated for [C15H12
35ClN2O3]
+: 303.0538 [M+H]+, found 303.0538; M.p = 160 – 
161 oC (MeOH). 
 
(2) (Z)-4-Chloro-3-(2-oxo-2-(pyridin-3-yl)ethylidene)indolin-2-one 14 
 
Using representative procedure 2, 4-chloro-3-hydroxy-3-(2-oxo-2-(pyridin-3-
yl)ethyl)indolin-2-one (0.25 g, 0.93 mmol) in EtOH (10.0 mL), HCl(aq) (0.4 mL) and 
glacial ethanoic acid (1.0 mL) for 1.5 hours, provided the title compound as a yellow 
solid, (0.04 g, 17%).  
1H NMR (400 MHz, DMSO) δ 10.93 (s, 1H), 9.05 (s, 1H, NH), 8.80 (d, J = 5.0 Hz, 1H, 
ArH), 8.27 (d, J = 8.0 Hz, 1H, ArH), 7.92 (s, 1H, CH alkene), 7.57 (dd, J = 8.0, 5.0 Hz, 
1H, ArH), 7.34 (t, J = 8.0 Hz, 1H, ArH), 7.10 (d, J = 8.0 Hz, 1H, ArH), 6.86 (d, J = 8.0 Hz, 
1H, ArH); 194.5, 165.6, 153.6, 149.5, 144.9, 135.8, 134.8, 132.0, 131.2, 131.2, 129.4, 
124.0, 122.8, 117.6, 109.2;14 M.p. = 193-194 oC (iPrOH). 
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(50) 4-Chloro-1-methylindoline-2,3-dione (N-methyl-4-chloroisatin)14 
 
4-Chloroisatin (2.0 g, 11.0 mmol) was dissolved in DMF (20 mL), potassium 
carbonate (4.6 g, 33.0 mmol) followed by methsyl iodide (1.7 g, 12.1 mmol) was 
added. The resultant reaction mixture stirred for 24 hours at 19 oC, then diluted 
with ethyl acetate (50 mL) and then washed with H2O (3 x 50 mL).  The organic layer 
then dried over MgSO4, filtered and then concentrated in vacuo to afford the title 
compound as an orange solid, which was purified via recrystallisation, (CH2Cl2 : 
Petroleum ether 40-60) (1.00 g, 50%).  
1H NMR (250 MHz, CDCl3) δ 7.53 (t, J = 8.0 Hz, 1H, ArH), 7.09 (dd, J = 8.0, 0.5 Hz, 1H, 
ArH), 6.82 (dd, J = 8.0, 0.5 Hz, 1H, ArH), 3.29 (s, 3H, CH3);
 13C NMR (100.6 MHz, 
DMSO) δ 180.2, 157.5, 152.7, 138.7, 130.8, 124.1, 114.3, 109.3, 26.2; FTIR (film cm-
1)max: 1733 (s), 1598 (m), 1452 (w), 1351 (w), 1208 (w), 1158 (w), 1127 (w), 1045 
(w), 787 (m); HRMS (TOF MS ES+) m/z calculated for [C9H6
35ClNO2]
+: 196.0165 
[M+H]+, found 196.0159; M.p = 121-123 oC (EtOAc) 
 
(44) 4-Chloro-3-hydroxy-1-methyl-3-(2-oxo-2-phenylethyl)indolin-2-one 
 
Using representative procedure 1, N-methyl-4-chloroisatin (0.50 g, 2.56 mmol), 
acetophenone(0.46 g, 3.84 mmol) and diethylamine (0.28 g, 3.84 mmol) in MeOH 
(25 mL) gave a crude colourless solid which was purified by recrystallisation (CH2Cl2 
: petroleum ether 40 - 60) to afford the title compound as a colourless solid (0.81 g, 
100%). 
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1H NMR (250 MHz, DMSO) δ 7.89 (d, J = 7.0 Hz, 2H, ArH), 7.64 (t, J = 7.0 Hz, 1H, 
ArH), 7.53 (t, J = 7.5 Hz, 2H, ArH), 7.30 (t, J = 8.0 Hz, 1H, ArH), 7.01 (d, J = 7.0 Hz, 1H, 
ArH), 6.93 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 4.44 (d, J = 18.0 Hz, 1H, CH2), 3.72 (d, J = 
18.0 Hz, 1H, CH2), 3.16 (s, 3H, CH3);
 13C NMR (100.6 MHz, DMSO) δ 196.5, 175.9, 
146.5, 135.6, 133.7, 130.8, 129.4, 128.9, 127.9, 127.0, 122.8, 107.4, 73.6, 44.4, 26.3; 
FTIR (film cm-1)max: 3372 (br), 1713 (s), 1685 (s), 1611 (s), 1460 (s), 1393 (w), 1350 
(m), 1226 (m), 1124 (m), 992 (w), 754 (m); HRMS (TOF MS ES+) m/z calculated for 
[C17H15
35ClNO3]
+: 316.0739 [M+H]+, found 316.0740; M.p = 134 – 135 oC (MeOH). 
 
(48) (Z)-4-Chloro-1-methyl-3-(2-oxo-2-phenylethylidene)indolin-2-one 
 
Using representative procedure 2, 4-chloro-3-hydroxy-1-methyl-3-(2-oxo-2-
phenylethyl)indolin-2-one  (0.75 g, 2.50 mmol) in EtOH (25.0 mL), HCl(aq) (0.3 mL) 
and glacial ethanoic acid (7.0 mL) for 2 hours, provided the title compound as a 
yellow solid, (0.54 g, 58%).  
1H NMR (250 MHz, DMSO) δ 8.03 (s, 1H, CH alkene), 7.97 – 7.87 (m, 2H, ArH), 7.67 
(t, J = 7.0 Hz, 1H, ArH), 7.59 – 7.48 (m, 2H, ArH), 7.43 (t, J = 8.0 Hz, 1H, ArH), 7.17 (d, 
J = 8.0 Hz, 1H, ArH), 7.07 (d, J = 7.0 Hz, 1H, ArH), 3.08 (s, 3H, CH3);
 13C NMR (100.6 
MHz, DMSO) δ 195.1, 164.7, 146.3, 137.2, 136.2, 134.2, 132.3, 129.9, 129.6, 129.3, 
129.0, 123.8, 117.4, 108.6, 26.5; FTIR (thin film cm-1)max: 1713 (s), 1663 (s), 1609 
(s), 1457 (m), 1330 (m), 1241 (w), 1123 (m), 1057 (w), 768 (m), 704 (m); HRMS (TOF 
MS ES+) m/z calculated for [C17H13
35ClNO2]
+: 298.0635 [M+H]+, found 298.0633; 
M.p. = 196-198 oC (CH2Cl2 : Petroleum ether 40 - 60). 
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(45) 4-Chloro-3-hydroxy-1-methyl-3-(2-oxo-2-(pyridin-3-yl)ethyl)indolin-2-one 
 
Using representative procedure 1, N-methyl-4-chloroisatin (1.07 g, 5.50 mmol), 3-
acetyl pyridine (0.73  g, 6.00 mmol) and diethylamine (0.44 g, 6.0 mmol) in MeOH 
(50 mL) gave a crude colourless solid, which was purified by recrystallisation (CH2Cl2 
: petroleum ether 40 - 60) to afford the title compound as a colourless solid (1.60 g, 
92%). 
1H NMR (400 MHz, DMSO) δ 9.06 (s, 1H, ArH), 8.79 (dt, J = 5.0, 2.0 Hz, 1H, ArH), 8.24 
(dt, J = 8.0, 2.0 Hz, 1H, ArH), 7.53 (dd, J = 8.0, 5.0 Hz, 1H, ArH), 7.31 (t, J = 8.0 Hz, 1H, 
ArH), 7.02 (d, J = 8.0 Hz, 1H, ArH), 6.94 (d, J = 8.0 Hz, 1H, ArH), 6.42 (s, 1H, OH), 4.43 
(d, J = 18.0 Hz, 1H, CH2), 3.78 (d, J = 18.0 Hz, 1H, CH2), 3.16 (s, 3H, NCH3),
 13C NMR 
(100.6 MHz, DMSO) δ 196.6, 176.3, 154.3, 153.8, 150.0, 149.5, 146.8, 136.0, 131.4, 
130.0, 127.2, 124.4, 124.3, 123.3, 107.9, 74.0, 45.1, 26.9 ; FTIR (film cm-1)max: 3187 
(br), 1717 (s), 1693 (s), 1610 (s) 1590 (m), 1460 (m), 1422 (w), 1353 (m), 1236 (w), 
1125 (m), 1073 (m), 1028 (m), 993 (w), 781 (m), 735 (m); HRMS (TOF MS ES+) m/z 
calculated for [C16H14
35ClN2O3]
+: 317.0693 [M+H]+, found 317.0698; M.p = 120 – 121 
oC (MeOH). 
(49) (Z)-4-chloro-1-methyl-3-(2-oxo-2-(pyridin-3-yl)ethylidene)indolin-2-one 14 
 
Using representative procedure 2, 4-chloro-3-hydroxy-1-methyl-3-(2-oxo-2-(pyridin-
3-yl)ethyl)indolin-2-one (0.10 g, 0.32 mmol) in EtOH (3 mL), HCl(aq) (0.04 mL) and 
glacial ethanoic acid (1.0 mL) for 2 hours, provided the title compound as a yellow 
solid, (0.54 g, 57%). 
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1H NMR (400 MHz, DMSO) δ 9.06 (d, J = 2.0 Hz, 1H, ArH), 8.82 (d, J = 5.0 Hz, 1H, 
ArH), 8.28 (dt, J = 8.0, 2.0 Hz, 1H, ArH), 8.01 (s, 1H, CH alkene), 7.58 (dd, J = 8.0, 5.0, 
Hz, 1H, ArH), 7.45 (t, J = 8.0 Hz, 1H, ArH), 7.19 (d, J = 8.0 Hz, 1H, ArH), 7.08 (d, J = 8.0 
Hz, 1H, ArH), 3.09 (s, 3H, CH3);
 13C NMR (100.6 MHz, DMSO) δ 194.8, 164.8, 154.2, 
150.0, 146.5, 136.3, 135.8, 132.4, 131.7, 130.6, 129.7, 124.5, 123.9, 117.4, 108.7, 
26.6;14 M.p. = 187-189 oC (CH2Cl2 : Petroleum ether 40 - 60). 
 
(51) 6-Chloro-3-hydroxy-3-(2-oxo-2-phenylethyl)indolin-2-one 
 
Using representative procedure 1, 6-chloroisatin (0.50 g, 2.75 mmol), acetophenone 
(0.47 g, 4.13 mmol) and diethylamine (0.30 g, 4.13 mmol)) in MeOH (30 mL) 
afforded the title compound as a colourless solid (0.65 78%). 
1H NMR (250 MHz, DMSO) δ 10.46 (s, 1H, NH), 7.89 (d, J = 7.5 Hz, 2H, ArH), 7.63 (t, J 
= 7.5 Hz, 1H, ArH), 7.50 (t, J = 7.5 Hz, 2H, ArH), 7.30 (d, J = 8.0 Hz, 1H, ArH), 6.91 (dd, 
J = 8.0, 2.0 Hz, 1H, ArH), 6.83 (d, J = 2.0 Hz, 1H), 4.12 (d, J = 18.0 Hz, 1H, CH2), 3.63 
(d, J = 18.0 Hz, 1H, CH2);
 13C NMR (100.6 MHz, DMSO) δ 196.6, 178.3, 144.6, 136.0, 
133.5, 133.2, 130.8, 128.8, 127.9, 125.1, 120.8, 109.5, 72.6, 45.8; FTIR (film cm-
1)max: 3335 (br), 1734 (m), 1682 (m), 1349 (m), 1265 (w), 1223 (m), 1066 (m), 994 
(w); HRMS (TOF MS ES+) m/z calculated for [C16H13
35ClNO3]
+: 302.0584 [M+H]+, 
found 302.0591; M.p = 174 – 175 oC (MeOH). 
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(53) (E)-6-Chloro-3-(2-oxo-2-phenylethylidene)indolin-2-one 
 
Using representative procedure 2, 6-chloro-3-hydroxy-3-(2-oxo-2-
phenylethyl)indolin-2-one (0.45 g, 1.49 mmol) in EtOH (15.0 mL), HCl(aq) (0.5 mL), 
and glacial ethanoic acid (1.5 mL), for 3 hours, provided the title compound as an 
orange solid, (0.77 g, 99%). 
1H NMR (250 MHz, DMSO) 1H NMR (400 MHz, DMSO) δ 11.00 (s, 1H, NH), 8.09 (t, J = 
7.5 Hz, 2H, ArH), 7.77 (s, 1H, CH alkene), 7.73 (t, J = 7.5 Hz, 2H, ArH), 7.61 (t, J = 7.5 
Hz, 2H, ArH), 7.04 (dd, J = 7.5, 2.0 Hz, 1H, ArH), 6.91 (d, J = 2.0 Hz, 1H, ArH); 13C NMR 
(100.6 MHz, DMSO) δ 191.0, 168.2, 146.3, 137.0, 135.4, 134.1, 129.1, 128.8, 128.6, 
128.2, 126.2, 121.6, 118.8, 110.4; FTIR (thin film cm-1)max:, 1728 (s), 1663 (m), 1624 
(w) 1600 (m), 1447 (w), 1334 (m), 1236 (w), 1016 (m), 842 (m), 824 (s) 722 (s), 682 
(s); HRMS (TOF MS ES+) m/z calculated for [C16H11
35ClNO2]
+: 284.0478 [M+H]+, 
found 284.0487; M.p. = 229-230 oC (iPrOH). 
 
(52) 6-Chloro-3-(2-(4-chlorophenyl)-2-oxoethyl)-3-hydroxyindolin-2-one 
 
Using representative procedure 1, 6-chloroisatin (0.50 g, 2.75 mmol), 4-
chloroacetophenone (0.64 g, 4.13 mmol) and diethylamine (0.30 g, 4.13 mmol) in 
MeOH (30 mL) afforded the title compound as a colourless solid (0.67 g, 72%).  
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1H NMR (400 MHz, DMSO) δ 10.47 (s, 1H, ANH), 7.90 (app d, J = 8.5 Hz, 2H, ArH), 
7.57 (app d, J = 8.5 Hz, 2H, ArH), 7.29 (d, J = 8.0 Hz, 1H, ArH), 6.91 (dd, J = 8.0, 2.0 
Hz, 1H, ArH), 6.82 (d, J = 2.0 Hz, 1H, ArH), 4.10 (d, J = 18.0 Hz, 1H, CH2), 3.60 (d, J = 
18.0 Hz, 1H, CH2); 
13C NMR (100.6 MHz, DMSO) δ 195.6, 178.2, 144.5, 138.5, 134.7, 
133.2, 130.6, 129.9, 128.9, 125.1, 120.8, 109.5, 72.6, 45.7; FTIR (film cm-1)max: 3299 
(br), 1730 (m), 1683 (s) 1625 (w), 1589 (m), 1399 (m), 1220 (m), 1094 (m), 1065 (s), 
812 (m); HRMS (TOF MS ES+) m/z calculated for [C16H13
35ClNO3]
+: 336.0194 [M+H]+, 
found 336.0190; M.p = 180 – 184 oC (MeOH). 
 
(54) (E)-6-Chloro-3-(2-(4-chlorophenyl)-2-oxoethylidene)indolin-2-one 
 
Using representative procedure 2, 6-chloro-3-(2-(4-chlorophenyl)-2-oxoethyl)-3-
hydroxyindolin-2-one (0.50 g, 1.49 mmol) in EtOH (15.0 mL) using HCl(aq) (0.5 mL) 
and glacial ethanoic acid (1.5 mL), for 3 hours, provided the title compound as a red 
solid, (0.34 g, 72%). 
1H NMR (400 MHz, DMSO) δ 10.99 (s, 1H, NH), 8.12 (d, J = 8.5 Hz, 1H, ArH), 8.07 
(app d, J = 8.5 Hz, 2H, ArH), 7.65 (app d, J = 8.5 Hz, 2H, ArH), 7.03 (dd, J = 8.5, 2.0 Hz, 
1H, ArH), 6.89 (d, J = 2.0 Hz, 1H, ArH); 13C NMR (100.6 MHz, DMSO) δ 189.7, 168.1, 
146.4, 139.0, 137.2, 135.9, 135.7, 130.5, 129.2, 128.4, 125.5, 121.6, 118.8, 110.4; 
FTIR (thin film cm-1)max: 1726 (s), 1665 (m), 1622 (m) 1603 (m), 1436 (m), 1329 (m), 
1231 (w), 1010 (w), 840 (m), 824 (m); HRMS (EI+) m/z calculated for 
[C16H10
35Cl2NO2]
+: 317.0010 [M+H]+, found 316.9999; M.p. = 239-241 oC (iPrOH). 
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(Z-33) (Z)-3-(2-Oxo-2-phenylethylidene)indolin-2-one 15 
 
(E)-3-(2-oxo-2-phenylethylidene)indolin-2-one (0.50 g, 2.00 mmol) was dissolved in 
dichloromethane (25 mL). To this was added aluminium trichloride (0.27 g, 2.00 
mmol) and resultant reaction mixture was stirred at 20 oC for three days under an 
argon atmosphere upon which a black precipitate formed. Reaction quenched via 
the slow addition of saturated NaHCO3(aq) at 0 
oC and then extracted with ethyl 
acetate (2x 40 mL). The combined extracts were dried over MgSO4 and the solvent 
was removed in vacuo to give an orange solid which was a 1.0 : 2.5 (E : Z). 
Separation of isomers was achieved via reverse phase preparative HPLC (Waters 
XBridgeTM Prep C18 5 m OBD 19 x 25 mm; eluting with 70:30 methanol : water at 
17 mL/min.) affording the title compound as a yellow solid (19 mg, 4 %). 
1H NMR (400 MHz, DMSO) δ 10.59 (s, 1H, NH), 7.93 (d, J = 7.5 Hz, 2H, ArH), 7.70 (s, 
1H, CH alkene), 7.77 – 7.63 (m, 2H, ArH), 7.54 (t, J = 7.5 Hz, 2H, ArH), 7.31 (t, J = 7.5 
Hz, 1H, ArH), 7.04 (t, J = 7.5 Hz, 1H, ArH), 6.87 (d, J = 7.5 Hz, 1H); 13C NMR (100.6 
MHz, DMSO) δ 195.5, 166.8, 143.4, 136.4, 132.7, 132.6, 131.4, 129.3, 129.0, 122.4, 
122.1, 110.6;3 FTIR (CH2Cl2 film cm
-1)max: 1706 (s), 1660 (m), 1619 (w), 1468 (m), 
1349 (m), 1196 (w), 745 (m); HRMS (TOF MS ES+) m/z calculated for [C17H13NO2]
+: 
250.0868 [M+H]+, found 250.0865; M.p = 155-157 oC. 
 
 
 
 
 
                                                          
3 Two signals at same chemical shift 
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(59) 3-Hydroxy-4-methyl-3-(2-oxo-2-phenylethyl)indolin-2-one 
 
4-Methylindoline-2,3-dione (4-methylisatin) (0.08 g, 0.50 mmol) was dissolved in 
MeOH (5 ML). To this was added acetophenone (0.09 g, 0.75 mmol) followed by 
diethylamine (0.06 g, 0.75 mmol). The reaction mixture was stirred at 20 oC for 48 
hours and then concentrated in vacuo to give a pale orange solid, which was 
purified via flash column chromatography (1:1 ethyl acetate : petroleum ether) 
affording the title compound as a colourless solid (0.08 g, 57 %)  
1H NMR (250 MHz, DMSO) δ 10.24 (s, 1H, NH), 7.87 (d, J = 7.5 Hz, 2H, ArH), 7.62 (t, J 
= 7.5 Hz, 1H, ArH), 7.48 (t, J = 7.5 Hz, 2H, ArH), 7.04 (t, J = 7.5 Hz, 1H, ArH), 6.61 (d, J 
= 7.5 Hz, 2H, 2 x ArH), 6.03 (s, 1H, OH), 4.10 (d, J = 17.5 Hz, 1H, CH2), 3.61 (d, J = 17.5 
Hz, 1H, CH2), 2.26 (s, 3H, CH3);
 13C NMR (100.6 MHz, Acetone) δ 197.6, 157.7, 145.3, 
137.8, 134.0, 132.1, 131.5, 129.6, 129.5, 128.8, 106.0, 104.0, 103.9, 55.6, 45.1; FTIR 
(thin film cm-1)max: 3190 (br), 1713 (m), 1680 (s), 1615 (m), 1499 (w), 1468 (w), 
1348 (m), 1278 (s), 1215 (m), 1060 (w), 993 (w), 783 (w); HRMS (TOF MS ES+) m/z 
calculated for [C17H16NO3]
+: 282.1130 [M+H]+, found 282.1126; M.p. = 158 - 159 oC 
(EtOH). 
(60) (Z)-4-methyl-3-(2-oxo-2-phenylethylidene)indolin-2-one 
 
Using representative procedure 2, 43-hydroxy-4-methyl-3-(2-oxo-2-
phenylethyl)indolin-2-one  (0.07 g, 0.22 mmol) in EtOH (2.0 mL), HCl(aq) (0.08 mL, 
0.99 mmol) and glacial ethanoic acid (0.23 mL, 3.96 mmol), for 2.5 hours, provided 
the title compound as a yellow solid, (0.05 g, 80%). 
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1H NMR (400 MHz, DMSO) δ 10.58 (s, 1H, NH), 7.93 (d, J = 7.5 Hz, 2H, ArH), 7.65 (t, J 
= 7.5 Hz, 1H, ArH), 7.52 (t, J = 7.5 Hz, 2H, ArH), 7.43 (s, 1H, CH alkene), 7.20 (t, J = 8.0 
Hz, 1H, ArH), 6.86 (d, J = 8.0 Hz, 1H, ArH), 6.70 (d, J = 8.0 Hz, 1H, ArH), 3.34 (s, 3H, 
CH3); 
13C NMR (100.6 MHz, DMSO) δ 195.7, 167.1, 142.2, 136.3, 135.8, 134.1, 133.8, 
133.4, 130.7, 129.0, 128.8, 125.2, 119.5, 108.3, 20.7; FTIR (CH2Cl2 film cm
-1)max: 
2824 (w), 2853 (w), 1710 (s), 1662 (s), 1616 (m), 1597 (m), 1449 (w), 1336 (m), 1244 
(w), 742 (m); HRMS (TOF MS ES+) m/z calculated for [C17H13NO2]
+: 264.1025 [M+H]+, 
found 264.1019; M.p = 182-184 oC 
 
(61) Trimethyl((2-nitrophenyl)ethynyl)silane40 
 
1-iodo-2-nitrobenzene (5.00 g, 20.0 mmol) was dissolved in THF (100 mL), to this 
was added bis(triphenylphosphine)palladium(II) dichloride (0.70 g, 1.0 mmol), 
copper iodide (0.38 g, 2.0 mmol), diisopropylamine (6.10 g, 30.0 mmol), and 
ethynyltrimethylsilane (2.50 g, 25.0 mmol). The reaction mixture was stirred at 20 
oC for 16 hours, after which it was diluted with ethyl acetate (200 mL) and then 
washed with saturated NaHCO3(aq) at 0 
oC (3x 100 mL) and then brine (50 mL). The 
organic layer was then dried over MgSO4 and reduced in vacuo to give a brown 
viscous oil which was purified via flash column chromatography on silica gel (1:9 
ethyl acetate : petroleum ether) providing the title compound as a light yellow oil 
(4.20 g, 96%). 
1H NMR (250 MHz, CDCl3) δ 7.99 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.64 (dd, J = 7.5, 1.5 
Hz, 1H, ArH), 7.54 (app td, J = 7.5, 1.5 Hz, 1H, ArH), 7.43 (app td, J = 8.0, 1.0 Hz, 1H, 
ArH), 0.26 (s, 9H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 150.2, 135.1, 132.7, 128.9, 
124.5, 118.3, 103.7, 99.4, 0.3.40 
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(62) 1-(Iodoethynyl)-2-nitrobenzene40 
 
Trimethyl((2-nitrophenyl)ethynyl)silane (3.00 g, 13.7 mmol) and AgNO3 (0.117 g, 
0.69 mmol were dissolved in DMF (50.0 mL). To this was added N-iodosuccinimide 
(3.40 g, 15.1 mmol) in DMF (25.0 mL). The resulting reaction mixture was then 
stirred at room temperature and in the absence of light for 18 hours. The reaction 
mixture was then diluted with Et2O (200 mL) and then washed with brine (5 x 100 
mL), after which the organic layer was dried over MgSO4, filtered and then reduced 
in vacuo to give a pale yellow solid which was purified via recrystallisation (CH2Cl2 : 
petroleum ether 40 -60) affording the title compound as a pale yellow solid (3.03 g, 
81%).  
1H NMR (400 MHz, CDCl3) δ 8.05 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.65 (dd, J = 8.0, 1.5 
Hz, 1H, ArH), 7.58 (app td, J = 7.5, 1.0 Hz, 1H, ArH), 7.47 (app td, J = 8.0, 1.5 Hz, 1H, 
ArH); 13C NMR (100.6 MHz, CDCl3) δ 150.5, 136.0, 133.0, 129.3, 124.8, 118.7, 89.1, 
16.8; M.p = 63-65oC (CH2Cl2 : petroleum ether 40 -60) (lit 68-70 
oC).40 
 
(63) 1-Ethynyl-2-nitrobenzene 
 
Trimethyl((2-nitrophenyl)ethynyl)silane (1.00 g, 4.57 mmol) and K2CO3 (0.63 g, 4.57 
mmol) were dissolved in MeOH (5 mL) and stirred at room temperature for 3 hours. 
After which the reaction mixture was then filtered and extracted with EtOAc (10 
mL) then washed with water (2 x 10 mL). The organic layer was then dried over 
MgSO4, filtered and concentrated in vacuo to afford the title compound as a grey 
solid (0.21 g, 32%). 
 
Page | 148  
 
1H NMR (400 MHz, CDCl3) δ 7.90 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.56 (dd, J = 7.5, 1.5 
Hz, 1H, ArH), 7.49 (app td, J = 7.5, 1.0 Hz, 1H, ArH), 7.40 (app td, J =7.5 1.5 Hz, 1H, 
ArH), 3.47 (s, 1H, CH terminal); 13C NMR (100.6 MHz, CDCl3) δ 150.43, 135.66, 
132.98, 129.50, 124.74, 117.59, 85.27, 78.65; M.p = 55-60oC (CHCl3) (lit = 52-54 
oC).133 
 
(64) Indoline-2,3-dione (Isatin) 
 
1-(Iodoethynyl)-2-nitrobenzene (0.100 g, 0.37 mmol) was dissolved in THF (10 mL), 
and Pd(PPh3)2Cl2 (0.013 g, 0.09 mmol) was added. The reaction mixture was then 
heated at reflux for 16 hours, after which it was cooled to room temperature and 
then filtered through Celite. The filtrate was then concentrated in vacuo to give a 
dark brown viscous oil, which was purified via flash column chromatography on 
silica gel (1:1 ethyl acetate : petroleum ether) providing the title compound as a red 
crystalline solid (0.030 g, 55%). 
1H NMR (400 MHz, DMSO) δ 11.04 (s, 1H, NH), 7.57 (t, J = 7.5, 1H, ArH), 7.49 (d, J = 
7.5 Hz, 1H, ArH), 7.05 (t, J = 7.5 Hz, 1H, ArH), 6.90 (d, J = 7.5 Hz, 1H, ArH); 13C NMR 
(100.6 MHz, DMSO) δ 184.4, 159.4, 150.7, 138.4, 124.7, 122.8, 117.8, 112.2; M.p = 
192 – 194 oC (lit = 195 – 197 oC).134 
(70) 2-Iodo-3-oxo-3H-indole 1-oxide (2-Iodoisatogen) 
 
1-(Iodoethynyl)-2-nitrobenzene (0.100 g, 0.366 mmol) was dissolved in THF (10.0 
mL), and CuBr.DMS (0.020 g, 0.090 mmol) was added. The reaction mixture was 
then heated at reflux for 16 hours, after which it was cooled to room temperature 
and then filtered through Celite. The filtrate was then concentrated in vacuo 
affording a red amorphous solid, which was purified via flash column 
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chromatography on silica gel (1:4 ethyl acetate : petroleum ether) affording the title 
compound as a red crystalline solid (0.090 g, 90%). 
1H NMR (400 MHz, CDCl3) δ 7.67 – 7.62 (m, 3H, ArH), 7.56 – 7.50 (m, 1H, ArH);
 13C 
NMR (100.6 MHz, DMSO) δ 183.3, 149.0, 134.8, 131.4, 124.1, 122.4, 114.2, 97.1; 
FTIR (film cm-1)max: 1710 (s), 1599 (m), 1491 (s), 1447 (s), 1283 (s), 1191 (m), 1127 
(m), 1853 (m), 760 (s), 689 (s), 652 (s); HRMS (EI+) m/z calculated for [C8H4INO2]
+: 
272.9287 [M+H]+, found 272.9289; M.p = 85 oC decomp. 
 
(71) 1-Hydroxyindoline-2,3-dione (N-hydroxy isatin) 
 
2-Iodo-3-oxo-3H-indole 1-oxide  (0.20 g, 0.73 mmol) was dissolved in DMSO (10 mL) 
and stirred at 30 oC for 20 hours. The solution was then diluted with EtOAc (20 mL) 
and washed with water (3 x 10 mL) then dried over MgSO4, filtered and then 
concentrated in vacuo to give a crude amorphous red solid. This was purified via 
flash column chromatography on silica gel (1:1 ethyl acetate : petroleum ether) 
gave a 3:1 mixture of 1-hydroxyindoline-2,3-dione 71 and indoline-2,3-dione 64 
(0.09 g, 80%). It was then possible to further isolate an analytic quantity of 1-
hydroxyindoline-2,3-dione 71 via fractional recrystallisation (acetone : Et2O).  
1H NMR (400 MHz, DMSO) δ 11.23 (s, 1H, OH), 7.64 (t, J = 7.5 Hz, 1H, ArH), 7.49 (d, J 
= 7.5 Hz, 1H, ArH), 7.11 (t, J = 7.5 Hz, 1H, ArH), 7.04 (d, J = 7.5 Hz, 1H, ArH); 13C NMR 
(100.6 MHz, DMSO) δ 181.4, 153.9, 149.4, 138.1, 123.8, 123.4, 116.4, 108.8; FTIR 
(film cm-1)max: 1750 (s), 1699 (s), 1619 (s), 1453 (m), 1323 (m), 1092 (w), 889 (m), 
758 (s), 471 (m); HRMS (TOF MS ES-) m/z calculated for [C8H4NO3]
-: 162.0191 [M-H]-
, found 162.0185; M.p = 177 oC decomp. 
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(64) Indoline-2,3-dione (Isatin) 
 
A mixture (1.0 : 3.0) of 1-hydroxyindoline-2,3-dione and isatin (0.020 g, 0.20 mmol) 
were dissolved in DMF (1.0 mL), and to this was added triphenyl phosphine (0.288 
g, 1.10 mmol). The resulting reaction mixture then heated at 135 oC for 18 hours, 
after which it was cooled to room temperature and diluted with EtOAc (10 mL).  The 
organic extract was washed with brine (5 x 10 mL) then dried over MgSO4, filtered 
and then concentrated in vacuo to give a red amorphous solid, which was purified 
via flash column chromatography on silica gel (1:1 ethyl acetate : petroleum ether) 
providing the title compound as an orange  solid (0.012 g, 68%). 
For characterisation data, see page 148. 
 
(64) Indoline-2,3-dione (Isatin) 
 
2-Iodo-3-oxo-3H-indole 1-oxide (0.200 g, 0.73 mmol) and triphenyl phosphine 
(0.288 g, 1.10 mmol) were dissolved in DMSO (5.0 mL). The resulting reaction 
mixture then heated at 135 oC for 16 hours, after which it was cooled to room 
temperature and diluted with EtOAc (20 mL).  The organic extract was washed with 
brine (5 x 10 mL) then dried over MgSO4, filtered and then concentrated in vacuo to 
give a crude orange solid, which was purified via flash column chromatography on 
silica gel (1:1 ethyl acetate : petroleum ether) providing the title compound as an 
orange  solid (0.075 g, 70%) 
For characterisation data, see page 148. 
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(55) Trimethyl((2-methyl-6-nitrophenyl)ethynyl)silane  
 
2-Iodo-3-nitrotoluene (5.00 g, 19.0 mmol) and bis(triphenylphosphine)palladium(II) 
dichloride (1.33 g, 1.9 mmol) were dissolved in triethylamine (100 mL). 
Ethynyltrimethylsilane (3.73 g, 38.0 mmol) was added to the resultant mixture 
which was then heated at reflux for 24 hours. It was then cooled to room 
temperature and the solvent removed in vacuo affording a crude brown oil, which 
was purified via flash column chromatography on silica gel (1:19 ethyl acetate : 
petroleum ether) providing the title compound as an yellow oil (3.66 g, 83%) 
1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 8.0 Hz, 1H, ArH), 7.47 (d, J = 8.0 Hz, 1H, ArH), 
7.31 (t, J = 8.0 Hz, 1H, ArH), 2.52 (s, 3H, CH3), 0.28 (s, 9H, CH3);
 13C NMR (100.6 MHz, 
CDCl3) δ 151.0, 143.8, 133.7, 128.0, 121.7, 117.7, 108.5, 97.7, 21.2, -0.3. FTIR (film 
cm-1)max: 2961 (s), 2159 (m), 1532 (s), 1459 (m), 1349 (s), 1289 (m), 1251 (s), 1219 
(m), 1088 (m), 867 (s), 790 (m), 742 (s); HRMS (TOF MS ES+) m/z calculated for 
[C12H15NO2Si]
+: 234.0950 [M+H]+, found 234.0942. 
(56) 2-(Iodoethynyl)-1-methyl-3-nitrobenzene 
 
Trimethyl((2-methyl-6-nitrophenyl)ethynyl)silane (3.50 g, 15.0 mmol) and AgNO3 
(2.55 g, 15.0 mmol) were dissolved in DMF (50.0 mL). N-iodosuccinimide (3.71 g, 
16.5 mmol) was added as a solution of DMF (100 mL). The resulting reaction 
mixture was then stirred at room temperature and in the absence of light for 1.5 
hours. The reaction mixture was then diluted with Et2O (100 mL) and washed with 
brine (5 x 50 mL). The organic layer was then dried over MgSO4, filtered and then 
reduced in vacuo to give a pale yellow solid which was purified via recrystallisation 
(CH2Cl2 : Petroleum ether 40 - 60) affording the title compound as a pale yellow 
solid (3.79 g, 82%). 
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1H NMR (250 MHz, CDCl3) δ 7.84 (d, J = 7.5 Hz, 1H, ArH), 7.51 (d, J = 7.5 Hz, 1H, ArH), 
7.35 (t, J = 7.5 Hz, 1H, ArH), 2.55 (s, 3H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 151.4, 
144.8, 133.9, 128.2, 121.9, 117.9, 87.6, 21.2, 20.4; M.p = 88 - 89 oC (CH2Cl2 : 
petroleum ether 40 - 60) (lit = 87 - 88 oC).40 
 
(57) 4-Methylindoline-2,3-dione (4-Methylisatin) & (58) 2-Iodo-4-methyl-3-oxo-
3H-indole 1-oxide 
 
2-(Iodoethynyl)-1-methyl-3-nitrobenzene (0.43 g, 1.5 mmol) was dissolved in THF 
(20 mL), and CuBr.DMS (0.31 g, 1.5 mmol) was added. The reaction mixture was 
then heated at reflux for 24 hours, after which it was cooled to room temperature 
and filtered through Celite. The filtrate was then concentrated in vacuo to give a red 
amorphous solid which was purified via flash column chromatography on silica gel 
(1:9 ethyl acetate : petroleum ether - 3:7 ethyl acetate : petroleum ether) providing 
2-Iodo-4-methyl-3-oxo-3H-indole 1-oxide 58 as a yellow crystalline solid (0.28 g, 
39%) and also 4-Methylindoline-2,3-dione 57 as an orange solid (0.10 g, 41%). 
- (57) 
1H NMR (400 MHz, CDCl3) δ 8.40 (s, 1H, NH), 7.40 (t, J = 8.0 Hz, 1H, ArH), 6.88 (d, J = 
8.0 Hz, 1H, ArH), 6.72 (d, J = 8.0 Hz, 1H. ArH), 2.57 (s, 3H, CH3); 
13C NMR (100.6 MHz, 
CDCl3) δ 183.4, 159.3, 149.0, 141.7, 126.2, 116.4, 111.2, 109.6, 18.1; FTIR (film cm
-
1)max:1729 (s), 1603 (s), 1496 (w), 1459 (w), 1318 (w), 1039 (w), 933 (w), 779 (w), 
727 (w); HRMS (TOF MS ES+); m/z calculated for [C9H7NO2] 162.0555 [M+H]
+, found 
162.0547; M.p = 170 – 174 oC (EtOAc). 
- (58) 
1H NMR (400 MHz, CDCl3) δ 7.54 – 7.44 (m, 2H), 7.33 – 7.24 (m, 1H), 2.63 (s, 3H, 
CH3);
 13C NMR (100.6 MHz, CDCl3) δ; 
13C NMR (100.6 MHz, CDCl3) δ 184.2, 181.6, 
149.3, 148.1, 137.9, 137.8, 134.3, 134.2, 134.0, 133.8, 121.2, 120.2, 119.6, 111.9, 
111.8, 17.6; FTIR (film cm-1)max: 1712 (s), 1698 (m), 1513 (s), 1501 (s), 1350 (w), 
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1303 (m), 1252 (w), 1170 (w), 1124 (m), 793 (m) ; HRMS (TOF MS ES+); m/z 
calculated for [C9H6INO2] 287.9522 [M+H]
+, found 287.9521; M.p = 102 oC decomp.4 
 
(57) 4-Methylindoline-2,3-dione (4-Methylisatin)  
 
2-Iodo-4-methyl-3-oxo-3H-indole 1-oxide (0.20 g, 0.79 mmol) and triphenyl 
phosphine (0.28 g, 1.05 mmol) were dissolved in DMSO (20.0 mL). The resultant 
reaction mixture was then heated at 135 oC for 16 hours, after which it was cooled 
to room temperature and diluted with EtOAc (20 mL). The organic extracts were 
then washed with brine (5 x 10 mL) then dried over MgSO4, filtered and then 
concentrated in vacuo to give a crude orange solid. This crude solid was then 
purified via flash column chromatography on silica gel (3:7 ethyl acetate : 
petroleum ether) providing the title compound as an orange  solid (0.08 g, 80%) 
For characterisation data, see page 152. 
 
(88) 4-Methoxy-1-nitro-2-(phenylethynyl)benzene 
 
2-iodo-4-methoxy-1-nitrobenzene (2.00 g, 7.17 mmol) was dissolved in THF (50 mL), 
to this was added bis(triphenylphosphine)palladium(II) dichloride (0.25 g, 0.36 
mmol), copper iodide (0.14 g, 0.72 mmol), diisopropylamine (2.18 g, 21.50 mmol), 
and phenylacetylene (0.88 g, 8.60 mmol) at 0 oC. The resultant reaction mixture was 
stirred for 18 hours and allowed to warm to room temperature, after which it was 
                                                          
4 Appeared to decompose in solution, thus NMR data is characterisation for 58 and 
unknown decomposition product 
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diluted with ethyl acetate (30 mL) and then washed with saturated NaHCO3(aq) (3x 
30 mL) and then brine (15 mL). The organic layer was then dried over MgSO4, 
filtered and then reduced in vacuo to give a brown viscous oil which was purified via 
flash column chromatography on silica gel (3:7 ethyl acetate : petroleum ether) 
providing the title compound as a light yellow oil (4.20 g, 96%). 
1H NMR (250 MHz, CDCl3) δ 8.15 (d, J = 9.0 Hz, 1H, ArH), 7.67 – 7.56 (m, 2H, ArH), 
7.43 – 7.35 (m, 3H, ArH), 7.15 (d, J = 3.0 Hz, 1H, ArH), 6.94 (dd, J = 9.0, 3.0 Hz, 1H, 
ArH), 3.93 (s 3H, OCH3);
 13C NMR (100.6 MHz, CDCl3) δ 163.0, 142.8, 132.2, 129.4, 
128.6, 127.4, 122.6, 121.2, 118.6, 114.7, 97.1, 85.6, 56.2; M.p = 58 - 59 oC (CH2Cl2 : 
petroleum ether 40 - 60) (lit = 64.5 – 65.5 oC).135 
 
(89) 5-Methoxy-3-oxo-2-phenyl-3H-indole 1-oxide 
 
4-Methoxy-1-nitro-2-(phenylethynyl)benzene (0.050 g, 0.180 mmol) was dissolved 
in THF (5.0 mL), and CuBr.DMS (0.090 g, 0.005 mmol) was added. The reaction 
mixture was then heated at reflux for 8 hours, after which it was cooled to room 
temperature and then filtered through celite. The filtrate was then concentrated in 
vacuo affording a dark purple amorphous solid, which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether) providing the 
title compound as a purple crystalline solid (0.037 g, 81%). 
1H NMR (400 MHz, CDCl3) δ 8.61 – 8.57 (m, 2H, ArH), 7.59 (d, J = 8.5 Hz, 1H, ArH), 
7.53 – 7.43 (m, 3H, ArH), 7.17 (d, J = 2.5 Hz, 1H, ArH), 7.09 (dd, J = 8.5, 2.5 Hz, 1H, 
ArH), 3.91 (s, 3H, OCH3). 
13C NMR (100.6 MHz, CDCl3) δ 186.8, 162.6, 140.9, 131.9, 
130.5, 128.6, 127.6, 126.2, 124.7, 118.4, 115.6, 108.0, 56.3; M.p = 134 - 136 °C 
(CH2Cl2: petroleum ether) (lit: 135.3 - 135.7 °C).
75 
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(90) 1-Nitro-2-(phenylethynyl)benzene & (85) 3-Oxo-2-phenyl-3H-indole 1-oxide 
 
1-Iodo-2-nitrobenzene (5.00 g, 20.1 mmol) was dissolved in THF (50 mL), to this was 
added bis(triphenylphosphine)palladium(II) dichloride (0.70 g, 1.0 mmol), copper 
iodide (0.38 g, 2.0 mmol), diisopropylamine (6.1 g, 60.3 mmol), and phenylacetylene 
(2.50 g, 24.1 mmol). The resultant reaction mixture was stirred at RT for 24 hours, 
after which it was diluted with ethyl acetate (100 mL) and then washed with 
saturated NaHCO3(aq) (3x 50 mL) and then brine (30 mL). The organic layer was then 
dried over MgSO4, filtered and then reduced in vacuo to give a brown viscous oil 
which was purified via flash column chromatography on silica gel (5 : 95 ethyl 
acetate : petroleum ether to 1 : 4 ethyl acetate : petroleum ether to) affording 90 as 
an orange oil (2.18 g, 49%) and the by-product 85 as a bright orange crystalline solid 
(1.70 g, 36%). 
- (90) 
1H NMR (400 MHz, CDCl3) δ 8.09 (dd, J = 8.0 1.0 Hz, 1H, ArH), 7.73 (dd, J = 8.0, 1.0 
Hz, 1H, ArH), 7.64 – 7.58 (m, 3H, ArH), 7.50 – 7.45 (m, 1H, ArH), 7.42 – 7.37 (m, 3H, 
ArH); 13C NMR (100.6 MHz, CDCl3) δ 149.8, 134.7, 132.9, 132.2, 129.4, 128.7, 128.6, 
124.9, 122.6, 119.0, 97.3, 84.9.136 
- (85) 
1H NMR (400 MHz, CDCl3) δ 8.69 – 8.64 (m, 2H, ArH), 7.74 – 7.69 (m, 2H, ArH), 7.69 
– 7.64 (m, 1H, ArH), 7.60 – 7.46 (m, 4H, ArH); 13C NMR (100.6 MHz, CDCl3) δ 187.1, 
148.0, 135.0, 132.3, 131.3, 130.9, 128.7, 128.0, 126.0, 123.0, 121.8, 114.4; M.p = 
195 - 196 °C (CH2Cl2: petroleum ether) (lit: 186 - 190 °C).
62 
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(85) 3-Oxo-2-phenyl-3H-indole 1-oxide62 
 
1-Nitro-2-(phenylethynyl)benzene (0.100 g, 0.448 mmol) was dissolved in THF (5.0 
mL), and Pd(MeCN)2,Cl2, (0.012 g, 0.01 mmol) was added. The reaction mixture was 
then heated at reflux for 6 hours, after which it was cooled to room temperature 
and then filtered through Celite. The filtrate was then concentrated in vacuo 
affording a dark purple amorphous solid, which was purified via flash column 
chromatography on silica gel (1:4 ethyl acetate : petroleum ether) providing the 
title compound as a bright orange crystalline solid (0.074 g,74%). 
For characterisation data, see page 155. 
 
(68) 2-(Iodoethynyl)-4-methoxy-1-nitrobenzene40 
 
2-Iodo-4-methoxy-1-nitrobenzene (5.00 g, 17.92 mmol) was dissolved in THF (70 
mL), to this was added bis(triphenylphosphine)palladium(II) dichloride (0.63 g, 0.90 
mmol), copper iodide (0.34 g, 1.79 mmol), diisopropylamine (5.43 g, 53.76 mmol), 
and ethynyltrimethylsilane (2.10 g, 21.50 mmol). The reaction mixture was stirred at 
RT for 24 hours, after which it was diluted with ethyl acetate (120 mL) and then 
washed with saturated NaHCO3(aq) at 0 
oC (3x 100 mL) and then brine (75 mL). The 
organic layer was then dried over MgSO4, filtered and then reduced in vacuo to give 
a brown viscous oil which was purified via flash column chromatography on silica 
gel (dry loaded) (1:9 ethyl acetate : petroleum ether to 1:4 ethyl acetate : 
petroleum ether) providing the intermediate arylalkyne as a colourless solid (4.20 g, 
96%). The intermediate arylalkyne (1.50 g, 6.02 mmol) and AgNO3 (0.102 g, 0.60 
mmol) were dissolved in DMF (15.0 mL). N-iodosuccinimide (1.49 g, 6.62 mmol) was 
Page | 157  
 
added as a solution of DMF (15.0 mL). The resulting reaction mixture was then 
stirred at 0 oC and in the absence of light for 0.5 hours. The reaction mixture was 
then diluted with Et2O (30 mL) and washed with brine (5 x 30 mL). The organic layer 
was dried over MgSO4, filtered and then reduced in vacuo to give a pink solid which 
was purified via flash column chromatography on silica gel (dry loaded) (1:9 ethyl 
acetate : petroleum ether to 1:4 ethyl acetate : petroleum ether)  affording the title 
compound as a pale pink solid (1.39 g, 76% - 73% over 2 steps). 
1H NMR (400 MHz, CDCl3) δ 8.12 (d, J = 9.0 Hz, 1H, ArH), 7.09 (d, J = 3.0 Hz, 1H, ArH), 
6.95 (dd, J = 9.0, 3.0 Hz, 1H, ArH), 3.92 (s, 3H, OCH3); 
13C NMR (100.6 MHz, CDCl3) δ 
162.9, 143.3, 127.1, 120.8, 119.9, 115.2, 89.6, 56.1, 16.7; M.p = 88 - 90 oC (CH2Cl2 : 
Petroleum ether 40-60) (lit = 87 - 88 oC).40 
 
(69) 2-Iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
 
2-(Iodoethynyl)-4-methoxy-1-nitrobenzene (1.390 g, 4.58 mmol) was dissolved in 
THF (50.0 mL), and CuBr.DMS (0.236 g, 1.15 mmol) was added. The reaction mixture 
was then heated at reflux for 0.5 hours, after which it was cooled to room 
temperature and filtered through Celite. The filtrate was then concentrated in 
vacuo to give a purple amorphous solid which was purified via flash column 
chromatography on silica gel (dry loaded) (CH2Cl2) providing the title compound as a 
purple crystalline solid (4.35 g, 95%). 
1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.5 Hz, 1H, ArH), 7.16 (d, J = 2.5 Hz, 1H, ArH), 
7.02 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 3.90 (s, 3H, OCH3); 
13C NMR (100.6 MHz, CDCl3) δ 
183.2, 162.5, 142.2, 126.0, 117.8, 115.5, 109.1, 95.0, 56.4; FTIR (film cm-1)max: 3082 
(w), 2980 (w), 2939 (w), 1709 (s), 1487 (s), 1284 (s), 1234 (m), 1008 (m), 823 (s); 
HRMS (TOF MS ES+); m/z calculated for [C9H7INO3] 162.0555 [M+H]
+, found 
162.0547; M.p = 175 – 178 oC (CH2Cl2) (lit: 172 - 175 °C).
40 
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4.3 – Representative Procedure: 3 
(89) 5-Methoxy-3-oxo-2-phenyl-3H-indole 1-oxide 
 
A flame dried flask, equipped with a magnetic stirrer bar, was charged with a 
solution of phenylmagneisum bromide (0.83 mL, 2.500 mmol, 3.0 M Et2O) and 
flushed with nitrogen. A solution of Zinc chloride (2.75 mL, 2.750 mmol, 1.0 M Et2O) 
was added dropwise and the resultant mixture was stirred at 20 oC for 15 minutes 
resulting in the formation of a white precipitate and affording a solution of PhZnCl. 
A separate flame dried flask, equipped with magnetic stirrer bar, was charged with 
2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide (0.150 g, 0.500 mmol) and THF (20.00 
mL). To this solution was added PhZnCl (3.50 mL) via cannula and the resultant 
reaction mixture was stirred at 20 oC for 5 hours. After which the reaction was 
quenched with saturated NH4Cl(aq) (10.00 mL) and brine (20.0 mL) then extracted 
with EtOAc (2 x 30.0 mL). Organic extracts were combined and dried over MgSO4 
then concentrated in vacuo to afford a purple amorphous solid which was purified 
via flash column chromatography on silica gel (2:8 ethyl acetate : petroleum ether) 
providing the title compound as a dark red-purple crystalline solid (0.078 g, 62%). 
For characterisation data, see page 154. 
 
(91) 5-Methoxy-2-(4-methoxyphenyl)-3-oxo-3H-indole 1-oxide 
 
Using representative procedure 3, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.150 g, 0.500 mmol) in THF (20.0 mL) with 4-methoxyphenylmagnesium bromide 
(5.0 mL, 2.500 mmol, 0.50 M Et2O) and zinc chloride (2.75 mL, 2.750 mmol, 1.0 M 
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Et2O) afforded a dark purple amorphous solid which was purified via flash column 
chromatography on silica gel (1:19 ethyl acetate : petroleum ether) providing the 
title compound as a purple crystalline solid (0.094 g, 66%). 
1H NMR (400 MHz, CDCl3) δ 8.65 (d, J = 9.0 Hz, 2H, ArH), 7.53 (d, J = 8.5 Hz, 1H, ArH), 
7.11 (d, J = 2.5 Hz, 1H, ArH), 7.04 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 7.00 (d, J = 9.0 Hz 2H, 
ArH), 3.88 (s, 3H, OCH3), 3.87 (s, 3H, OCH3); 
13C NMR (100.6 MHz, CDCl3) δ 187.3, 
162.2, 161.2, 153.5, 141.0, 129.6, 124.7, 119.2, 118.4, 115.3, 114.2, 108.0, 56.3, 
55.5; M.p = 196 - 198 °C (CH2Cl2: petroleum ether) (lit: 196 - 196.8 °C).
75 
 
(92) 5-Methoxy-3-oxo-2-(4-(trifluoromethyl)phenyl)-3H-indole 1-oxide 
 
Using representative procedure 3, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.150 g, 0.500 mmol) in THF (20.0 mL) with 4-(trifluoromethyl) benzylmagnesium 
bromide (2.5 mL, 2.500 mmol, 1.00 M Et2O) and zinc chloride (2.75 mL, 2.750 mmol, 
1.0 M, Et2O) afforded a dark red amorphous solid which was purified via flash 
column chromatography on silica gel (2:8 ethyl acetate : petroleum ether) providing 
the title compound as a dark red crystalline solid (0.093 g, 59%). 
1H NMR (400 MHz, CDCl3) δ 8.73 (d, J = 8.5 Hz, 2H, ArH), 7.72 (d, J = 8.5 Hz, 2H, ArH), 
7.59 (d, J = 8.5 Hz, 1H, ArH), 7.16 (d, J = 2.5 Hz, 1H, ArH), 7.09 (dd, J = 8.5, 2.5 Hz, 1H, 
ArH), 3.96 (s, 3H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 186.4, 163.1, 140.7, 131.4 (q, J 
= 31 Hz), 130.8, 129.5, 127.6, 125.5 (q, J = 4 Hz), 124.7, 123.7 (q, J = 231 Hz), 118.7, 
115.9, 108.2, 56.4; 19F NMR (376.6 MHz, CDCl3) δ -63.10;  M.p 195 - 196 °C (CH2Cl2: 
petroleum ether) (lit: 193-198 °C).75 
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(93) 2-(4-Chlorophenyl)-5-methoxy-3-oxo-3H-indole 1-oxide 
 
Using representative procedure 3, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.150 g, 0.500 mmol) in THF (20.0 mL) with 4-chlorophenylmagnesium bromide 
(2.5 mL, 2.500 mmol, 1.00 M Et2O) and zinc chloride (2.75 mL, 2.750 mmol, 1.0 M, 
Et2O) afforded a purple amorphous solid which was purified via flash column 
chromatography on silica gel (2:8 ethyl acetate : petroleum ether) providing the 
title compound as a purple crystalline solid (0.093 g, 65%). 
1H NMR (400 MHz, CDCl3) δ 8.61 (d, J = 8.5, 2H, ArH), 7.58 (d, J = 8.5 Hz, 1H, ArH), 
7.46 (d, J = 8.5, 2H, ArH), 7.16 (d, J = 2.5 Hz, 1H, ArH), 7.09 (dd, J = 8.5, 2.5 Hz, 1H, 
ArH), 3.91 (s, 3H, OCH3); 
13C NMR (100.6 MHz, CDCl3) δ 186.7, 162.7, 154.5, 140.8, 
136.4, 129.0, 128.8, 124.7, 118.6, 116.8, 115.7, 108.2, 56.4; M.p 192 - 193 °C(CH2Cl2: 
petroleum ether) (lit: 190.5-191.1 °C).75 
 
(94) 2-Ethyl-5-methoxy-3-oxo-3H-indole 1-oxide & (95) 1-Ethoxy-2,2-diethyl-5-
methoxyindolin-3-one 
 
A flame dried flask equipped with magnetic stirrer bar was charged with 2-iodo-3-
oxo-3H-indole 1-oxide (0.050 g, 0.165 mmol) in anhydrous THF (5.0 mL) at 20 oC. 
EtZnI (0.80 mL, 0.660 mmol, 0.83 M THF) was added dropwise, the resultant 
reaction mixture was stirred under nitrogen for 18 hours. The reaction mixture was 
quenched with saturated NH4Cl(aq) (5.0 mL), extracted with ethyl acetate (10.0 mL) 
and washed with brine (5.0 mL). The organic layer was dried over MgSO4, filtered 
and then concentrated in vacuo to give a viscous brown oil, which was purified by 
flash column chromatography on silica gel (5:95 ethyl acetate : petroleum ether to 
1:85:95 ethyl acetate : petroleum ether) affording 94 (0.005 g, 15%) as a red 
crystalline solid and 95 as a  bright yellow oil (0.020 g, 45 %). 
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- (94) 
1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.5 Hz, 1H, ArH), 7.08 (d, J = 2.5 Hz, 1H, ArH), 
7.01 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 3.87 (s, 3H, CH3), 2.65 (q, J = 7.5 Hz, 2H, CH2), 1.21 
(t, J = 7.5 Hz, 3H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 186.6, 162.3, 140.3, 139.6, 
125.0, 117.3, 115.0, 108.2, 56.2, 15.0, 9.8; FTIR (film cm-1)max: 2937 (w), 1704 (s), 
1618 (w), 1531 (s), 1486 (s), 1435 (m), 1390 (s), 1356 (s), 1280 (m), 1230 (m), 1097 
(m), 821 (m), 801 (w); HRMS (TOF MS ES+) m/z calculated for [C11H12NO3]
+: 
206.0817 [M+H]+, found 206.0807; M.p = 51 – 55 oC (CH2Cl2). 
- (95) 
1H NMR (400 MHz, CDCl3) δ 7.20 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.14 (d, J = 9.0 Hz, 1H, 
ArH), 7.02 (d, J = 2.5 Hz, 1H, ArH), 4.10 (q, J = 7.0 Hz, 2H, CH2), 3.79 (s, 3H, CH3) , 
1.92 (dq, J = 14.5, 7.5 Hz, 2H, CH2), 1.77 (dq, J = 14.5, 7.5 Hz, 2H, CH2), 1.37 (t, J = 7.0 
Hz, 3H, CH3), 0.70 (t, J = 7.5 Hz, 6H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 201.4, 
158.3, 155.3, 126.8, 122.6, 114.8, 103.1, 80.3, 71.7, 55.8, 29.3, 14.4, 8.8; FTIR (thin 
film cm-1)max: 2969 (w), 2929 (w), 1706 (s), 1488 (s), 1439 (m), 1266 (m), 1229 (w), 
1145 (w), 1030 (m), 826 (w), 804 (w); HRMS (TOF MS ES+) m/z calculated for 
[C15H22NO3]
+: 264.1600 [M+H]+, found 264.1593. 
  
(95) 1-Ethoxy-2,2-diethyl-5-methoxyindolin-3-one 
 
A flame dried flask equipped with magnetic stirrer bar was charged with 2-ethyl-5-
methoxy-3-oxo-3H-indole 1-oxide (0.030 g, 0.146 mmol) in anhydrous THF (1.5 mL) 
at 20 oC. EtZnI (0.53 mL, 0.438 mmol, 0.83 M THF) was added dropwise, and the 
resultant reaction mixture was stirred under nitrogen for 18 hours. The reaction 
mixture was quenched with H2O (1.8 mL), extracted with ethyl acetate (10.0 mL) 
and washed with brine (5.0 mL). The organic layer was dried over MgSO4, filtered 
and then concentrated in vacuo to give a viscous orange oil, which was purified by 
flash column chromatography on silica gel (5:95 ethyl acetate : petroleum ether) 
providing the title compound as a  bright yellow oil (0.026 g, 49 %). 
For characterisation data, see page 161.  
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(95) 1-Ethoxy-2,2-diethyl-5-methoxyindolin-3-one 
 
A flame dried flask equipped with magnetic stirrer bar was charged with 2-iodo-3-
oxo-3H-indole 1-oxide (0.030 g, 0.100 mmol) in anhydrous THF (3.0 mL) at 20 oC. 
Et2Zn (0.25 mL, 0.150 mmol, 0.6 M hexanes) was added dropwise, the resultant 
reaction mixture was stirred under nitrogen for 2 hours. The reaction mixture was 
quenched with H2O (1.8 mL), extracted with ethyl acetate (10.0 mL) and washed 
with brine (5.0 mL). The organic layer was dried over MgSO4, filtered and then 
concentrated in vacuo to give a viscous orange oil, which was purified by flash 
column chromatography on silica gel (5:95 ethyl acetate : petroleum ether) 
providing the title compound as a  bright yellow oil (0.018 g, 68 %). 
For characterisation data, see page 161.  
 
(100) 2,2-Dicyclohexyl-1-(cyclohexyloxy)-5-methoxyindolin-3-one 
 
A flame dried flask equipped with magnetic stirrer bar was charged with 2-iodo-3-
oxo-3H-indole 1-oxide (0.100 g, 0.367 mmol) in anhydrous THF (10.0 mL) at 20 oC. 
Cy2Zn (2.48 mL, 0.990 mmol, 0.40 M THF) was added dropwise, the resultant 
reaction mixture was stirred under nitrogen for 2 hours. The reaction mixture was 
quenched with H2O (5.0 mL), extracted with ethyl acetate (25.0 mL) and washed 
with brine (15.0 mL). The organic layer was dried over MgSO4, filtered and then 
concentrated in vacuo to give a viscous orange oil, which was purified by flash 
column chromatography on silica gel (5:95 ethyl acetate : petroleum ether) 
providing the title compound as a  bright yellow oil (0.057 mg, 41%). 
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1H NMR (400 MHz, CDCl3) δ 7.15 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.12 (d, J = 9.0 Hz, 1H, 
ArH), 6.96 (d, J = 2.5 Hz, 1H, ArH), 3.93 (tt, J = 10.0, 3.5 Hz, 1H, CH1), 3.77 (s, 3H, 
CH3), 2.20 – 2.11 (m, 2H, CH), 2.09 – 2.01 (m, 2H, CH), 1.92 – 1.81 (m, 9H, CH), 1.48 
– 1.25 (m, 7H, CH), 1.32 – 1.02 (m, 9H, CH), 0.94 – 0.80 (m, 3H, CH); 13C NMR (100.6 
MHz, CDCl3) δ 202.8, 159.6, 155.1, 126.6, 123.2, 115.3, 102.5, 84.9, 82.4, 55.8, 41.4, 
32.4, 28.5, 27.1, 26.9, 25.9, 24.8; FTIR (film cm-1)max: 2933 (s), 2853 (m), 1698 (s), 
1487 (s), 1448 (w), 1342 (w), 1272 (m), 1272 (m), 1030 (w), 823 (w), 785 (w), 754 
(w); HRMS (TOF MS ES+) m/z calculated for [C27H40NO3]
+: 426.3008 [M+H]+, found 
426.3002; M.p = 148 – 151 oC (iPrOH). 
 
(95) 1-Ethoxy-2,2-diethyl-5-methoxyindolin-3-one 
 
A flask, equipped with a magnetic stirrer bar, was charged with LiCl (0.194 g, 4.58 
mmol), then thoroughly flame dried and backfilled with nitrogen. CuCN (0.205 g, 
2.29 mmol) was added and the two solids were dissolved in THF (2.5 mL), over 20 
minutes, providing a yellow green solution of CuCN.2LiCl. This solution was cooled 
to -30 oC and ethylzinc iodide (2.5 mL, 2.08 mmol, 0.83 M THF) was added dropwise. 
After stirring at -30 oC for 10 minutes the solution was gradually warmed to 0 oC and 
the resulting alkylcuprate, EtCu(CN)ZnI.2LiCl, was used immediately.91,137 
A flame dried flask equipped with magnetic stirrer bar was charged with 2-ethyl-5-
methoxy-3-oxo-3H-indole 1-oxide (0.025 g, 0.122 mmol) in anhydrous THF (1.5 mL) 
at 20 oC. EtCu(CN)ZnI.2LiCl (0.89 mL, 0.366 mmol, 0.41 M THF) was added dropwise 
over 5 minutes. The reaction mixture was stirred at 20 oC for 18 hours then 
quenched with saturated NH4Cl(aq) (1.5 mL) and brine (10.0 mL) then extracted with 
EtOAc (2 x 15.0 mL). The organic extracts were combined and dried over MgSO4, 
filtered and then concentrated in vacuo to afford a red amorphous solid which was 
purified via flash column chromatography on silica gel (1:18 ethyl acetate : 
petroleum ether) providing the title compound as a yellow (0.025 g, 79%). 
For characterisation data, see page 161.  
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(101) 1-(Iodoethynyl)-4-methyl-2-nitrobenzene40 
 
1-iodo-4-methyl-2-nitrobenzene (2.50 g, 9.50 mmol) was dissolved in THF (45 mL), 
to this was added bis(triphenylphosphine)palladium(II) dichloride (0.33 g, 0.48 
mmol), copper iodide (0.18 g, 0.95 mmol), diisopropylamine (2.88 g, 28.5 mmol), 
and ethynyltrimethylsilane (1.12 g, 11.40 mmol). The reaction mixture was stirred at 
RT for 24 hours, after which it was diluted with ethyl acetate (80 mL) and then 
washed with saturated NaHCO3(aq) at 0 
oC (3x 50 mL) and then brine (50 mL). The 
organic layer was then dried over MgSO4, filtered and then reduced in vacuo to give 
a brown viscous oil which was purified via flash column chromatography on silica 
gel (dry loaded) (1:9 ethyl acetate : petroleum ether to 1:4 ethyl acetate : 
petroleum ether) providing the intermediate arylalkyne as a colourless solid (1.45 g, 
65%). The intermediate arylalkyne (1.40 g, 6.00 mmol) and AgNO3 (0.510 g, 3.00 
mmol) were dissolved in DMF (15.0 mL). N-iodosuccinimide (1.19 g, 5.29 mmol) was 
added as a solution of DMF (15.0 mL). The resulting reaction mixture was then 
stirred at 0 oC and in the absence of light for 0.5 hours. The reaction mixture was 
then diluted with Et2O (30 mL) and washed with brine (5 x 30 mL). The organic layer 
was dried over MgSO4, filtered and then reduced in vacuo to give a orange solid 
which was purified via flash column chromatography on silica gel (dry loaded) (1:9 
ethyl acetate : petroleum ether to 1:4 ethyl acetate : petroleum ether)  affording 
the title compound as a light yellow solid (1.07 g, 99% - 64% over 2 steps). 
1H NMR (400 MHz, CDCl3) δ 7.88 (s, 1H, ArH), 7.54 (d, J = 8.0 Hz, 1H, ArH), 7.40 (d, J 
= 8.0 Hz, 1H, ArH), 2.47 (s, 3H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 150.6 , 140.2, 
135.6, 133.7, 125.0, 115.7, 89.1, 21.3, 15.1; M.p = 92-94 oC (lit = 94-96 oC)40 
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(102) 2-Iodo-6-methyl-3-oxo-3H-indole 1-oxide  
 
1-(Iodoethynyl)-4-methyl-2-nitrobenzene (1.000 g, 3.48 mmol) was dissolved in THF 
(40.0 mL), and CuBr.DMS (0.179 g, 0.87 mmol) was added. The reaction mixture was 
then heated at reflux for 2.0 hours, after which it was cooled to room temperature 
and filtered through Celite. The filtrate was then concentrated in vacuo to give a 
purple amorphous solid which was purified via flash column chromatography on 
silica gel (dry loaded) (1:4 EtOAc : Petroleum ether 40 - 60) providing the title 
compound as a purple crystalline solid (0.823 g, 48%). 
1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 7.5 Hz, 1H, ArH), 7.48 (s, 1H, ArH), 7.31 (d, J 
= 7.5 Hz, 1H, ArH), 2.53 (s, 3H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 183.1, 149.5, 
146.9, 131.5, 122.5, 121.7, 115.0, 97.5, 22.5; FTIR (film cm-1)max: 3062 (w), 1716 (s), 
1596 (m), 1505 (s), 1467 (m), 1302 (m), 1189 (w), 811 (m); HRMS (TOF MS ES+); m/z 
calculated for [C9H7INO2] 287.9522 [M+H]
+, found 287.9528; M.p = 208 - 210 oC 
(CH2Cl2). 
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4.4 – Representative Procedure: 4  
(94) 2-Ethyl-5-methoxy-3-oxo-3H-indole 1-oxide & (95) 1-Ethoxy-2,2-diethyl-5-
methoxyindolin-3-one 
 
A flask, equipped with a magnetic stirrer bar, was charged with LiCl (0.254 g, 6.00 
mmol), then thoroughly flame dried and backfilled with nitrogen. CuCN (0.269 g, 
3.00 mmol) was added and the two solids were dissolved in THF (3.0 mL), over 20 
minutes, providing a yellow green solution of CuCN.2LiCl. This solution was cooled 
to -30 oC and ethylzinc iodide (3.0 2.mL, 2.73 mmol, 0.91 M THF) was added 
dropwise. After stirring at -30 oC for 10 minutes the solution was gradually warmed 
to 0 oC and the resulting alkylcuprate, EtCu(CN)ZnI.2LiCl, was used immediately.91,137 
A flame dried flask equipped with magnetic stirrer bar was charged with 2-iodo-5-
methoxy-3-oxo-3H-indole 1-oxide (0.050 g, 0.165 mmol) in anhydrous THF (5.0 mL) 
at 20 oC. EtCu(CN)ZnI.2LiCl (0.62 mL, 0.281 mmol, 0.45 M THF) was added dropwise 
over 5 minutes. The reaction mixture was stirred at 20 oC for 18 hours then 
quenched with saturated NH4Cl(aq) (5.0 mL) and brine (10.0 mL) then extracted with 
EtOAc (2 x 15.0 mL). The organic extracts were combined and dried over MgSO4 
then concentrated in vacuo to afford a red amorphous solid which was purified via 
flash column chromatography on silica gel (1:18 ethyl acetate : petroleum ether) 
providing 94 as a red crystalline solid (0.023 g, 68%) and the by-product 95 as a  
bright yellow oil (0.008 g, 18%) 
- (94) 
For characterisation data, see page 161. 
- (95) 
For characterisation data, see page 161. 
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(97) 2-Hexyl-5-methoxy-3-oxo-3H-indole 1-oxide & (98) 2,2-Dihexyl-1-(hexyloxy)-
5-methoxyindolin-3-one 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and n-HexCu(CN)ZnI (0.70 mL, 0.281 mmol, 
0.40 M THF), afforded a red amorphous solid which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether) providing 97 
compound as a red crystalline solid (0.031 g, 72%) and the by-product 98 as bright 
yellow oil (0.013 g, 13%). 
- (97) 
1H NMR (400 MHz, CDCl3) δ 7.49 (d, J = 8.4 Hz, 1H, ArH), 7.09 (d, J = 2.5 Hz, 1H, ArH), 
7.01 (dd, J = 8.4, 2.5 Hz, 1H, ArH), 3.88 (s, 3H, OCH3), 2.66 – 2.60 (m, 2H, CH2), 1.69 – 
1.59 (m, 2H, CH2), 1.40 – 1.24 (m, 6H, CH2), 0.92 – 0.85 (m, 3H, CH3);
 13C NMR (100.6 
MHz, CDCl3) δ 186.8, 162.4, 140.5, 139.0, 125.2, 117.4, 115.0, 108.3, 56.3, 31.6, 
29.4, 25.6, 22.6, 21.6, 14.1; FTIR (film cm-1)max: 2953 (w), 2929 (m), 1702 (s), 1619 
(w), 1528 (s), 1487 (m), 1435 (s), 1388 (s), 1281 (w), 821 (m); HRMS (TOF MS ES+) 
m/z calculated for [C15H20NO3]
+: 262.1443 [M+H]+, found 262.1436; M.p = 46 – 49 oC 
(CH2Cl2). 
- (98) 
1H NMR (400 MHz, CDCl3) δ 7.20 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.12 (d, J = 9.0 Hz, 1H, 
ArH), 7.02 (d, J = 2.5 Hz, 1H, ArH), 4.05 (t, J = 6.5 Hz, 2H, OCH2), 3.79 (s, 3H, OCH3), 
1.91 – 1.80 (m, 2H, CH2), 1.80 – 1.64 (m, 4H, CH2), 1.50 – 1.41 (m, 2H, CH2), 1.40 – 
1.31 (m, 4H, CH2), 1.26 – 1.12 (m, 16H, CH2), 0.92 (t, J = 7.0 Hz, 3H, CH3), 0.82 (t, J = 
7.0 Hz, 6H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 201.6, 158.0, 155.3, 126.8, 122.4, 
114.8, 103.2, 79.6, 76.6, 55.8, 36.8, 31.7, 31.5, 29.7, 29.6, 28.9, 25.9, 24.0, 22.6, 
22.6, 14.0; FTIR (film cm-1)max: 2934 (m), 2929 (s), 2855 (m), 1708 (s), 1448 (s), 
1339 (w), 1273 (w), 1029 (w), 824 (w); HRMS (TOF MS ES+) m/z calculated for 
[C27H45NaNO3]
+: 454.3297 [M+Na]+, found 454.3285. 
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(111) 2-Isobutyl-5-methoxy-3-oxo-3H-indole 1-oxide & (112) 1-Isobutoxy-2,2-
diisobutyl-5-methoxyindolin-3-one 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and i-BuCu(CN)ZnI (0.41 mL, 0.281 mmol, 0.44 
M THF), afforded a red amorphous solid which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether) providing 111 as 
a red crystalline solid (0.032 g, 83%) providing the by-product 112 as a  bright 
yellow oil (0.007 g, 12%). 
- (111) 
1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 8.5 Hz, 1H, ArH), 7.10 (d, J = 2.5 Hz, 1H, ArH), 
7.02 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 3.89 (s, 3H, OCH3), 2.53 (d, J = 7.5 Hz, 2H, CH2), 
2.25 – 2.13 (m, 1H, CH), 0.97 (d, J = 7.0 Hz, 6H, CH3):
 13C NMR (100.6 MHz, CDCl3) δ 
187.1, 162.4, 140.5, 138.5, 125.1, 117.5, 115.1, 108.3, 56.3, 30.3, 26.9, 22.9: FTIR 
(film cm-1)max: 2951 (m), 1702 (s), 1618 (w), 1531 (m), 1487 (m), 1435 (s), 1383 (s), 
1360 (s), 1275 (m), 1231 (m), 823 (m); HRMS (TOF MS ES+) m/z calculated for 
[C13H16NO3]
+: 234.1130 [M+H]+, found 234.1129; M.p = 113 – 114 oC (CH2Cl2). 
- (112) 
1H NMR (400 MHz, CDCl3) δ 7.20 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.14 (d, J = 9.0 Hz, 1H, 
ArH), 7.05 (d, J = 2.5 Hz, 1H, ArH), 3.88 (d, J = 6.5 Hz, 2H, CH2), 3.80 (s, 3H, CH3), 2.03 
(hept, J = 6.5 Hz, 1H, CH1), 1.82 – 1.69 (m, 4H, CH), 1.35 – 1.19 (m, 2H, CH), 1.05 (d, J 
= 6.5 Hz, 6H, CH3), 0.82 (d, J = 6.5 Hz, 6H, CH3), 0.63 (d, J = 6.5 Hz, 6H, CH3);
 13C NMR 
(100.6 MHz, CDCl3) δ 201.6, 157.8, 155.5, 126.8, 123.0, 115.0, 103.5, 83.1, 79.2, 
55.9, 46.9, 28.3, 24.7, 24.5, 23.8, 19.8; FTIR (film cm-1)max: 2957 (s), 2934 (m), 2870 
(w), 1709 (s), 1489 (s), 1338 (w), 1276 (m), 1223 (m), 1029 (m), 824 (w); HRMS (TOF 
MS ES+) m/z calculated for [C21H34NO3]
+: 348.2533 [M+H]+, found 348.2530. 
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(96) 2-Methyl-5-methoxy-3-oxo-3H-indole 1-oxide 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and MeCu(CN)ZnI.2LiCl (0.40 mL, 0.281 mmol, 
0.70 M THF), afforded a red amorphous solid which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether) providing the 
title compound as a red crystalline solid (0.022 g, 70%). 
1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 8.5 Hz, 1H, ArH), 7.08 (d, J = 2.5 Hz, 1H, ArH), 
7.00 (dd, J = 8.8, 2.5 Hz, 1H, ArH), 3.87 (s, 3H, OCH3), 2.15 (s, 3H, CH3); 
13C NMR 
(100.6 MHz, CDCl3) δ 186.7, 162.3, 140.5, 135.6, 125.2, 117.4, 115.0, 108.5, 56.3, 
6.9; FTIR (film cm-1)max: 2917 (w), 1700 (s), 1639 (w), 1487 (m), 1399 (s), 1344 (s), 
1288 (m), 1226 (m), 1091 (m), 831 (s); HRMS (TOF MS ES+) m/z calculated for 
[C10H10NO3]
+: 192.0655 [M+H]+, found 192.0654; M.p = 125 – 128 oC (CH2Cl2). 
 
(113) 2-Cyclopropyl-5-methoxy-3-oxo-3H-indole 1-oxide 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and Cy-PrCu(CN)ZnI (4.01 mL, 0.281 mmol, 
0.07 M THF), afforded a red amorphous solid which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether) providing the 
title compound as an orange crystalline solid (0.016 g, 45%). 
1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.5 Hz, 1H, ArH), 7.02 (dd, J = 8.5, 2.5 Hz, 1H, 
ArH), 6.99 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 3.86 (s, 3H, OCH3), 2.20 – 2.12 (m, 1H, CH), 
1.54 – 1.49 (m, 2H, CH2), 1.12 – 1.06 (m, 2H, CH2);
 13C NMR (100.6 MHz, CDCl3) δ 
186.2, 162.1, 140.2, 138.6, 124.8, 117.5, 114.6, 108.3, 56.3, 7.0, 6.8k; FTIR (film cm-
1)max: 3051 (w), 2980 (w), 1700 (s), 1538 (w), 1486 (m), 1437 (s), 1408 (s), 1359 (s), 
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1284 (m), 1229 (m), 825 (m), 723 (m); HRMS (TOF MS ES+) m/z calculated for 
[C12H12NO3]
+: 218.0812 [M+H]+, found 218.0814; M.p = 121 – 122 oC (iPrOH). 
 
(114) 2-Cyclopentyl-5-methoxy-3-oxo-3H-indole 1-oxide & (115) 2,2-Dicyclopentyl-
1-(cyclopentyloxy)-5-methoxyindolin-3-one 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and Cy-PentCu(CN)ZnI (1.04 mL, 0.281 mmol, 
0.27 M THF), afforded a red amorphous solid which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether) providing 114 as 
an orange crystalline solid (0.021 g, 49%) and the by-product 115 as a bright yellow 
oil (0.016 g, 23%). 
- (114) 
1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 8.4 Hz, 1H, ArH), 7.07 (d, J = 2.4 Hz, 1H, ArH), 
7.01 (dd, J = 8.4, 2.4 Hz, 1H, ArH), 3.88 (s, 3H, OCH3), 3.38 – 3.27 (m, 1H, CH), 2.03 – 
1.85 (m, 6H, CH2), 1.71 – 1.64 (m, 2H, CH2);
 13C NMR (100.6 MHz, CDCl3) δ 186.7, 
162.3, 140.9, 140.4, 125.2, 117.4, 115.0, 108.1, 56.3, 33.4, 29.2, 26.4; FTIR (film cm-
1)max:2959 (w), 1698 (s), 1616 (w), 1524 (m), 1485 (w), 1396 (m), 1358 (m), 1281 
(w), 1230 (w), 822 (w); HRMS (TOF MS ES+) m/z calculated for [C14H16NO3]
+: 
246.1138 [M+H]+, found 246.1138; M.p = 114 – 115 oC (CH2Cl2). 
- (115) 
1H NMR (400 MHz, CDCl3) δ 7.19 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.08 (d, J = 9.0 Hz, 1H, 
ArH), 7.00 (d, J = 2.5 Hz, 1H, ArH), 4.65 – 4.57 (m, 1H, CH1), 3.81 (s, 3H, OCH3), 2.61 – 
2.47 (m, 2H, CH1), 1.96 – 1.79 (m, 7H, CH2), 1.78 – 1.64 (m, 5H, CH2), 1.56 – 1.41 (m, 
9H, CH2), 1.32 – 1.17 (m, 3H, CH2); 
13C NMR (100.6 MHz, CDCl3) δ 202.2, 158.9, 
155.3, 126.7, 123.0, 115.2, 102.9, 86.5, 82.5, 55.9, 45.5, 32.0, 28.3, 26.5, 25.4, 25.2, 
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24.3; FTIR (film cm-1)max: 2954 (m), 2868 (w), 1698 (s), 1487 (s), 1437 (w), 1270 (m), 
1222 (w), 1028 (w), 822 (w); HRMS (TOF MS ES+) m/z calculated for [C24H34NO3]
+: 
384.2533 [M+H]+, found 384.2532. 
 
(99) 2-Cyclohexyl-5-methoxy-3-oxo-3H-indole 1-oxide & (100) 2,2-Dicyclohexyl-1-
(cyclohexyloxy)-5-methoxyindolin-3-one 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and Cy-HexCu(CN)ZnI (1.28 mL, 0.281 mmol, 
0.22 M THF), afforded a red amorphous solid which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether) 99 as an orange 
crystalline solid (0.035 g, 82%) and the by-product 100 as a bright yellow oil (0.016 
g, 23%).  
- (99) 
1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 8.5 Hz, 1H, ArH), 7.06 (d, J = 2.5 Hz, 1H, ArH), 
7.00 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 3.87 (s, 3H, OCH3), 3.07 – 2.95 (m, 1H, CH1), 1.94 – 
1.78 (m, 4H, CH2), 1.76 – 1.67 (m, 3H, CH2), 1.38 – 1.27 (m, 3H, CH2);
 13C NMR (100.6 
MHz, CDCl3) δ 186.80, 162.4, 141.1, 140.2, 125.0, 117.4, 115.1, 108.0, 56.3, 33.4, 
27.8, 26.2, 25.7; FTIR (film cm-1)max: 3048 (w), 2934 (m), 2856 (m), 1701 (s), 1616 
(m), 1522 (s), 1489 (s), 1398 (s), 1359 (s), 1284 (m), 1232 (m), 1014 (w), 822 (m), 
737 (m); HRMS (TOF MS ES+) m/z calculated for [C15H18NO3]
+: 260.1281 [M+H]+, 
found 260.1280; M.p = 109 – 110 oC (CH2Cl2). 
- (100) 
For characterisation data, see page 163. 
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(103) 2-Ethyl-3-oxo-3H-indole 1-oxide, (104) 1-ethoxy-2,2-diethylindolin-3-one & 
(64) isatin 
 
Using representative procedure 4, 2-iodo-3-oxo-3H-indole 1-oxide  (0.022 g, 0.082 
mmol) in THF (2.5 mL) and EtCu(CN)ZnI (0.31 mL, 0.139 mmol, 0.45 M THF), 
afforded an orange amorphous solid which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether - 1 : 1 ethyl 
acetate : petroleum ether) providing 103 as a yellow viscous oil (0.006 g, 42%) and 
the byproducts: 104 as a bright yellow oil (0.002 g, 10%) and 64 as an impure 
orange solid (0.004 g, ~33%) 
- (103) 
1H NMR (400 MHz, CDCl3) δ 7.69 – 7.47 (m, 4H, ArH), 2.70 (q, J = 7.5 Hz, 2H, CH2), 
1.23 (t, J = 7.5 Hz, 3H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 186.89, 147.59, 134.51, 
131.14, 123.30, 121.53, 113.92, 15.04, 9.85; FTIR (film cm-1)max: 2918 (m), 2852 
(w), 1699 (s), 1638 (s), 1453 (w), 1390 (m); HRMS (TOF MS ES+) m/z calculated for 
[C10H10NO2]
+: 176.0712 [M+H]+, found 176.0713. 
- (104) 
1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.0 Hz, 1H, ArH), 7.56 – 7.51 (m, 1H, ArH), 
7.18 (dt, J = 8.0, 1.0 Hz, 1H, ArH), 6.99 – 6.93 (m, 1H, ArH), 4.13 (q, J = 7.0 Hz, 2H, 
CH2), 1.93 (dq, J = 14.5, 7.5 Hz, 2H, CH2), 1.78 (dq, J = 14.5, 7.5 Hz, 2H, CH2), 1.38 (t, J 
= 7.0 Hz, 3H, CH3), 0.69 (t, J = 7.5 Hz, 6H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 201.4, 
162.9, 136.8, 123.2, 122.1, 121.4, 112.9, 79.7, 72.0, 29.3, 14.5, 8.8; FTIR (thin film 
cm-1)max: 2972 (s), 2936 (m), 1710 (s), 1608 (m), 1476 (w), 1455 (m), 1143 (w), 1047 
(m); HRMS (TOF MS ES+) m/z calculated for [C14H20NO2]
+: 223.1494 [M+H]+, found 
234.1485. 
- (64) 
For characterisation data, see page 148. 
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(105) 2-Ethyl-6-methyl-3-oxo-3H-indole 1-oxide, (106) 1-Ethoxy-2,2-diethyl-6-
methylindolin-3-one & (107) 6-Methylisatin 
 
Using representative procedure 4, 2-iodo-6-methyl-3-oxo-3H-indole 1-oxide (0.024 
g, 0.082 mmol) in THF (2.5 mL) and EtCu(CN)ZnI (0.31 mL, 0.139 mmol, 0.45 M THF), 
afforded an orange amorphous solid which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether - 1 : 1 ethyl 
acetate : petroleum ether) providing 105 as a yellow viscous oil (0.006 g, 39%) and 
the byproducts: 106 as a bright yellow oil (0.002 g, 10%) and 107 as an impure 
orange solid (0.004 g, ~30%) 
- (105) 
1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 7.5 Hz, 1H, ArH), 7.42 (s, 1H, ArH), 7.28 (d, J 
= 7.5 Hz, 1H, ArH), 2.68 (q, J = 7.5 Hz, 2H, CH2), 2.49 (s, 3H, CH3), 1.22 (t, J = 7.5 Hz, 
3H, CH3); 
13C NMR (100.6 MHz, CDCl3) δ 186.6, 148.1, 146.3, 140.43, 131.11, 121.5, 
120.8, 114.8, 29.8, 15.0, 9.8; FTIR (film cm-1)max: 2979 (m), 2921 (m), 2852 (w), 
1710 (s), 1644 (m), 1546 (s), 1387 (m), 1364 (m), 884 (m); HRMS (TOF MS ES+) m/z 
calculated for [C11H12NO2]
+: 190.0863 [M+H]+, found 190.0864. 
- (106) 
1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.0 Hz, 1H, ArH), 6.97 (s, 1H, ArH), 6.78 (d, J 
= 8.0 Hz, 1H, ArH), 4.12 (q, J = 7.0 Hz, 2H, CH2), 2.41 (s, 3H, CH3), 1.91 (dq, J = 14.5, 
7.5 Hz, 2H, CH2), 1.77 (dq, J = 14.5, 7.5 Hz, 2H, CH2), 1.38 (t, J = 7.0 Hz, 3H, CH3), 0.68 
(t, J = 7.5 Hz, 6H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 200.7, 163.2, 148.4, 123.1, 
123.0, 120.0, 112.9, 79.9, 71.9, 29.3, 22.7, 14.5, 8.8. FTIR (thin film cm-1)max: 2970 
(m), 2936 (m), 1706 (s), 1613 (s), 1456 (w), 1286 (w), 1116 (w), 1046 (m); HRMS 
(TOF MS ES+) m/z calculated for [C15H22NO2]
+: 248.1651 [M+H]+, found 248.1653. 
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- (107)  
1H NMR (400 MHz, CDCl3) δ 8.34 (s, 1H, NH), 7.51 (d, J = 7.5 Hz, 1H, ArH), 6.93 (d, J = 
7.5 Hz, 1H, ArH), 6.75 (s, 1H, ArH), 2.42 (s, 3H, CH3).
138,5 
(119) 2-(But-3-en-1-yl)-5-methoxy-3-oxo-3H-indole 1-oxide 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and n-but-1-lyCu(CN)ZnI (1.00 mL, 0.281 
mmol, 0.54 M THF), afforded a red amorphous solid which was purified via flash 
column chromatography on silica gel (1:9 ethyl acetate : petroleum ether) providing 
the title compound as an orange crystalline solid (0.011 g, 29%) 
1H NMR (400 MHz, CDCl3) δ 7.49 (d, J = 8.5 Hz, 1H, ArH), 7.10 (d, J = 2.5 Hz, 1H, ArH), 
7.02 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 5.83 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH, alkene), 
5.07 (dd, J = 17.0, 1.5 Hz, 1H, CH, alkene), 4.99 (dd, J = 10.0, 1.5 Hz, 1H, CH, alkene), 
3.89 (s, 3H, OCH3), 2.75 (t, J = 7.5 Hz, 2H, CH2), 2.48 – 2.40 (m, 2H, CH2);
 13C NMR 
(100.6 MHz, CDCl3) δ 186.7, 162.4, 140.4, 138.1, 136.7, 125.1, 117.4, 116.1, 115.1, 
108.3, 56.3, 29.5, 21.0.; FTIR (film cm-1)max: 3080 (w), 2967 (m), 2921 (m), 1699 (s), 
1641 (s), 1531 (m), 1482(s), 1384 (s), 1280 (s), 1020 (w), 827 (m); HRMS (TOF MS 
ES+) m/z calculated for [C13H14NO3]
+: 232.0968 [M+H]+, found 232.0966; M.p = (48 - 
50 oC) (CH2Cl2). 
 
 
 
 
 
 
                                                          
5
 Suitable 
13
C NMR not obtained, 
1
H NMR consistent with literature.  
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(120) 2-(4-Ethoxy-4-oxobutyl)-5-methoxy-3-oxo-3H-indole 1-oxide &  (121) Diethyl 
4,4'-(1-(4-ethoxy-4-oxobutoxy)-5-methoxy-3-oxoindoline-2,2-diyl)dibutanoate 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and C(O)OEt(CH2)3Cu(CN)ZnI (0.91 mL, 0.281 
mmol, 0.31 M THF), afforded a red amorphous solid which was purified via flash 
column chromatography on silica gel (15:85 ethyl acetate : petroleum ether) 
providing 120 as an orange crystalline solid (0.024 g, 50%) and the by-product 121 
as a bright yellow oil (0.013 g, 15%). 
- (120) 
1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.5 Hz, 1H, ArH), 7.09 (d, J = 2.5 Hz, 1H, ArH), 
7.01 (dd, J = 8.5, 2.5 Hz, 1H, ArH), 4.10 (q, J = 7.0 Hz, 2H, OCH2), 3.87 (s, 3H OCH3), 
2.68 (t, J = 7.5 Hz, 2H, CH2), 2.36 (t, J = 7.5 Hz, 2H, CH2), 1.99 (p, J = 7.5 Hz, 2H, CH2), 
1.23 (t, J = 7.0 Hz, 3H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 186.6, 172.9, 162.5, 
140.3, 137.9, 125.1, 117.4, 115.1, 108.4, 60.6, 56.3, 34.0, 21.1, 20.9, 14.3; FTIR (film 
cm-1)max: 2973 (m), 2910 (m), 2857 (w), 1711 (s), 1702 (s), 1529 (s), 1488 (m), 1439 
(m), 1320 (w); HRMS (TOF MS ES+) m/z calculated for [C15H18NO5]
+: 292.1179 
[M+H]+, found 292.1179; M.p = 79 – 80 oC (CH2Cl2). 
- (121) 
1H NMR (400 MHz, CDCl3) δ 7.22 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.15 (d, J = 9.0 Hz, 1H, 
ArH), 7.02 (d, J = 2.5 Hz, 1H, ArH), 4.21 – 4.12 (m, 4H, CH2), 4.11 – 4.03 (m, 4H, CH2), 
3.80 (s, 3H, OCH3), 2.52 (t, J = 7.5 Hz, 2H, CH2), 2.26 – 2.16 (m, 4H, CH2), 2.12 – 2.04 
(m, 2H, CH2), 1.96 – 1.84 (m, 2H, CH2), 1.82 – 1.69 (m, 2H, CH2), 1.34 – 1.15 (m, 14H, 
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CH2/CH3);
13C NMR (100.6 MHz, CDCl3) δ 200.5, 173.3, 157.8, 155.8, 127.2, 122.5, 
115.3, 103.5, 78.9, 75.5, 60.6, 60.4, 55.9, 53.6, 35.9, 34.4, 31.1, 29.8, 24.5, 19.7, 
14.3; FTIR (film cm-1)max: 2970 (w), 2918 (m), 1732 (s), 1489 (s), 1439 (m), 1271 (m), 
1182 (m), 1027 (m), 912 (m); HRMS (TOF MS ES+) m/z calculated for [C27H40NO9]
+: 
522.2698 [M+H]+, found 522.2699. 
(108) ±9-Methoxy-2,3,3a,4-tetrahydrocyclopenta[3,4]isoxazolo[2,3-a]indol-
11(1H)-one, (109) 5-Methoxy-2,2-di(pent-4-en-1-yl)-1-(pent-4-en-1-yloxy)indolin-
3-one & (123) ± 2-(hydroxymethyl)-5'-methoxyspiro[cyclopentane-1,2'-indolin]-3'-
one 
 
Using representative procedure 4, 2-iodo-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.050 g, 0.165 mmol) in THF (5.0 mL) and n-pent-1-lyCu(CN)ZnI (0.80 mL, 0.281 
mmol, 0.35 M THF), afforded a brown oil which was purified via flash column 
chromatography on silica gel (1:9 ethyl acetate : petroleum ether) to (2:8 ethyl 
acetate : petroleum ether) providing the cyclo-adduct 108 as a bright yellow oil 
(0.025 g, 62%), the by-products: 109 as a bright yellow oil (0.009 g, 14%), and 123 as 
a bright yellow oil (0.008 g, 15%). 
- (108) 
1H NMR (400 MHz, CDCl3) δ 7.34 (d, J = 9.0 Hz, 1H, ArH), 7.26 (dd, J = 9.0, 2.5 Hz, 1H, 
ArH), 7.06 (d, J = 2.5 Hz, 1H, ArH), 3.82 (s, 3H, CH3), 3.79 (d, J = 9.0 Hz, 1H, OCH2), 
3.66 (dd, J = 9.0, 6.0 Hz, 1H, OCH2), 2.89 (dt, J = 9.0, 6.0 Hz, 1H, CH1), 2.32 – 2.22 (m, 
1H, CH2), 2.15 – 1.94 (m, 3H, CH2), 1.93 – 1.84 (m, 1H, CH2), 1.81 – 1.72 (m, 1H, CH2);
 
13C NMR (100.6 MHz, CDCl3) δ 200.9, 158.4, 156.2, 126.9, 126.8, 119.7, 103.8, 87.3, 
74.1, 55.9, 53.7, 35.4, 33.6, 27.8; FTIR (film cm-1)max: 2957 (m), 2867 (w), 1713 (s), 
1227 (w), 1486 (s), 1438 (m), 1341 (m), 1278 (m), 1444 (w), 1026 (m); HRMS (TOF 
MS ES+) m/z calculated for [C14H16NO3]
+: 246.1130 [M+H]+, found 246.1142. 
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- (109) 
1H NMR (400 MHz, CDCl3) δ 7.20 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.13 (d, J = 9.0 Hz, 1H, 
ArH), 7.01 (d, J = 2.5 Hz, 1H, ArH), 5.86 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH alkene), 
5.69 (ddt, J = 17.0, 10.0, 6.5 Hz, 2H, CH alkene), 5.09 (dd, J = 17.0, 3.5 Hz, 1H, CH 
alkene), 5.03 (dd, J = 10.0, 3.5 Hz, 1H, CH alkene), 4.93 (dd, J = 17.0, 3.5 Hz, 2H, CH 
alkene), 4.90 (dd, J = 10.0, 3.5 Hz, 4H, CH alkene), 4.07 (t, J = 6.5 Hz, 2H, OCH2), 3.79 
(s, J = 4.2 Hz, 3H, OCH3), 2.24 (q, J = 6.5 Hz, 2H, CH2), 2.00 – 1.90 (m, 4H, CH2), 1.90 – 
1.80 (m, 4H, CH2), 1.80 – 1.69 (m, 2H, CH2), 1.38 – 1.24 (m, 2H, CH2), 1.09 – 0.95 (m, 
2H, CH2); 
13C NMR (100.6 MHz, CDCl3) δ 201.4, 158.1, 155.6, 138.5, 137.9, 127. 2, 
122.5, 115.4, 115. 4, 114.9, 103.4, 79.4, 75.9, 55.9, 36.3, 34. 3, 30.5, 28.2, 23.5; FTIR 
(film cm-1)max: 3076 (w), 2938 (m), 2869 (m), 1706 (s), 1641 (w), 1488 (s) 1438 (m), 
1230 (m), 1269 (m), 1230 (m), 1144 (w), 1028 (m), 912 (m), 825 (w); HRMS (TOF MS 
ES+) m/z calculated for [C24H34NO3]
+: 384.2533 [M+H]+, found 384.2529. 
- (123) 
1H NMR (400 MHz, CDCl3) δ 7.16 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.08 (d, J = 2.5 Hz, 1H, 
ArH), 6.90 (d, J = 9.0 Hz, 1H, ArH), 4.50 (s, 1H, NH), 3.79 (s, 3H, OCH3), 3.59 (d, J = 4.9 
Hz, 2H, OCH2), 3.49 (s, 1H, OH), 2.62 – 2.50 (m, 1H, CH), 2.23 – 2.13 (m, 1H, CH), 
2.08 – 1.96 (m, 2H, CH), 1.91 – 1.82 (m, 1H, CH), 1.81 – 1.73 (m, 1H, CH), 1.74 – 1.63 
(m, 1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 205.1, 156.0, 154.2, 127.5, 122.5, 115.0, 
104.7, 62.5, 55.9, 50.4, 39.5, 29.8, 27.4, 23.7; FTIR (film cm-1)max: 3328 (br), 2946 
(w), 1669 (m), 1497 (s), 1439 (w), 1274 (m), 1226 (m), 1028 (m), 787 (w); HRMS 
(TOF MS ES+) m/z calculated for [C14H18NO3]
+: 248.1281 [M+H]+, found 248.1283. 
 
 
 
 
 
 
 
Page | 178  
 
(125) ±2,3,3a,4-Tetrahydrocyclopenta[3,4]isoxazolo[2,3-a]indol-11(1H)-one 
 
Using representative procedure 4, 2-iodo-3-oxo-3H-indole 1-oxide (0.027 g, 0.099 
mmol) in THF (3.0 mL) and n-pent-1-lyCu(CN)ZnI (0.53 mL, 0.168 mmol, 0.32 M 
THF), afforded a brown oil which was purified via flash column chromatography on 
silica gel (1:9 ethyl acetate : petroleum ether) to (2:8 ethyl acetate : petroleum 
ether) providing the cyclo-adduct compound as a light yellow oil (0.011 g, 52%). 
1H NMR (400 MHz, CDCl3) δ 7.69 – 7.61 (m, 2H, ArH), 7.41 (dt, J = 8.0, 1.0 Hz, 1H, 
ArH), 7.25 (td, J = 8.0, 1.0 Hz, 1H, ArH), 3.80 (d, J = 9.0 Hz, 1H, OCH2), 3.67 (dd, J = 
9.0, 6.0 Hz, 1H OCH2), 2.90 (dt, J = 9.0, 6.0 Hz, 1H, CH1), 2.33 – 2.23 (m, 1H, CH2), 
2.15 – 1.96 (m, 3H, CH2), 1.94 – 1.85 (m, 1H, CH2), 1.82 – 1.71 (m, 1H, CH2);
 13C NMR 
(100.6 MHz, CDCl3) δ 200.9, 162.0, 137.0, 126.0, 125.7, 123.6, 118.2, 86.4, 74.7, 
53.6, 35.4, 33.7, 27.8; FTIR (film cm-1)max: 2953 (m), 2866 (w), 1716 (s), 1607 (s), 
1477 (m), 1456 (m), 1326 (w), 1294 (m), 1191 (w), 1150 (w); HRMS (TOF MS ES+) 
m/z calculated for [C13H14NO2]
+: 216.1019 [M+H]+, found 216.1017.  
 
(110) 2,2-Diethyl-5-methoxyindolin-3-one 
 
To a solution of 1-ethoxy-2,2-diethyl-5-methoxyindolin-3-one (0.020 g, 0.076 mmol) 
in MeOH (2.0 mL) was added 10% palladium on carbon (0.008 g). The reaction 
mixture was stirred under a hydrogen atmosphere for 4 hours then filtered through 
Celite and washed with MeOH and concentrated in vacuo to afford a yellow oil 
which was purified by flash column chromatography on silica gel (1:9 ethyl acetate : 
petroleum ether) providing the title compound as a yellow oil (0.013 g, 77 %). 
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1H NMR (400 MHz, CDCl3) δ 7.13 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.01 (d, J = 2.5 Hz, 1H, 
ArH), 6.84 (d, J = 9.0 Hz, 1H, ArH), 4.21 (s, 1H, NH), 3.77 (s, 3H, CH3), 1.78 (dq, J = 
15.0, 7.5 Hz, 2H, CH2), 1.65 (dq, J = 15.0, 7.5 Hz, 3H, CH2), 0.77 (t, J = 7.5 Hz, 6H, 
CH3);
 13C NMR (100.6 MHz, CDCl3) δ 205.7, 157.1, 153.2, 127.8, 122.3, 113.8, 104.2, 
72.0, 55.9, 30.2, 7.9; FTIR (thin film cm-1)max: 3339 (w, br), 2966 (w), 2929 (w), 1672 
(m), 1497 (s), 1457 (w), 1262 (w), 1142 (w), 1031 (w), 789 (m), 668 (w); HRMS (TOF 
MS ES+) m/z calculated for [C13H18NO2]
+: 220.1338 [M+H]+, found 220.1328. 
 
(116) 4-Iodobut-1-ene139 
 
To a solution of 4-bromobut-1-ene (3.00 g, 22.2 mmol) in acetone (50.0 mL) was 
added NaI (6.66 g, 44.4 mmol), and then heated at 60 oC for 2 hours. The mixture 
was cooled to room temperature and filtered, after which it was extracted with 
pentane (50.0mL) and washed with saturated Na2S2O3(aq)(20.0 mL) followed by brine 
(30.0 mL). The organic extract was dried with MgSO4, filtered and then 
concentrated in vacuo at 0 oC to afford the title compound as a clear oil (3.30 g, 
81%). 
1H NMR (400 MHz, CDCl3) δ 5.82 – 5.69 (m, 1H, CH alkene), 5.15 – 5.13 (m, 1H, CH 
alkene), 5.13 – 5.08 (m, 1H, CH alkene), 3.18 (t, J = 7.2 Hz, 2H, CH2), 2.62 (app q, J = 
7.0 Hz, 2H, CH2); 
13C NMR (100.6 MHz, CDCl3) δ 137.0, 117.1, 37.8, 4.8.
140 
 
(117) Ethyl 4-iodobutanoate139 
 
To a solution of ethyl 4-bromobutanoate (3.90 g, 20.0 mmol) in acetone (50.0 mL) 
was added NaI (6.00 g, 40.0 mmol), and then heated at 60 oC for 2 hours. The 
mixture was cooled to room temperature and filtered, after which it was extracted 
with pentane (50.0mL) and washed with saturated Na2S2O3(aq)(20.0 mL) followed by 
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brine (30.0 mL). The organic extract was dried with MgSO4, filtered and then 
concentrated in vacuo at 0 oC to afford the title compound as a clear oil (4.76 g, 
98%). 
1H NMR (400 MHz, CDCl3) δ 4.15 (q, J = 7.0 Hz, 2H, OCH2), 3.25 (t, J = 7.0 Hz, 1H, 
CH2), 2.45 (t, J = 7.0 Hz, 1H, CH2), 2.20 – 2.08 (m, 2H, CH2), 1.27 (t, J = 7.0 Hz, 2H, 
CH3);
 13C NMR (100.6 MHz, CDCl3) δ 172.5, 60.7, 34.9, 28.6, 14.4, 5.7.
141 
 
(118) 2-(3-Iodopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane139 
 
To a solution of 2-(3-bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.50 g, 
10.0 mmol) in acetone (20.0 mL) was added NaI (3.01 g, 20.1 mmol), and then 
heated at 60 oC for 2 hours. The mixture was cooled to room temperature and 
filtered, after which it was extracted with pentane (25.0mL) and washed with 
saturated Na2S2O3(aq)(10.0 mL) followed by brine (15.0 mL). The organic extract was 
dried with MgSO4, filtered and then concentrated in vacuo at 0 
oC to afford the title 
compound as a clear oil (2.88 g, 92%). 
1H NMR (400 MHz, CDCl3) δ 3.19 (t, J = 7.0 Hz, 2H, CH2), 1.91 (app quint, J = 7.0 Hz, 
1H, CH2), 1.22 (s, 12H, CH3), 0.86 (t, J = 7.0 Hz, 2H, CH2); 
13C NMR (100.6 MHz, CDCl3) 
δ 83.3, 34.2, 28.4, 24.9, 10.1;111 11B NMR (128 MHz, CDCl3) δ 33.59. 
 
(122) 5-Iodopent-1-ene139 
 
To a solution of 5-bromopent-1-ene (2.50 g, 16.8 mmol) in acetone (30.0 mL) was 
added NaI (5.02 g, 33.6 mmol), and then heated at 60 oC for 2 hours. The mixture 
was cooled to room temperature and filtered, after which it was extracted with 
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pentane (50.0mL) and washed with saturated Na2S2O3(aq)(20.0 mL) followed by brine 
(30.0 mL). The organic extract was dried with MgSO4, filtered and then 
concentrated in vacuo at 0 oC to afford the title compound as a clear oil (2.75 g, 
84%). 
1H NMR (400 MHz, CDCl3) δ 5.77 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, CH, alkene), 5.09 
(dd, J = 17.0, 2.0 Hz, 1H, CH, alkene), 5.03 (dd, J = 10.0, 2.0 Hz, 1H, CH, alkene), 3.20 
(t, J = 7.0 Hz, 2H, CH2), 2.18 (app q, J = 7.0Hz, 2H, CH2), 1.93 (app quint, J = 7.0 Hz, 
2H, CH2); 
13C NMR (100.6 MHz, CDCl3) δ 136.5, 116.0, 34.3, 32.5, 6.4.
142 
 
4.5 – Representative Procedure: 5 
(126) 1-Ethoxy-2-ethyl-2-phenylindolin-3-one: 
 
A flame dried flask equipped with magnetic stirrer bar was charged with 2-iodo-3-
oxo-3H-indole 1-oxide (0.50 g, 0.244 mmol) in anhydrous THF (5.0 mL) at 20 oC. 
EtZnI (0.81 mL, 0.672 mmol, 0.81 M THF) was added dropwise, the resultant 
reaction mixture was stirred under nitrogen for 3 hours. The reaction mixture was 
quenched with H2O (1.8 mL), extracted with ethyl acetate (10.0 mL) and washed 
with brine (5.0 mL). The organic layer was dried over MgSO4, filtered and then 
concentrated in vacuo to give a viscous orange oil, which was purified by flash 
column chromatography on silica gel (5:95 ethyl acetate : petroleum ether) 
providing the title compound as a  bright yellow oil (0.038 g, 60 %). 
1H NMR (400 MHz, CDCl3) δ 7.56 – 7.50 (m, 2H, ArH), 7.38 – 7.34 (m, 2H, ArH), 7.27 
– 7.16 (m, 4H, ArH), 6.97 – 6.92 (m, 1H, ArH), 3.96 – 3.82 (m, 2H, CH2), 2.49 (dq, J = 
14.5, 7.0 Hz, 1H, CH2), 2.23 (dq, J = 14.5, 7.5 Hz, 1H, CH2), 1.17 (t, J = 7.0 Hz, 3H, 
CH3), 0.72 (t, J = 7.5 Hz, 3H, CH2); 
13C NMR (100.6 MHz, CDCl3) δ 199.6, 162.7, 139.5, 
137.2, 128.5, 127.8, 127.2, 124.0, 121.9, 120.9, 112.8, 80.1, 71.7, 27.39, 14.3, 9.4; 
FTIR (thin film cm-1)max: 2974 (w), 1714 (s), 1607 (s), 1475 (m), 1457 (m), 1457 (m), 
1381 (w), 1322 (w), 1044 (m), 1756 (m); HRMS (TOF MS ES+) m/z calculated for 
[C18H20NO2]
+: 282.1494 [M+H]+, found 282.1497 
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(127) 2-Hexyl-1-(hexyloxy)-2-phenylindolin-3-one 
 
Using representative procedure 5, 3-oxo-2-phenyl-3H-indole 1-oxide  (0.050 g, 
0.224 mmol) in THF (5.0 mL) and n-HexZnI (0.81 mL, 0.672 mmol 0.83 M THF), 
afforded a viscous orange oil, which was purified by flash column chromatography 
on silica gel (5:95 diethyl ether : petroleum ether - 1:9 ethyl acetate : petroleum 
ether) providing the title compound as a yellow oil, (0.054 g, 61 %). 
1H NMR (400 MHz, CDCl3) δ 7.60 – 7.54 (m, 2H, ArH), 7.43 – 7.39 (m, 2H, ArH), 7.31 
– 7.19 (m, 4H, ArH), 3.98 – 3.79 (m, 2H, OCH2), 2.51 – 2.39 (m, 2H, CH2), 2.26 – 2.15 
(m, 1H, CH2), 1.63 – 1.54 (m, 1H, CH2), 1.32 – 1.16 (m, 14H, CH2), 0.85 (t, J = 7.0 Hz, 
3H, CH3), 0.80 (t, J = 7.0 Hz, 3H, CH3); 
 13C NMR (100.6 MHz, CDCl3) δ 199.7, 162.5, 
139.6, 137.2, 128.4, 128.4, 127.8, 127.2, 124.1, 121.9, 120.8, 112.8, 79.7, 76.4, 34.5, 
31.7, 31.6, 29.8, 28.8, 25.8, 24.4, 22.7, 22.7, 14.1; FTIR (thin film cm-1)max: 2955 
(m), 2929 (s),2857 (m), 1716 (s), 1607 (m), 1474 (m), 1458 (w), 1305 (w), 1037 (w), 
756 (m); HRMS (TOF MS ES+) m/z calculated for [C26H36NO2]
+: 394.2746 [M+H]+, 
found 394.2763. 
(128) 2-Hexyl-2-phenylindolin-3-one 
 
To a solution of 2-hexyl-1-(hexyloxy)-2-phenylindolin-3-one  (0.060 g, 0.153 mmol) 
in MeOH (4.0 mL) was added 10% palladium on carbon (0.015 g). The reaction 
mixture was stirred under a hydrogen atmosphere for 6 hours then filtered through 
Celite and washed with MeOH and concentrated in vacuo to afford a yellow oil 
which was purified by flash column chromatography on silica gel (1:9 ethyl acetate : 
petroleum ether) providing the title compound as a yellow solid (0.028 g, 62 %). 
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1H NMR (400 MHz, CDCl3) δ 7.59 – 7.53 (m, 3H, ArH), 7.47 (t, J = 7.5 Hz, 1H, ArH), 
7.36 – 7.30 (m, 2H, ArH), 7.28 – 7.23 (m, 1H, ArH), 6.96 (d, J = 8.0 Hz, 1H, ArH), 6.81 
(t, J = 7.5 Hz, 1H, ArH), 5.03 (s, 1H, NH), 2.19 – 2.02 (m, 2H, CH2), 1.34 – 1.14 (m, 8H, 
CH2), 0.83 (t, J = 7.0 Hz, 1H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 202.0, 160.5, 139.4, 
137.4, 128.8, 127.6, 125.8, 125.5, 119.9, 119.1, 112.0, 72.1, 38.5, 31.7, 29.6, 24.1, 
22.7, 14.2; FTIR (film cm-1)max: 3351 (w br), 2957 (m), 2930 (m), 2856 (m), 1683 (s), 
1621 (s), 1492 (m), 1468 (m), 1325 (m), 1294 (w), 751 (w); HRMS (TOF MS ES+) m/z 
calculated for [C20H24NO]
+: 294.1852 [M+H]+, found 294.1851; M.p = 67 – 69 oC 
(CH2Cl2). 
 
(95) 1-Ethoxy-2-ethyl-2-phenylindolin-3-one: 
 
Using representative procedure 5, 3-oxo-2-phenyl-3H-indole 1-oxide (0.022 g, 0.100 
mmol) in THF (3.0 mL) and Et2Zn (0.25 mL, 0.150 mmol, 0.60 M THF), afforded a 
viscous orange oil, which was purified by flash column chromatography on silica gel 
(5:95 diethyl ether : petroleum ether - 1:9 ethyl acetate : petroleum ether) 
providing the title compound as a yellow oil, (0.017 g, 61 %). 
For characterisation data, see page 181. 
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(104) 1-Ethoxy-2,2-diethylindolin-3-one 
 
Using representative procedure 5, 2-iodo-3-oxo-3H-indole 1-oxide  (0.045 g, 0.165 
mmol) in THF (5.0 mL) and Et2Zn (0.50 mL, 0.495 mmol, 1.00 M THF), afforded a 
viscous orange oil, which was purified by flash column chromatography on silica gel 
(5:95 ethyl acetate : petroleum ether) providing the title compound as a yellow oil, 
(0.024 g, 60 %). 
For characterisation data, see page 172. 
(106) 1-Ethoxy-2,2-diethyl-6-methylindolin-3-one 
 
Using representative procedure 5, 2-iodo-6-methyl-3-oxo-3H-indole 1-oxide (0.047 
g, 0.165 mmol) in THF (5.0 mL) and Et2Zn (0.50 mL, 0.495 mmol, 1.00 M THF), 
afforded a viscous orange oil, which was purified by flash column chromatography 
on silica gel (5:95 ethyl acetate : petroleum ether) providing the title compound as a 
yellow oil, (0.026 g, 61 %). 
For characterisation data, see page 173. 
 
(136) 2-Cyclohexyl-1-ethoxy-2-ethyl-5-methoxyindolin-3-one 
 
Using representative procedure 5, 2-cyclohexyl-5-methoxy-3-oxo-3H-indole 1-oxide 
(0.015 g, 0.059 mmol) in THF (1.75 mL) and Et2Zn (0.30 mL, 0.178 mmol, 0.60 M 
THF), afforded a viscous orange oil, which was purified by flash column 
chromatography on silica gel (5:95 ethyl acetate : petroleum ether) providing the 
title compound as a bright yellow oil, (0.016 g, 85 %). 
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1H NMR (400 MHz, CDCl3) δ 7.18 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.11 (d, J = 9.0 Hz, 1H, 
ArH), 7.00 (d, J = 2.5 Hz, 1H, ArH), 4.14 (q, J = 7.0 Hz, 2H, OCH2), 3.79 (s, 3H, CH3), 
2.01 (dq, J = 14.5, 7.5 Hz, 1H, CH2), 1.96 – 1.86 (m, 1H, CH1), 1.79 (dq, J = 14.5, 7.5 
Hz, 1H, CH2), 1.70 – 1.65 (Hz, 3H, CH2), 1.36 (t, J = 7.0 Hz, 3H, CH3), 1.29 – 1.15 (m, 
3H, CH2), 1.14 – 1.00 (m, 2H, CH2), 0.95 – 0.78 (m, 2H, CH2), 0.68 (t, J = 7.5 Hz, 3H, 
CH3);
 13C NMR (100.6 MHz, CDCl3) δ 202.1, 158.8, 155.3, 126.8, 122.9, 114.5, 103.1, 
82.5, 71.7, 55.9, 43.9, 28.4, 27.0, 26.7, 26.6, 14.4, 8.9; FTIR (thin film cm-1)max: 2930 
(s), 2852 (m), 1705 (s), 1488 (s), 1439 (m), 1277 (m), 1225 (m), 1147 (w), 1032 (m); 
HRMS (TOF MS ES+) m/z calculated for [C19H28NO3]
+: 318.2064 [M+H]+, found 
318.2062. 
 
(137) 1-Ethoxy-2-ethyl-5-methoxy-2-methylindolin-3-one 
 
Using representative procedure 5, 5-methoxy-2-methyl-3-oxo-3H-indole 1-oxide 
(0.020 g, 0.105 mmol) in THF (3.0 mL) and Et2Zn (0.26 mL, 0.158 mmol, 0.60 M THF), 
afforded a viscous orange oil, which was purified by flash column chromatography 
on silica gel (5:95 ethyl acetate : petroleum ether) providing the title compound as a 
bright yellow oil, (0.016 g, 61 %). 
1H NMR (400 MHz, CDCl3) δ 7.21 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 7.16 (d, J = 9.0 Hz, 1H, 
ArH), 7.04 (d, J = 2.5 Hz, 1H, ArH), 4.18 – 4.06 (m, 2H, OCH2), 3.79 (s, 3H, CH3), 1.96 
(dq, J = 14.5, 7.5 Hz, 1H, CH2), 1.77 (dq, J = 14.5, 7.5 Hz, 1H, CH2), 1.36 (t, J = 7.0 Hz, 
3H, CH3), 0.76 (t, J = 7.5 Hz, 3H, CH3);
 13C NMR (100.6 MHz, CDCl3) δ 201.9, 157.6, 
155.8, 126.8, 121.9, 116.0, 103.8, 77.0, 71.9, 55.9, 29.7, 21.8, 14.5, 8.9; FTIR (thin 
film cm-1)max: 2976 (s), 2932 (s), 2881 (m), 2837 (w), 1711 (s), 1618 (w), 1491 (s), 
1442 (m), 1341 (m), 1277 (m), 1147 (m), 1046 (m), 1031 (m); HRMS (TOF MS ES+) 
m/z calculated for [C14H20NO3]
+: 250.1438 [M+H]+, found 250.1435. 
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(126) 1-Ethoxy-2-ethyl-2-phenylindolin-3-one 
 
A flame dried flask equipped with magnetic stirrer bar was charged with 1-ethoxy-2-
ethyl-2-phenylindolin-3-one (0.027 g, 0.096 mmol) in anhydrous THF (3.0 mL) at 20 
oC. EtZnI (0.23 mL, 0.192 mmol, 0.83 M THF) was added dropwise, and the resultant 
reaction mixture was stirred under nitrogen for 3 hours. The reaction mixture was 
quenched with H2O (2.0 mL), extracted with ethyl acetate (10.0 mL) and washed 
with brine (5.0 mL). The organic layer was dried over MgSO4, filtered and then 
concentrated in vacuo to give a viscous orange oil, which was purified by flash 
column chromatography on silica gel (5:95 ethyl acetate : petroleum ether) 
providing a significant amount of apparent Iodine and also the title compound as a  
bright yellow oil (0.023 g, 82 %). 
For characterisation data, see page 181 
 
(95) 1-Ethoxy-2,2-diethyl-5-methoxyindolin-3-one 
 
A flame dried flask equipped with magnetic stirrer bar was charged with 1-ethoxy-
2,2-diethyl-5-methoxyindolin-3-one (0.017 g, 0.130 mmol) in anhydrous THF (2.0 
mL) at 20 oC. EtZnI (0.16 mL, 0.130 mmol, 0.83 M THF) was added dropwise, and the 
resultant reaction mixture was stirred under nitrogen for 3 hours. The reaction 
mixture was quenched with H2O (2.0 mL), extracted with ethyl acetate (10.0 mL) 
and washed with brine (5.0 mL). The organic layer was dried over MgSO4, filtered 
and then concentrated in vacuo to give a viscous orange oil, which was purified by 
flash column chromatography on silica gel (5:95 ethyl acetate : petroleum ether) 
providing a significant amount of apparent Iodine and also the title compound as a  
bright yellow oil (0.014 g, 82 %). 
For characterisation data, see page 161 
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4.6 – General procedure: 1 (Preparation of Alkylzinc Halides)91 
A flame dried flask, equipped with magnetic stirrer bar and reflux condenser, was 
charged with a dispersion of zinc dust (26.00 mmol) in THF (2.00 mL) and flushed 
with nitrogen. 1,2-dibromoethane (0.10 mL) was added and the reaction mixture 
was heated to reflux with a heat gun, this process was repeated a further two 
times. After which the reaction mixture was cooled to room temperature and 
TMSCl (0.10 mL) was added slowly followed by 10 minutes of vigorous stirring. 
Primary alkyl iodide (26.00 mmol) was then added as a solution of THF (10.0 mmol), 
the resultant reaction mixture was stirred vigorously and heated at 50 oC for 18 
hours. The molarity of the newly afforded alkylzinc iodides was determined by 
iodometric titration in a 0.5 M solution of LiCl in THF.92 
 
General procedure: 2 (Preparation of Alkylzinc Halides) 98 
A flame dried flask, equipped with magnetic stirrer bar and reflux condenser, was 
charged with a dispersion of zinc dust (20.00 mmol) and dry LiCl (20.00 mmol) in 
THF (9.00 mL) and flushed with nitrogen. 1,2-dibromoethane (0.10 mL) was added 
and the reaction mixture was heated to reflux with a heat gun, this process was 
repeated a further two times. After which the reaction mixture was cooled to room 
temperature and TMSCl (0.10 mL) was added slowly followed by 10 minutes of 
vigorous stirring. A solution of iodine (0.50 mmol) in THF (1.00 mL) was added and 
the reaction mixture was stirred until the resultant brown colour had dissipated, 
around 2 minutes. Alkyl iodide (10.00 mmol) was then added neat, the resultant 
reaction mixture was stirred vigorously and heated at 50 oC for 18 hours. The 
molarity of the newly afforded alkylzinc halides was determined by iodometric 
titration in a 0.5 M solution of LiCl in THF.92  
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Appendix. 
 nOe spectra of 95. 
 
 For X-Ray crystallographic data of compounds: 24, 28, 33, 36, 40, 46, 49, 70, 
& 100 - see attached CD-ROM 
 For raw data of figures 17 – 20, 22 – 23, 34 – 35 see attached CD-ROM  
